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Abstract 
Anorexia nervosa (AN) is characterised by self-induced weight loss, a fear of weight gain, 
and a disturbance in the perception of one’s body image. It can severely affect physical, 
social, and emotional development and is also one of the most serious and chronic illnesses 
to affect adolescents and young adults. There has been a shift from treating patients with 
AN in inpatient settings towards outpatient based treatments.  
While there is considerable evidence to support the effectiveness of adult day 
programs for treating individuals with eating disorders, the use of adolescent day programs 
is an emerging area. The first study reviewed the outcomes of day program attendance in 39 
adolescents with AN and the potential predictors of treatment outcome and drop-out. The 
results provide support for the effectiveness of day program treatment in adolescents, in 
terms of improving weight, core eating disorder cognitions and behaviours, and general 
psychosocial functioning. Findings also suggested the relevance of pre-treatment weight 
and patient age in impacting on outcome, and pre-treatment weight on completion rates.  
In contrast to the limited research around adolescent day programs, a growing 
evidence base suggests that Family Based Treatment (FBT) should be the first line 
outpatient treatment for adolescents with AN. The second study aimed to review the impact 
of length of treatment on rates of cognitive change and outcomes, and predictors of 
outcome and drop-out in a ‘real world’ sample of 45 adolescents with AN. The study found 
support for the notion that completion of all three phases of FBT regardless of the number 
of sessions, leads to weight restoration, return of menstruation, and improvements in core 
eating disorder cognitions and behaviours, and general psychosocial functioning. The study 
also suggested a role for expected body weight and severity of eating disordered cognitions 
on drop-out rates.  
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The third study aimed to investigate the effectiveness of FBT (n = 45) compared 
with a day program (n = 39) for adolescents with AN, given that a key deficiency in the 
research is that there have been no clinical trials comparing the effectiveness of FBT with 
day programs. The findings suggest differences between the two treatment modalities with 
lower drop-out rates from day program, but improved outcomes in FBT for weight, menses 
and core eating disorder cognitions and behaviours at completion.  
The final study aimed to provide a qualitative investigation into the family 
experience, including the sibling perspective, of having an adolescent with AN participate 
in both day program treatment and FBT as this has not been a focus of previous studies. 
The study was preliminary in nature and due to the small sample size it has been included 
in Appendix A. Three adolescents, their parents and siblings provided feedback regarding 
their experiences of participating in both treatment modalities. Their responses indicated 
that overall each family member considered both treatment modalities to be beneficial in 
unique and overlapping ways, with most reporting wanting a combination of both 
treatments.  
Overall the results from the four studies suggest that day program and FBT are 
effective treatments for adolescents with AN in terms of improving physical factors and 
eating disordered cognitions and behaviours, with a number of factors impacting on 
treatment outcome and drop-out. Families also found components of both treatments to be 
beneficial. Clinical implications of the findings and future research directions are discussed.  
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Chapter 1 
Introduction to Anorexia Nervosa 
Chapter Overview 
Eating disorders are serious psychiatric illnesses that can severely affect physical, 
social, and emotional development (Fisher, Hetrick, & Rushford, 2010: Hay et al., 2014). 
For many patients, they can become chronic and result in long periods of hospitalisation 
(Hay et al., 2014). It is common for those with an eating disorder not to seek professional 
treatment (Hudson, Hiripi, Pope, & Kessler, 2007), and past treatments have not been 
highly effective (Bulik, Berkman, Brownley, Sedway & Lohr, 2007). Anorexia nervosa 
(AN) in particular, is one of the most serious and chronic illnesses to affect adolescents and 
young adults (Beumont & Touyz, 2003; Herpertz-Dahlmann, Buhren, & Seitz, 2011). This 
chapter will provide an overview of AN, including subthreshold AN (where partial criteria 
for AN are met), discuss the diagnostic criteria for AN including changes in the latest 
revision of the Diagnostics and Statistical Manual of Mental Disorders (DSM-5; American 
Psychiatric Association [APA], 2013), and review the epidemiology and risk factors for 
AN. The chapter will conclude by providing a brief overview of the current program of 
research.  
Diagnostic Criteria for Anorexia Nervosa 
Prior to 2013, one of the most commonly used diagnostic tools for mental disorders 
was the DSM-IV-TR (APA, 2000) which referred to three main types of eating disorders 
including: anorexia nervosa (AN), bulimia nervosa (BN), and eating disorder not otherwise 
specified (EDNOS). While not as well known, EDNOS was the most commonly diagnosed 
eating disorder (Call, Walsh, & Attia, 2013; Eddy, Celio Doyle, Hoste, Herzog, & Le 
Grange, 2008), and included subthreshold AN where partial criteria for AN were met.  
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The DSM-IV-TR (APA, 2000) specified four diagnostic criteria that an individual 
must meet to be classified as suffering from AN, and which of these criteria did not need to 
be met to be diagnosed with EDNOS (see Table 1.1). The diagnostic criteria for AN 
include self-induced weight loss, a fear of weight gain or being ‘fat,’ some type of body 
image disturbance (e.g., a disturbance of the way in which one’s body or body parts are 
experienced), and amenorrhoea. Weight loss is usually achieved by extreme weight control 
behaviours such as restricted dietary intake, excessive exercise, self-induced vomiting, 
and/or diuretic and laxative abuse (APA, 2000). In addition to these core diagnostic criteria, 
many patients with AN exhibit traits such as perfectionism and obsessionality (Beumont, & 
Touyz, 2003; Hartmann, Thomas, Greenberg, Matheny, & Wilhelm, 2014).  
Critics of the DSM-IV criteria for eating disorders suggested that it relied too 
strongly on the diagnostic category of EDNOS (Murphy, Straebler, Cooper, & Fairburn, 
2010; Smink, van Hoeken, Oldehinkel, & Hoek, 2014). Despite its intention to comprise a 
residual category for those who did not fit into any other diagnostic category, studies on 
community samples of those with an eating disorder found that approximately 70-80% of 
participants were diagnosed with EDNOS (Le Grange, Swanson, Crow, & Merikangas, 
2012; Wade, Bergin, Tiggemann, Bulik, & Fairburn, 2006). Research has found that 
subclinical eating disorders, such as EDNOS, cause clinically significant distress and 
impairment, can be as debilitating as AN or BN, and involve serious health consequences 
(Eddy et al., 2010; Levine & Smolak, 2006; Murphy et al., 2010; Wade & O’Shea, 2014). 
Therefore, research needs to focus not only on presentations that meet criteria for AN, but 
also its subthreshold presentations.  
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Table 1.1 
DSM-IV-TR Diagnostic Criteria for Anorexia Nervosa (AN) and Eating Disorder not 
Otherwise Specified (EDNOS) (APA, 2000). 
Anorexia Nervosa (AN) 
 A. Refusal to maintain body weight at or above a minimally normal weight 
for age and height, for example, weight loss leading to maintenance of 
body weight less than 85% of that expected or failure to make expected 
weight gain during period of growth, leading to body weight less than 
85% of that expected.  
B. Intense fear of gaining weight or becoming fat, even though underweight.  
C. Disturbance in the way one's body weight or shape is experienced, undue 
influence of body weight or shape on self evaluation, or denial of the 
seriousness of the current low body weight.  
D. In postmenarcheal females, amenorrhoea, i.e., the absence of at least 3 
consecutive menstrual cycles. A woman having periods only while on 
hormone medication still qualifies as having amenorrhoea. 
Specify type: 
Restricting Type: During the current episode of Anorexia Nervosa, the person has 
not regularly engaged in binge-eating or purging behaviour (self-induced 
vomiting or misuse of laxatives, diuretics, or enemas).  
Binge Eating/Purging Type: During the current episode of Anorexia Nervosa, the 
person has regularly engaged in binge-eating or purging behaviour (i.e., self-
induced vomiting or misuse of laxatives, diuretics, or enemas).  
 
Eating Disorder Not Otherwise Specified (EDNOS) 
 This diagnosis is given when full criteria for Anorexia Nervosa (or Bulimia 
Nervosa) are not met. For Anorexia Nervosa this includes:  
1. For female patients, all of the criteria for Anorexia Nervosa are met except 
that the patient has regular menses.  
2. All of the criteria for Anorexia Nervosa are met except that, despite 
significant weight loss, the patient's current weight is in the normal range.  
 
Given these problems with the DSM-IV eating disorder diagnostic criteria, revisions 
were introduced with the DSM-5 (APA, 2013), including a number of revisions designed to 
improve the diagnostic classification of AN (see Table 1.2). Firstly, the DSM-5 criteria 
include the criterion of low weight, rather than specifying a single cut-off (previously less 
than 85% of expected body weight or a body mass index [BMI = kg/m
2
] of less than 17.5), 
which has the effect of increasing the number of individuals meeting criteria for AN in the 
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DSM-5, rather than EDNOS in the DSM-IV system (APA, 2013; Call et al., 2013). 
Secondly, there is an additional diagnosis of Atypical AN (APA, 2013), which reduces the 
focus on being underweight and highlights that an individual can have the behavioural and 
cognitive features of AN, whilst being in the healthy weight range.  
Another subtle but useful change in the criteria is related to a fear of weight gain. 
Rather than having to articulate a fear of weight gain or being ‘fat,’ as was the case in the 
DSM-IV, in the DSM-5 it is sufficient that the individual’s behaviour reflects a fear of 
weight gain. This is particularly useful in cases where there is a lack of insight into the 
disorder, or in children or younger adolescents who have difficulty verbalising their 
motivation for their restricted intake (APA, 2013; Call et al., 2013; Madden, Morris, 
Zurynski, Kohn, & Elliot, 2009).  
Finally, the DSM-5 has removed the criterion of amenorrhoea as a diagnostic 
indicator for AN because this criterion was not a significant indicator of eating disordered 
behaviour or cognitions. Women who meet all of the other criteria for AN, and menstruate 
regularly or irregularly do not differ clinically from those with AN who have amenorrhoea 
(Attia & Roberto, 2009; Pike, 1998). In addition, this criterion could not be applied to pre- 
and post-menarchal women, those taking oral contraceptives, and males. However, there is 
some research that amenorrhoea is important to consider as it is associated with worse 
outcomes and indicates problems with physical health including bone density (Howard, 
Evans, Quintero-Howard, Bowers, & Anderson, 1999; Le Grange, Doyle et al., 2012).  
As well as changing a number of the diagnostic criteria for AN, the DSM-5 includes 
a severity rating which ranges from mild to extreme. Clinicians are encouraged to track 
patient progress by giving severity ratings based on symptoms and degree of functional 
impairment (APA, 2013). However, these ratings have received criticism for relying too 
 16 
heavily on clinician judgement (Call et al., 2013).  
There are several advantages of the DSM-5 criteria for AN including the removal of 
the amenorrhoea criterion so that the diagnostic criteria are no longer female specific. With 
the emerging evidence that AN may be more common in males than previously thought, 
and that there is no difference in eating disordered symptoms between the sexes (Raevuori, 
Keski-Rahkonen, & Hoek, 2014), the more gender-neutral diagnostic criteria for AN are 
viewed as a positive step for the identification, diagnosis, and treatment of males with AN.  
A further advantage of the DSM-5 criteria is a decrease in the number of individuals 
being diagnosed with a residual eating disorder category. Research has found that the DSM-
5 classification has been successful in reducing the number of cases identified as 
unspecified or other eating disorders compared with the DSM-IV, which has led to 
increased clinical utility in diagnosis (Allen, Byrne, Oddy, & Crosby, 2013b; Call et al., 
2013). Other research has found that prevalence rates in adolescents are higher when using 
the DSM-5 compared with the DSM-IV criteria (Allen, Byrne, Oddy, & Crosby 2013a; 
Smink et al., 2014).  
Notwithstanding these improvements in the diagnostic criteria for AN, the DSM-5 
has received criticism for trying to classify AN, which is a complex illness with many 
symptom presentations, into a single entity. This criticism stems from the fact that the 
DSM-5 retained the DSM-IV method of specifying subtypes of restricting or binge 
eating/purging types. Others have argued that it is common for a person to move between 
subtypes (or change behaviours; Peat, Mitchell, Hoek, & Wonderlich, 2009), and that it is 
therefore difficult to classify patients into distinct categories, although the DSM-5 stipulates 
that the specified type is based on behaviours in the past three months (APA, 2013). Others 
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have argued against the DSM-5 classification entirely, believing that the diagnosis of AN 
should be based on characteristics which reflect the underlying mechanisms of the illness 
(Wildes, Forbush, & Markon, 2013). Thus, despite several improvements with recent 
revisions in the DSM classification of eating disorders, debate regarding the criteria 
continues and will inform future revisions. 
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Table 1.2 
DSM-5 Diagnostic Criteria for Anorexia Nervosa (AN) and Atypical Anorexia Nervosa 
(APA, 2013). 
Anorexia Nervosa (AN) 
 
   
 Restriction of energy intake relative to requirement, leading to a 
significantly low body weight in the context of age, sex, developmental 
trajectory, and physical health. Significantly low weight is defined as a 
weight that is less than minimally normal or, for children and adolescents, 
less than that minimally expected.  
  
 Intense fear of gaining weight or of becoming fat, or persistent behavior 
that interferes with weight gain, even though at a significantly 
low weight.  
  
 Disturbance in the way in which one's body weight or shape is 
experienced, undue influence of body weight or shape on self-evaluation, 
or persistent lack of recognition of the seriousness of the current low body 
weight.  
 
Specify type: 
Restricting Type: During the last 3 months, the individual has not engaged in 
recurrent episodes of binge-eating or purging behaviour (i.e., self-induced 
vomiting or misuse of laxatives, diuretics, or enemas). This subtype describes 
presentations in which weight loss is accomplished primarily through dieting, 
fasting, and/or excessive exercise. 
Binge Eating/Purging Type: During the last 3 months, the individual has engaged 
in recurrent episodes of binge-eating or purging behaviour (i.e., self-induced 
vomiting or misuse of laxatives, diuretics, or enemas).  
 
Specify if: 
In partial remission: After full criteria for Anorexia Nervosa were previously 
met, Criterion A (low body weight) has not been met for a sustained period, but 
either Criterion B (intense fear of gaining weight or becoming fat or behaviour 
that interferes with weight gain) or Criterion C (disturbances in self-perception of 
weight and shape) is still met.  
In full remission: After full criteria for Anorexia Nervosa were previously met, 
none of the criteria have been met for a sustained period of time.  
 
Specify current severity: The minimum level of severity is based, for adults, on 
current body mass index (BMI = kg/m
2
)  (mild: BMI >17, moderate: BMI 16-
16.99, severe: BMI 15-15.99, extreme: BMI <15), or, for children and 
adolescents on BMI percentile. The level of severity may be increased to reflect 
clinical symptoms, the degree of functional disability, and the need for 
supervision.  
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Other Specified Feeding or Eating Disorder (OSFED) 
 This category applies to presentations in which symptoms characteristics of a 
feeding or eating disorder that cause clinically significant distress or impairment 
in social, occupational, or other important areas of functioning predominate but 
do not meet the full criteria for any of the disorders in the feeding or eating 
disorder diagnostic class.  
 
For Anorexia Nervosa this includes:  
Atypical Anorexia Nervosa: All of the criteria for Anorexia Nervosa are meet, 
except that despite significant weight loss, the individual’s weight is within or 
above the normal range.  
 
 
Epidemiology of Anorexia Nervosa 
Eating disorders can develop at any age, but their typical onset is in adolescence or 
early adulthood (Hudson et al., 2007; Slane, Klump, McGue, & Iacono, 2014). It is 
currently estimated that eight in 100 000 people of all ages are diagnosed with an eating 
disorder each year, with an increased incidence in the 15-19 year old age group (Hoek, 
2006; Smink, van Hoeken, & Hoek, 2012). The 15-19 year old female age group accounts 
for around 40% of all cases (van Son, van Hoeken, Bartelds, van Furth, & Hoek, 2006). It 
is unclear if the increase in the adolescent age group is related to an increase in 
presentations or earlier diagnosis and treatment seeking. However, one study suggests that 
adolescents often experience AN for over two years prior to receiving a diagnosis and 
commencing treatment (Neubauer et al., 2014). Incidence rates of adolescent eating 
disorders in Australia may be even higher, with one study finding 21.8 females and 6 males 
from a sample of 1000 14-15 year olds had recently developed an eating disorder (Patton, 
Sezer, Coffey, Carlin, & Wolfe, 1999). Of particular concern is the fact that eating 
disorders are increasing in prevalence in younger adolescents, and with a younger age of 
onset, with children as young as 5 years old displaying AN behaviours (Gowers, & Bryant-
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Waugh, 2004; Madden et al., 2009; Slane et al., 2014). In Australia, the incidence of AN 
diagnosed in the 5-13 year old age group has been found to be 1.4 per 100 000 per person 
per year (Madden et al., 2009).  
As well as varying reported incidence rates of AN, estimates of the lifetime 
prevalence rates of AN vary. Problems with prevalence estimates arise because research is 
usually conducted through treatment sites and not all people who suffer from AN seek 
treatment (Hudson et al., 2007). Additional variability is due to the definition of AN, with 
studies investigating prevalence rates for AN including subclinical presentations reporting 
higher prevalence rates than those that rely on strict AN criteria. Lifetime prevalence rates 
for AN range from 0.9% to 2.4% for women and 0.3% for men (Hay, Girosi, & Mond, 
2015; Hoek & van Hoeken, 2003; Hudson et al., 2007; Patton et al., 1999; Wade, Bergin, 
Tiggerman, Bulik, & Fairburn, 2006). The lifetime prevalence of AN for male and female 
adolescents is estimated at 0.3% and 1.2%, respectively (Smink et al., 2014; Swanson, 
Crow, Le Grange, Swendsen, & Merikangas, 2011).  
It is clear that there is a gender differentiation of incidence and prevalence rates for 
AN. AN is more common in females, with the ratio rates estimated to be 1:10, however 
eating disorders are increasing in males (Hudson et al., 2007; Smink et al., 2012). It is 
suggested that AN in males may be more common than previously thought, due to being 
under detected in males as a result of factors such as the gender-specific DSM-IV diagnostic 
criteria and the potential for stigma towards male presentations (Keski-Rahkonen, 
Raevuori, & Hoek, 2008).  
Burden of Anorexia Nervosa  
AN has a significant cost to the individual and typically leads to impairment in 
everyday living and poor quality of life (Allen et al., 2013b; Brand-Gothelf, Leor, Apter, & 
Fennig, 2014; Hudson et al., 2007; Jenkins, Hoste, Meyer, & Blissett, 2011). For example, 
 21 
patients with current AN symptoms were found to have missed more days of work per year 
than those who had recovered (Zipfel, Lowe, Reas, Deter, & Herzog, 2000). The burden of 
AN on the individual, the community, and the health system is as high as that of other 
major psychiatric illnesses and serious medical disorders (Hay & Mond, 2005). AN is also 
associated with other comorbid mental health issues including depression, anxiety, 
obsessive-compulsive disorder and personality disorders, which can further reduce quality 
of life for the individual (Allen et al., 2013a; Brand-Gothelf et al., 2014; Gabriel & Waller, 
2014; Hudson et al., 2007; Young, Rhodes, Touyz & Hay, 2013). Adolescent girls with AN 
and comorbid anxiety and depression were more likely to experience increased severity of 
eating disordered symptoms, have a hospital admission, and attempt suicide compared to 
those without comorbid disorders (Brand-Gothelf et al., 2014), while those who met criteria 
for the binge/purge AN subtype were more likely to display self injurious behaviour and 
suicidality (Buhren et al., 2014).  
The high costs to the individual and the wider community associated with the illness 
are also due in part to treatment for AN being financially costly, with affected individuals 
often requiring lengthy hospital admissions (Stuhldreher, Wild, Konig, Konnopka, Zipfel, 
& Herzog, 2015). Inpatient treatment is often required for medical stability due to the 
physical complications of AN. The physical and medical complications associated with AN 
range from diminished bone mineral density and gastrointestinal problems to severe 
cardiovascular and pulmonary problems, electrolyte abnormalities, and death (Mitchell & 
Crow, 2006).  
The associated physical and psychological complications mean that AN is typically 
a chronic illness with a high morbidity rate (Hoek, 2006). Indeed, AN has the highest 
mortality rate of all psychiatric illnesses (Harris & Barraclough, 1998). The 20-year 
mortality rate for patients with AN has been found to be as high as 15-20%, although it is 
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difficult to fully estimate mortality rates in AN due to under-reporting of AN as the cause 
of death (Muir & Palmer, 2004). The elevated mortality rate associated with AN is due in 
part to high rates of suicide (Berkman et al., 2006; Beumont, & Touyz, 2003; Ward, 
Ramsay, Russell, & Treasure, 2014; Zipfel et al., 2000). One study found that 
approximately one in five of those with AN who died had committed suicide (Arcelus et 
al., 2011), and the risk for completing suicide for those with AN is 32 times higher than 
those of the same age with depression (Berkman et al., 2006; Beumont, & Touyz, 2003).  
Outcome for AN is variable. Those who are diagnosed at a younger age, and who 
receive treatment relatively close to onset, are more likely to achieve a good outcome 
within a short period of time (e.g., within a year), as are those who receive a longer 
duration of follow up (Steinhausen, 2002). Estimating rates of recovery for AN is difficult 
due to varying definitions of recovery and symptom reduction. For example, many patients 
with the restricting type of AN may improve their AN symptoms over time but may 
develop symptoms of bulimia nervosa (Eddy et al., 2002). The issue of estimating recovery 
rates for eating disorders is also exacerbated by problems with retention rates in treatment 
(Hoste, Zaitsoff, Hewell, & Le Grange, 2007).  
Overall it is thought that less than half of all patients with AN achieve full recovery 
with complete symptom reduction, about a third display some symptom reduction, and 
about 20% of patients with AN remain chronically unwell (Steinhausen, 2002). A range of 
factors have been investigated as possible predictors of outcome, such as duration of 
illness, age at diagnosis, and weight at treatment commencement. Some research suggests 
that purging, length of the illness, and obsessive personality features lead to poorer 
outcomes (Steinhausen, 2002). However, the findings have been markedly inconsistent 
such that it is difficult to predict who will recover completely and who will experience a 
chronic course of the illness (Pike, 1998).  
 23 
Risk Factors for Anorexia Nervosa 
There are many risk factors associated with developing an eating disorder. At a 
sociocultural level, there has been much emphasis on contemporary Western culture, 
particularly with it idealisation of thinness, as a risk factor for eating disorders (Keel & 
Forney, 2013). However, the cultural specificity of AN may have been over-represented 
with many other risk factors now identified (Herpertz-Dahlmann, Seitz, & Konrad, 2011). 
There has been a lack of epidemiological studies of AN in non-Western countries in the 
past (Keel & Klump, 2003; Pike, Hoek, & Dunne, 2014), however increasing research has 
shown that AN occurs across many different countries, ethnic groups, and cultures (Lee, 
Lee, Pathy, & Chan, 2005; Nobakht & Dezhkam, 2000; Pike et al., 2014; Hoek, 2006).  
A range of psychological risk factors for AN have also been investigated. 
Displaying characteristics of perfectionism, anxiety, depression, low self esteem, and 
disturbances in emotion regulation and processing are commonly seen in adolescents with 
AN and may be risk factors for the development of the illness (Fairburn, Cooper, Doll, & 
Welch, 1999; Gabriel & Waller, 2014; Hartmann et al., 2014; Hatch et al., 2010; 
Fitzpatrick, Lesser, Brandenburg, & Lesser, 2011; Le Grange et al., 2014). Dieting in 
adolescents has been found to be the strongest predictor of developing an eating disorder 
(Patton et al., 1998).  
Interest in potential biological risk factors for AN has increased in recent decades. 
Research suggests that there is a genetic predisposition for the development of AN (Bulik, 
2005; Steinhausen, Jakobsen, Helenius, Munk-Jørgensen, & Strober, 2014), with relatives 
of someone with AN being 11.3 times more likely to develop AN than relatives of controls 
(Strober, Freeman, Lampert, Diamond, & Kaye, 2000). The estimated heritability index for 
developing AN depends on the definition of AN, however estimates range from 28% to 
58% (Bulik et al., 2006; Bulik et al., 2010; Kortegaard, Hoerder, Joergensen, Gillberg, & 
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Kyvik, 2001). Research has also found that differences in neuroanatomical structures and 
functions may be a risk factor for the development of AN. For example, differences in the 
volume of the dorsal anterior cingulated cortex may create a vulnerability to the 
development of AN (McCormick et al., 2008). Other research suggests that those with AN 
have changes in the neurotransmitters and neuropeptides which regulate eating and weight. 
Neurochemicals (such as serotonin, leptin, brain-derived neurotrophic factor, and 
melanocortin-stimulating hormone), which normally reduce food intake are lower in 
patients with AN compared with controls, while neurochemicals which encourage food 
intake (such as ghrelin and neuropeptide-Y) are increased (Avena & Bocarsly, 2012; 
Favaro, Monteleone, Santonastaso, & Maj, 2008; Kaye et al., 2005). A limitation of this 
research is the difficulty in identifying whether neurochemical abnormalities are a risk 
factor or a consequence of self-starvation and/or malnutrition. Other research suggests that 
increased serotonin receptor activity may create vulnerabilities for eating and anxiety 
disorders. It is hypothesised that this contributes to higher levels of premorbid anxiety, and 
the restricted intake in AN helps to regulate the increased levels of anxiety (Kaye, Frank, 
Bailer, & Henry, 2005). Additional possible biological risk factors for AN include maternal 
dieting behaviour (Allen, Gibson, McLean, Davis, & Byrne, 2014; Le Grange et al., 2014), 
and perinatal and postnatal factors (Cnattingius, Hultman, Dhal, & Sparen, 1999; Favaro, 
Tenconi, & Santonastaso, 2006).  
Overview of the Current Program of Research 
Despite causing significant distress, often specialised treatment for eating disorders 
is not sought (Hudson et al., 2007), and this has been exacerbated by a lack of available 
effective treatments (Bulik et al., 2007). High drop-out and compliance rates for AN 
treatment have also been an issue (Mahon, 2000; Pike, 1998), which may in part be due to 
reduced motivation to change or engage in treatment given the often egosyntonic nature of 
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the illness (Beumont, & Touyz, 2003). These limitations in treatment, combined with the 
prevalence of AN among adolescents, its serious morbidity and mortality, and its often 
chronic nature combine to underscore the need for effective treatments in this population. 
The overarching aim of the current program of research is to provide further 
clarification of the most effective non-inpatient interventions for adolescents with AN 
(including its subthreshold variants) in a real-world clinical setting. Chapter 2 will provide 
an overview of both adult and adolescent day programs for patients with eating disorders, 
including the admission criteria, advantages and disadvantages of day programs, core 
treatment programs and the associated outcome data and its limitations. Chapter 3 will then 
present Study 1, which investigates the outcomes, and the predictors of outcome and drop-
out in an adolescent day program for patients with AN. Chapter 4 will then review the 
historical origins of Family Based Treatment (FBT), discuss the core components of this 
treatment modality, and then examine the evidence base for FBT, including its strengths 
and limitations. Chapter 5 will present Study 2, which entails an evaluation of FBT 
outcomes in a ‘real world’ setting of adolescents with AN, including assessing the impact 
of length of treatment on cognitive change, and predictors of outcome and drop-out. 
Chapter 6 will present Study 3, which will compare FBT with an adolescent day program, 
and evaluate the two treatments on a number of factors including drop-out rate, length of 
treatment, percentage of expected body weight, return of menses, eating disordered 
cognitions and behaviours, and general psychosocial functioning at completion of 
treatment. The final study is preliminary in nature and has been included in Appendix A. It 
will investigate the qualitative experience of all family members, including the patient, 
parents and siblings, after participating in both day program treatment and FBT. Chapter 7 
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will summarize the findings of the studies, discuss the clinical implications of the findings, 
and present future directions for research.  
Summary 
AN is one of the most serious and chronic illnesses to affect adolescents and young 
adults. It is characterised by self-induced weight loss (achieved by extreme weight control 
behaviours), a fear of weight gain, and a disturbance of one’s body image. Previously, the 
DSM-IV-TR (APA, 2000) diagnostic criteria for AN were widely used, however this led to 
an overrepresentation of the EDNOS diagnosis. Accordingly, the DSM-5 introduced 
changes to the diagnostic criteria for AN (APA, 2013), which has resulted in greater 
numbers of individuals being diagnosed with AN as opposed to a residual category, 
including males and those at less severe levels of weight loss (even potentially including 
those in the healthy weight range).  
AN has a typical onset in adolescence or early adulthood, however it is increasing in 
younger adolescents and children. The disorder carries a significant cost to the individual 
and to the wider community, and is associated with significant psychological and medical 
morbidity, and elevated mortality rates. AN is not unique to Western culture and there are a 
number of potential biopsychosocial predisposing factors. Given the high mortality rate, the 
severity of the illness, and the increasing onset in younger adolescents, the most effective 
treatments for adolescents with AN in real world settings need to be identified.  
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Chapter 2 
Treatments for Adolescents with Anorexia Nervosa: Day Program Treatment 
Chapter Overview 
This chapter will provide an overview of the historical context of day programs for 
patients with eating disorders, as well as describing the admission criteria for day programs, 
the advantages and disadvantages of day programs, and their core treatment components. 
The chapter will also review the available evidence for adult and adolescent day programs 
and conclude by discussing the limitations of the current outcome research for day 
programs.  
The Development of Day Program Treatment 
Historically, patients with eating disorders, particularly those with Anorexia 
Nervosa (AN), were treated via admissions to inpatient units. This was despite studies 
showing that readmission rates to inpatient units were as high as 30-50% (Pike, 1998). Day 
programs (or day hospital) initially started as a way to replace inpatient admissions and/or 
to reduce the length of stay in inpatient settings for patients with eating disorders (Piran, 
Langdon, Kaplan, & Garfinkel, 1989). Day programs are facilities where patients are 
provided with assessment and treatment as an outpatient, rather than on an inpatient basis, 
yet are provided with the same structure and support during the day that they would receive 
within an inpatient admission. Patients attend the program during the day (typically 3-7 
days per week) but are able to return home in the evenings (Rosie, 1987). For the treatment 
of eating disorders, day programs usually include meal support as well as therapeutic 
groups (Zipfel et al., 2002).  
Day programs have been used to treat a range of mental illnesses (Weir & Bidwell, 
2000), and over the past few decades there has been an increase in the number of eating 
disorder day programs reported in literature. This increase in publications reflects a 
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worldwide growth in the number of available day programs for people with eating disorders 
(Lammers, Exterkate, & De Jong, 2007).  
Day Program Admission Criteria 
Most day programs predominantly target patients with AN, with the primary aim of 
achieving weight restoration through meal supervision. However, it is also common to have 
patients with any eating disorder admitted to day programs. For example, one German day 
program had 65% of patients with Bulimia Nervosa (BN) and only 26% of patients with 
AN (Gerlinghoff, Backmund, & Franzen, 1998). Indeed, there is a strong argument that day 
programs should include all patients with an eating disorder and not focus primarily on 
treating patients with AN given that patients with eating disorders, regardless of diagnosis, 
display the same maintaining factors when viewed from a cognitive behavioural 
perspective (Fairburn, 2008). Regardless of diagnosis, day programs are usually offered to 
those with a severe eating disorder that requires more support than regular outpatient 
treatment can provide (Stewart & Williamson, 2004a).  
However, there is some debate about having patients with different eating disorders 
attending the same group. It can often lead to difficulties for staff, due to differences in 
meal options (for those who need to gain, lose or maintain weight) and differences in 
physical activity levels. Stigma related to some eating disorders (e.g., around weight or 
behaviours such as bingeing or purging) can also create issues between patients (Thornton, 
Touyz, Willinge, & La Puma, 2009).  
Many day programs have clear inclusion or exclusion criteria for attendance. 
Around the world, the most common exclusion criteria include severe medical risk, current 
substance dependence, suicidal risk, psychosis, or an unsafe home environment (such as 
abuse or homelessness). Some programs also include previous multiple unsuccessful 
attempts at day program treatment as an exclusion criterion, while others argue that these 
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are the patients who require ongoing support (Thornton et al., 2009; Zipfel et al., 2002). 
Day programs also include a weight cut-off, although there is no clear consensus as to what 
weight criterion should be used for determining the requirement for inpatient treatment. 
Most day programs treating adults usually suggest the exclusion criterion of a body mass 
index (BMI = kg/m
2
) of less than 16, while those treating adolescents suggest a weight less 
than 75% of expected body weight (EBW; APA, 2000; Thornton, Beumont, & Touyz, 
2002; Stewart & Williamson, 2004a). Based on their findings, Howard et al., (1999) 
suggest that, in order to increase the effectiveness of day programs, only patients with AN 
who are weight restored to 90% of EBW, have an illness duration of less than six years, and 
have experienced amenorrhoea for less than 2.5 years should be admitted. If these criteria 
are not met, they suggest that a more intensive and supportive inpatient admission is 
needed. However, this is only possible when the required inpatient services are available.  
Advantages of Day Programs Compared with Inpatient Treatment 
Traditionally, treatment for eating disorders, particularly AN, was either as an 
outpatient (typically individual therapy for one hour, once per week/fortnight) or as an 
inpatient in hospital (Thornton et al., 2002). Over the years, there has been a shift away 
from inpatient admissions, particularly due to questions about their greater effectiveness 
relative to other treatment modalities. A review of inpatient admissions for patients with 
AN found that admissions in the 1990s were associated with increased rates of readmission 
compared to admissions in the 1970s (Willer, Thuras, & Crow, 2005). One study of 14 
inpatient eating disorder units in the UK found that, although inpatient admission led to an 
increase in BMI and improved physical health, these patients continued to display eating 
disordered symptoms at a clinical level (Goddard et al., 2013). Other studies have found no 
difference for patients who have an inpatient admission compared with those who only 
receive outpatient treatment (Zipfel et al., 2002). For example, Crisp et al. (1991) randomly 
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allocated adolescent patients with AN to one of three treatment groups: inpatient treatment 
followed by outpatient individual sessions, outpatient individual/family sessions, or 
outpatient group therapy. Their results showed that the inpatient admission did not result in 
greater benefit to the patients compared with the other two conditions. These results have 
also been replicated in adolescents, where day program attendance was found to be just as 
effective for weight restoration and maintenance as inpatient treatment at discharge and at 
12-month follow-up in adolescents (Herpertz-Dahlmann et al., 2014).  
In addition to comparable effectiveness, there are a number of advantages to day 
programs over inpatient admissions. Compared to inpatient wards, day programs are 
usually able to accommodate a larger number of patients at one time (Zipfel et al., 2002). 
Day programs are also more cost effective than inpatient programs by reducing the high 
cost of inpatient care associated with beds, meals, and round the clock staff (Piran, Kaplan 
et al., 1989; Zipfel et al., 2002). One program found that a day hospital program produced 
cost savings of 43% of the average inpatient stay, which was a saving of about $9,645 per 
patient treated (Williamson, Thaw, & Varnado- Sullivan, 2001). Another study found that a 
day program was about 34% less expensive per day than an inpatient admission (Herpertz-
Dahlmann et al., 2014). 
One of the main advantages of day programs is that patients can attend the treatment 
whilst remaining engaged in their psychosocial environment including study, work, family, 
and friends. Being able to return home in the evening and on weekends also allows for 
greater family support (Zipfel et al., 2002). In addition, day programs result in patients 
having greater exposure to the environmental factors which maintain the eating disorder 
and therefore provide an opportunity to implement the skills being taught at the day 
program in everyday life (Thornton et al., 2002). Another advantage is that patients in day 
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programs are usually more motivated to recover than those in inpatient care and, as such, 
patients can support each other towards recovery (Zipfel et al., 2002).   
Disadvantages of Day Programs  
While there are noteworthy advantages of day programs, it is also important to 
consider their disadvantages. Compared to inpatient programs, day programs have strict 
exclusion criteria such as a low BMI, so that they do not cater for all individuals with eating 
disorders (Thornton et al., 2009).  
Day programs also provide less structure and support than inpatient admissions. 
This may benefit some patients but others, particularly those with AN, may require a higher 
level of supervision and support. This limitation is most evident in terms of the lack of 
structure outside of the program, which can mean that some patients can continue eating 
disordered behaviours such as excessive exercise, restricted intake or purging, outside of 
the day program. Thus, the patient or a family member must be prepared to disclose intake 
and any compensatory behaviours engaged in when the patient is not attending the day 
program to optimise the effectiveness of this treatment in reducing eating disordered 
behaviours (Stewart & Williamson, 2004a; Zipfel et al., 2002).   
Day programs may also be difficult to access for those who live long distances from 
the treatment facility. These patients may need to commute for long periods of time to 
attend the day program, and this may have adverse implications for treatment (e.g., poor 
attendance) and psychosocial functioning (Zipfel et al., 2002).  
Another limitation of day programs is that patients need to be willing to engage in a 
group treatment setting and have the necessary social skills to interact in the group (Zipfel 
et al., 2002). Piran, Langdon et al., (1989) found that those patients who had higher levels 
of social anxiety, which may have resulted in a reluctance to engage in a group setting, 
were more likely to drop-out of day program treatment.  
 32 
Considerations of cost indicate that day programs should only be reserved for those 
with severe eating disorders (Stewart & Williamson, 2004a). For example, although day 
programs have been found to be effective for patients with BN (e.g., Olmsted, Kaplan, & 
Rockert, 1994), there are also less time-consuming, and less costly treatments available 
such as outpatient cognitive-behavioural therapy (Waller et al., 2014). The length of time 
day programs require can also be a problem for staff. Cases of ‘burn out’ among staff in 
day program units have been reported, due to spending large periods of time with clients in 
groups and at meal times (Piran, Kaplan et al., 1989; Zeeck, Herzog, & Hartmann, 2004).  
Core Treatment in Eating Disorder Day Programs  
Typically, day programs for patients with eating disorders are open groups which 
rely on group therapy but also provide some individual therapy. They also have a 
behavioural focus, usually aiming for weight gain (in underweight patients) and 
normalisation of eating (Lammers et al., 2007). Reviews of day programs show that, while 
all programs are different, they share some common factors, including using 
multidisciplinary teams and group therapy as the primary treatment (Abbate-Daga et al., 
2009; Zipfel et al., 2002). This section describes core components of day program 
treatments. 
Treatment duration and intensity. Typically, day programs are open-ended, and 
patients are admitted when necessary and discharged based on their progress (Zipfel et al., 
2002; Thornton et al., 2009). Hence, there can be a high degree of variability across 
patients in terms of their required treatment duration. Reflecting this variability, a review of 
published day programs reported that the mean length of day program attendance ranged 
from four to 40 weeks (Zipfel et al., 2002). Given the limited research to date, there are no 
evidence-based guidelines concerning the optimum length of treatment for day programs 
(Lammers et al., 2007). However, preliminary findings suggest that treatments of longer 
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duration are more beneficial to patients. For instance, while one study found that only 59% 
of patients completed their entire 12-week day program, longer treatment was significantly 
associated with better outcome (Jones, Bamford, Ford, & Schreiber-Kounine, 2007). 
Specifically, those patients who attended for longer showed significantly higher BMI and 
lower depression scores at the end of treatment compared to those who attended for a 
shorter duration. Another study similarly found that weight gain was increased with longer 
length of treatment (deGraft-Johnson, Fisher, Rosen, Napolitano, & Laskin, 2013). 
Thornton et al. (2002) suggested that their program did not lead to significant reductions in 
eating disordered cognitions because patients only attended for a mean of 19.9 days. In 
support of this, mean treatment length was found to be longer in programs that achieved 
significant reductions in eating disordered cognitions than those that did not (55 days and 
90 days, respectively; Gerlinghoff et al., 1998; Piran & Kaplan, 1990).  
There is also limited research concerning the optimum number of days per week 
that day programs should be run, with programs varying from three to seven days per week 
(Thornton et al., 2002; Zipfel et al., 2002). Olmsted, Kaplan, and Rockert (2003) found 
that, compared with a four-day per week day program, the five-day per week day program 
resulted in better psychological outcomes at the end of treatment and reduced rates of 
bingeing and purging.   
Meal therapy. All programs provide meal therapy, which includes supervision and 
support around meal times (Piran, Kaplan et al., 1989). Patients are usually provided with 
an individual meal plan created by a dietitian to meet the patient’s needs (i.e., weight gain 
or maintenance). Typically, staff provide meals or patients are asked to bring in their own 
meals which are then approved by a dietitian. Some programs require staff to eat meals 
with patients to model appropriate behaviours at meal times and to normalise eating 
(Thornton et al., 2009). Most programs also use food diaries or monitoring logs to 
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encourage patients to be accountable for regular eating and food choices when not 
attending the day program. Staff review these food diaries either in the group format or in 
individual sessions. Meal therapy also includes exposure to ‘challenging’ foods and eating 
in social settings. Most programs include exposure to take away food and visits to cafés or 
restaurants (Thornton et al., 2009).  
Weight goals and monitoring. Day programs for eating disorders require patients 
to be weighed regularly. Frequency of weighing varies across programs, from daily to once 
per week. For patients who are underweight, weight gain is usually a requirement of 
treatment, and a goal is typically set ranging from 500 grams to 1.8 kilos per week (Thaler 
et al., 2014; Thornton et al., 2009). Stewart and Williamson (2004a) recommend aiming for 
an overall weight goal of 92% of EBW for underweight patients.  
Motivational enhancement groups. Due to the nature of eating disorders and 
research indicating that motivation to change can be low in patients with eating disorders 
(Goddard et al., 2013; Ngo & Isserlin, 2014), group sessions are often conducted in day 
programs to increase motivation to change. One study found that motivation was an 
important factor in completion of a day program, with less motivated patients being more 
likely to drop-out before the 12-week program was completed (Jones et al., 2007). They 
also found that more highly motivated patients had significantly greater reductions in eating 
disordered behaviours than those who were less motivated.  
Psychoeducation. Psychoeducation groups are provided to teach patients about 
eating disorders, including the physical, medical, and psychological effects, as well as the 
causal and maintaining factors. Education regarding how treatment works, treatment goals, 
and recovery rates may also be provided (Stewart & Williamson, 2004b). A key component 
of psychoeducation pertains to nutritional information. Nutrition sessions are provided by 
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dietitians and include accurate information about nutritional intake, meal plans and, in some 
cases, cooking classes (Piran, Kaplan et al., 1989; Stewart & Williamson, 2004b).  
Cognitive behavioural therapy (CBT). Given research supporting the 
effectiveness of CBT (Fairburn, 2008) for individual therapy, especially for adults with BN 
and EDNOS (Waller et al., 2014) and in treating adolescents (Dalle Grave, Calugi, Doll, & 
Fairburn, 2013), CBT is usually adapted for group settings and included in most day 
programs. Some components of CBT include goal setting, body image improvement (e.g., 
decreasing the emphasis on weight and body shape, reducing body checking, and increasing 
body acceptance), and the use of CBT strategies to improve overall psychosocial 
functioning (e.g., reducing perfectionism, improving self esteem, problem solving, reducing 
associated psychopathology such as anxiety and affect regulation; Piran, Langdon et al., 
1989; Stewart & Williamson, 2004a, 2004b).  
Additional groups. Given that excessive or compulsive exercise can be a feature of 
eating disorders (APA, 2013), many day programs include exercise groups to provide 
patients with guidelines around appropriate amounts and types of exercise, such as yoga or 
dance (Stewart & Williamson, 2004a). Some day programs also offer art therapy groups 
where patients are able to use art or another creative outlet to express difficult emotions and 
to develop an avenue to express themselves without resorting to eating disordered 
behaviours (Stewart & Williamson, 2004b).  
Individual therapy. Day programs may also include individual therapy in addition 
to the treatment groups. Individual therapy is seen as a beneficial part of day programs to 
provide more focused support for the patient, to allow for a more detailed and 
individualised case conceptualisation, and to ensure treatment remains client-centred 
(Stewart & Williamson, 2004b).  
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Family involvement. Most day programs also include sessions with family 
members or carers to provide feedback about the patient’s treatment which is seen as a vital 
part of treatment that leads to more successful outcomes (Stewart & Williamson, 2004a). 
Family members providing information to staff regarding the patient’s behaviour at home 
also reduces the secretive nature of eating disorders (Zipfel et al., 2002). Family sessions as 
part of day program treatments typically include improving family relationships, 
communication, and problem solving, and allowing family members to develop an 
understanding of the illness and how to support their unwell family member (Stewart & 
Williamson, 2004b). It is important to note that, in most cases, family therapy in day 
programs is different to Family Based Treatment (FBT) for adolescents. Family therapy 
sessions in day programs are aimed at improving interpersonal relationships within the 
family (Stewart & Williamson, 2004b), whereas FBT primarily uses the family as a 
resource to re-feed the young person and cease eating disordered behaviour (Lock, Le 
Grange, Agras, & Dare, 2001).   
A Review of Adult Eating Disorder Day Programs  
The number of day programs providing treatment to patients with eating disorders is 
increasing around the world. The content, structure, and outcomes of past and present 
published day programs for adults with eating disorders are described in Table 2.1.  
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Table 2.1 
Overview of Published Day Patient Programs for Adults with Eating Disorders 
Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Australia 
The Peter 
Beumont 
Centre for 
Eating 
Disorders 
(PBCED)  
Thornton et 
al., (2002); 
Willinge, 
Touyz, & 
Thornton  
(2010). 
Days per 
week: four. 
 
 
Focus: psychodynamic 
approach rather than on a 
behavioural approach. 
Content: psychotherapy 
based program. 
Outcomes: 
- Failed to result in behavioural change for 
patients with AN.  
- Resulted in 95% of patients losing weight and 
64% of patients being readmitted to inpatient 
units. 
- Highlighted the need for day programs to aim 
for behavioural change. 
 
 Days per 
week: three.  
Hours: 10am 
until 6pm. 
Meals: four 
per day. 
Length: three 
weeks. 
Number of 
patients: ten. 
 
Focus: behavioural change 
Criteria: medically stable 
with a BMI over 16. 
Content: CBT, meal 
therapy, nutrition, review 
and planning, body image, 
communication and self-
esteem. 
 
Outcomes: 
- Nineteen patients engaged in an average of 
19.9 days (about seven weeks).  
- Led to a significant amount of weight gain, and 
decrease in excessive exercise.  
- No differences on measures of cognitive 
change such as the drive for thinness scale 
(DT) on the EDI-2.  
Limitations: 
- Dropout rate of around 20%.  
- Two patients required readmission to an 
inpatient unit.  
 38 
Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
The Peter 
Beumont 
Centre for 
Eating 
Disorders 
(PBCED)  
(cont.) 
 
 
 
 
 
 
 
Days per 
week: five. 
Number of 
patients: six 
to eight. 
 
 
 
Focus: increased days to 
support patients with BMI 
of less than 16. 
Content: motivation 
therapy techniques, and 
similar to the three day per 
week program described 
above.  
Outcomes: 
- Led to significant reduction in eating 
disordered cognitions, anxiety, depression and 
improvements in quality of life measures, 
interpersonal functioning, and self-esteem.  
- Maintained at three-month follow up.  
Limitations: 
- Sample size was only 44 patients and 32% of 
patients did not complete the program. 
- Unclear how attending two programs of 
different length (five days and then three days 
per week) impacted the results.  
 
 
 Days per 
week: two. 
Hours: five 
hours. 
Length: 6 
months. 
 
Focus/ criteria: patients 
with chronic eating 
disorders who have 
engaged in multiple 
treatment modalities 
without success (including 
inpatient admissions and 
day programs), with an 
illness duration of 7 years 
or more. Focus was not on 
behavioural change.  
Content: motivational 
enhancement therapy. 
Outcomes: 
- Not described in the literature.  
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Canada  
 
Day Hospital 
Program 
(DHP)  
Maddocks, 
Kaplan, 
Woodside, 
Langdon & 
Piran (1992); 
Olmsted et 
al., (1994); 
Olmsted et 
al., (2003); 
Piran, 
Langdon et 
al., (1989); 
Piran, Kaplan 
et al., (1989). 
Days per 
week: five 
(reduced to 
four days later 
on). 
Hours: eight 
per day.  
Meals: three 
per day. 
Length: two 
to four 
months. 
Number of 
patients: 12 
 
 
Criteria: any eating 
disorder, previous failed 
attempts at outpatient 
treatment, motivation to 
engage and ability to 
engage in a group therapy 
setting. 
Content: eating based 
groups (e.g. meal therapy, 
nutrition) and non-eating 
based groups (e.g. 
cognitive-behavioural, 
psycho education).  
Outcomes: 
- Significant increase in weight for patients with 
AN. 
- Significant reduction in binge eating and 
purging for patients with BN.  
- Improved scores on the Eating Disorders 
Inventory (EDI), and improved symptoms of 
depression.  
- Around 70 -80% of patients with BN were 
symptom free at a 2 year follow up.  
- Cost effective compared with inpatient.  
- The five day per week program was more 
effective for those who were bingeing and 
purging.   
- Relapse rate of 31% for patients with BN at 
two year follow up. Relapse was associated 
with younger age, frequent purging, and higher 
score on the Bulimia subscale on the Eating 
Attitudes Test at commencement of treatment.  
Limitations: 
- The published studies are now dated and a 
description of how the program has changed in 
the last decade is needed as well as a review of 
clinical outcomes.  
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
England  
 
STEPS 
Eating 
Disorder Unit 
 
Jones et al., 
(2007). 
Days per 
week: four 
and a half 
days. 
Meals: one 
meal and one 
snack. 
Length: 12 
weeks.  
Number of 
patients: 
eight. 
 
Focus: nutritional 
rehabilitation.  
Criteria: a diagnosis of an 
eating disorder and being 
able to maintain a meal 
plan.  
Content: CBT focus, 
interpersonal interventions 
and creative and 
movement groups. 
Individual support also 
provided.  
Outcomes: 
- Significant improvements in BMI, eating 
disordered cognitions, mood and self-esteem.  
- Only 59% completed the program. 
- Motivation scores were higher in those who 
completed than those who did not complete. 
- Longer attendance led to higher BMI and 
lower depression scores.  
Limitations: 
- Mean BMI only increased by 1.56 points after 
12 weeks resulting in patients with AN 
remaining underweight.  
 
The Oxford 
Adult Eating 
Disorders 
Service 
(OAEDS)  
Peake, 
Limbert, 
&Whitehead 
(2005). 
 
Days per 
week: four 
Meals: two 
meals and two 
snacks per 
day. 
Length: up to 
nine months 
in three 
month blocks.  
Number of 
patients: 
eight. 
Focus: normalisation of 
weight, reduced eating 
disordered behaviour and 
over evaluation of weight 
and shape.  
Content: CBT based, 
group sessions with one 
individual session per 
week and family sessions.  
  
Outcomes: 
- Two thirds of patients completed the program. 
- Significant improvements in BMI, EDI-2 
scores, depression and anxiety scores. 
- Reduced binges and compensatory behaviours 
such as purging, laxative use, and excessive 
exercise.  
- Over the 8 year period, 17.3% of patients were 
re-referred to the service. 
Limitations  
- Around 44% of the patients with AN still met 
criteria for AN after attending the program 
(BMI of less than 17.5). 
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
England 
(cont.) 
Leicester 
Eating 
Disorder 
Service 
(LEDS) 
 
 
Birchall, 
Palmer, 
Waine, 
Gadsby, & 
Gatward 
(2002). 
 
 
Days per 
week: five 
Meals: two 
per day 
Number of 
patients: ten 
 
 
 
 
Focus: step up from 
individual outpatient 
therapy and as a step 
down from inpatient 
treatment. Cost effective 
solution compared to 
long inpatient stays for 
patients with severe AN. 
 
Outcomes: 
- Preliminary results suggest that it is more cost 
effective than long inpatient stays and may 
help to reduce readmission rates.  
Limitations: 
- Minimal information is available regarding the 
effectiveness of this program.  
 
Germany 
 
Day Clinic 
Programme 
(DCP)  
 
Zeeck et al., 
(2004). 
Days per 
week: five 
Hours: 8am 
to 4pm.  
Meals: two 
meals and 
two snacks 
per day. 
Length: three 
months.  
Number of 
patients: 
twelve.  
 
 
Focus: reduction in 
symptoms and treating 
underlying conflicts or 
personality problems.  
Criteria: excluded if 
suicide risk, psychosis, 
substance abuse, BMI 
less than 14.5 or if too far 
to commute.  
Content: based on a 
psychodynamic approach 
with educational and 
cognitive behavioural 
components. 
Outcomes: 
- Reduction in bingeing and purging and eating 
disordered cognitions in patients with BN.  
- Inpatient resulted in better outcomes with 72% 
in remission compared with only 50% of day 
program patients in remission at discharge. 
- At follow up 50% of day program patients 
remained in remission.  
Limitations: 
- Small sample of 14 patients at follow up.  
- The recommended first line treatment for BN 
is self-help or individual therapy using CBT - 
E (NICE; 2004), therefore comparison of day 
program and individual therapy for BN would 
be beneficial.  
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Germany 
(cont.) 
 
The Centre 
for Eating 
Disorders 
(TCE)  
Gerlinghoff, 
et al., (1998). 
Days per 
week: seven.  
Hours: 8am 
until 4:30pm.  
Length: three 
months. 
Average was 
13 weeks. 
Number of 
patients: 24. 
Focus: self-management, 
with trust and 
cooperation encouraged 
between patients and 
staff.  
Criteria: all eating 
disorder patients, 
excluded if suicide risk, 
substance dependence, or 
psychotic symptoms.  
Content: meal therapy, 
therapy groups including 
body image, 
psychotherapy, and 
family sessions.  
Outcomes: 
- Significant weight gain for patients with AN.  
- Reduction in the number of binges for patients 
with BN.  
- Patients with AN showed less improvement 
with being preoccupied with nutrition and 
body shape when compared to patients with 
BN and EDNOS.  
- Follow up at an average of 17.2 months 
(ranged from 6-33 months) found only one 
patient continued to meet criteria for AN while 
two met criteria for BN. 
Limitations: 
- Follow-up group may represent a subset of 
patients who were more motivated to return to 
the service or had not relapsed.  
- Day program is one of four phases (outpatient 
motivational enhancement, day hospital 
program, outpatient treatment, and self-help), 
and it is unclear to which degree the outcomes 
are due to this component as opposed to the 
other components. 
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Italy 
 
Day Hospital 
Programme 
– The Eating 
Disorders 
Centre 
Abbate- 
Daga et al., 
(2009). 
Days per 
week: five 
Hours: seven 
hours per day  
Meals: two 
meals per 
day  
Length: 24-
26 weeks 
Number of 
patients: ten. 
  
Focus: weight gain, 
reduction in eating 
disordered behaviours, 
and improving 
interpersonal functioning. 
Criteria: DSM diagnosis 
of AN or BN, medically 
stable, BMI above 13.5, 
motivated and be able to 
participate in a group 
setting. 
Content: bio-psycho-
social framework with 
psychodynamic 
orientation, meal therapy, 
cognitive behaviour 
techniques, group,  
individual and family 
sessions.   
 
Outcomes:  
- Described as being similar to other adult 
programs.  
Limitations: 
- Has not published data on outcomes. 
Netherlands  
 
Amarum  
 
Lammers et 
al., (2007). 
Days per 
week: five. 
Hours: seven 
per day. 
Meals: two 
per day. 
Focus: cognitive 
behavioural therapy 
model. 
Content: CBT and family 
or couple therapy. 
Outcomes:  
- Described as being similar to other adult 
programs.  
Limitations: 
- Has not published data on outcomes. 
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
South Korea 
 
Day 
Treatment 
Program 
(DTP)  
Kong (2005). Days per 
week: four. 
Hours: 8 
hours per 
day. 
 
 
Content: CBT framework 
and included some family 
sessions. 
Outcomes: 
- RCT comparing an outpatient day program 
with a control group who received individual 
interpersonal psychotherapy (IPT), CBT and 
pharmacotherapy.  
- Significant reduction in bingeing and purging, 
increase in weight, better scores on the EDI -2 
and improved depression and self-esteem 
scores in day program compared with the 
control group.  
Limitations: 
- The sample size was relatively small for a 
RCT (21 participants in the day program and 
22 participants in the control group).  
United States 
of America 
 
Eating 
Disorder 
Program 
(EDP)  
Levitt & 
Sansone 
(2003). 
Days per 
week: five. 
Length: four 
to five 
weeks.  
Number of 
patients: 20. 
 
 
 
Focus: normalisation of 
eating, identify factors 
perpetuating the eating 
disorder, and develop self 
regulation. 
Criteria: DSM diagnosis 
of an eating disorder. 
Content: CBT based, 
group format, some 
family sessions, body 
image, social skills, art 
therapy, interpersonal 
functioning.  
Outcomes:  
- Described as being similar to other adult 
programs.  
Limitations: 
- Has not published data on outcomes. 
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
 
United States 
of America 
(cont.) 
 
Our Lady of 
the Lake 
Eating 
Disorder 
Program 
(OLOL)  
 
Stewart & 
Williamson, 
(2004a); 
Williamson 
et al., (2001).   
 
 
Days per 
week: five 
Hours: 
9:30am until 
5:30 or 
6:30pm. 
Meals: two 
meals per 
day.  
Length: 
average is 50 
days. 
Number of 
patients: five 
to 13.  
 
 
Focus: weight gain 
aiming for 1-3 pound 
gain per week.  
Criteria: inclusion criteria 
were repeated failure of 
other outpatient 
treatments, weight loss, 
and body weight of 5-
15% below what is 
expected. 
Content: CBT, group 
therapy and some 
individual and family 
sessions, as well as a 
support group for parents 
and carers. 
 
Outcomes: 
- As effective as inpatient treatment for cost and 
outcome at completion and one year follow 
up.   
- Recovery rates around 63%.  
- Reduced eating disorder cognitions and weight 
gain in AN patients.  
- Shorter duration of illness and older age of 
onset led to better treatment outcomes.  
- Higher levels of depression and eating 
disordered cognitions were found in those with 
a longer duration of illness. 
Limitations:  
- Outcomes measures (e.g. Multifactorial 
Assessment of Eating Disorder Symptoms) are 
not commonly used, which creates difficulties 
when comparing with other studies.  
 
Note. Studies are organised by country.  
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Summary of the outcome data for adult day programs. As shown in Table 
2.1, eating disorder day programs include some commonalities between programs, 
including the use of a cognitive behavioural framework, and a group-based format 
with some additional individual therapy. Common treatment goals include 
normalisation of eating disordered behaviour, nutritional rehabilitation, weight gain, 
identification of maintaining factors, reduction of over evaluation of weight and 
shape, and improvement in social interaction and self-esteem. Most programs provide 
pharmacotherapy and are staffed by a multidisciplinary team. There are also a number 
of differences between programs, with a variable duration of treatment ranging from 
three to 39 weeks, group sizes ranging from five to 20 patients, and follow-up support 
ranging from no follow-up to individual or group sessions on a weekly or monthly 
basis. Most day programs include patients with AN, while a few programs include 
patients with BN and EDNOS (Abbate-Daga et al., 2009; Thornton et al., 2009; 
Zipfel et al., 2002).   
Research over the past two decades has shown that day programs are as 
effective for weight gain in adults as inpatient stays (Stewart & Williamson, 2004a; 
Williamson et al., 2001) while being more cost-effective, and day programs can lead 
to reduced readmission rates to inpatient units (Birchall et al., 2002). Day programs 
have also been shown to lead to significant weight gain for patients with AN, and to 
reduce bingeing and compensatory behaviours such as purging, laxative misuse, and 
excessive exercise in both patients with BN and AN (Gerlinghoff, et al., 1998; Kong, 
2005; Maddocks et al., 1992; Peake et al., 2005; Piran, Langdon et al., 1989; 
Thornton et al., 2002; Willinge et al., 2010; Zeeck et al., 2004). Research concerning 
the effectiveness of day programs for reducing eating disordered cognitions is mixed, 
with some studies showing a reduction (Kong, 2005; Willinge et al., 2010), while 
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others have found no change in eating disordered cognitions (Thornton et al., 2002), 
which, as stated previously, may be due to insufficient duration of treatment. Day 
program participation has also led to improvements in other areas for adult patients, 
including lower scores on measures of anxiety and depression, and higher scores on 
self esteem and quality of life measures (Kong, 2005; Maddocks et al., 1992; Piran, 
Langdon et al., 1989; Olmsted et al., 1994; Willinge et al., 2010).  
There are a number of factors that have been found to predict the effectiveness 
of, and drop-out rates associated with, day programs. In terms of treatment outcome, 
adult patients with a shorter duration of illness and older age of onset were more 
likely to have better outcomes at the end of day program treatment (Williamson et al., 
2001). Howard, Evans, Quintero-Howard, Bowers and Anderson (1999) also found 
that illness duration was related to outcomes. They looked at predictors of successful 
transition from inpatient treatment to day program treatment for patients with AN. 
They found increased risk of day program failure and inpatient readmission in 
patients with a longer illness duration (worse for those with an illness duration of six 
years or more), amenorrhoea (increased risk for those who had amenorrhoea for more 
than 2.5 years), a BMI under 16.5 at inpatient admission, and a BMI under 19 at day 
program admission. Other evidence also suggests that those adult patients who start a 
day program with a lower BMI (in this case, a BMI under 16) are less likely to do 
well in day program treatment (Zipfel et al., 2000). 
Results on the predictors of drop-out from day programs are based primarily 
on adult patients. One study found that drop-out was related to low starting weight 
and levels of motivation to change eating disordered behaviours (Jones et al., 2007). 
Piran, et al., (1989) found that the factors which increased the drop-out rate in their 
day program were patients being directly referred from an inpatient admission (rather 
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than referral from an outpatient source) and higher social anxiety. Other studies have 
found that drop-out from a day program was associated with patients who had more 
severe bulimia symptoms, personality characteristics indicating deficits in inhibition, 
and displaying high levels of aggression and extraversion (Franzen, Backmund, & 
Gerlinghoff, 2004). However, other research in adult day programs has found no 
significant difference in the level of eating disorder symptoms, depression, self 
esteem or BMI at commencement of the day program, for those adults who 
completed treatment compared with those who dropped out (Jones et al., 2007). Thus, 
further clarification regarding the factors that predict treatment outcome and drop-out 
in the day program setting is needed. 
Limitations of research on adult day programs. In addition to limited and 
conflicting research regarding the predictors of outcome and drop-out, research 
examining adult day programs for eating disorder patients is limited in terms of 
investigating the effectiveness of day programs relative to other types of treatment. 
Specifically, while studies indicate that day programs are a cost- and time-effective 
treatment compared to inpatient admissions (Birchall et al., 2002; Stewart & 
Williamson, 2004a), there is limited data comparing day programs with other forms 
of treatment (e.g., FBT). A small randomised controlled trial (RCT) was completed, 
comparing day program attendance with individual therapy which included 
interpersonal psychotherapy (IPT), CBT, and pharmacotherapy (Kong, 2005). 
Although the results of this RCT were promising for day programs, the sample size 
was very small (N = 43, 21 patients in day program respectively and 22 in the 
individual therapy group), and it requires replication on a larger scale. Thus 
investigating the relative effectiveness of day programs to other evidence-based 
treatments for eating disorders is a high research priority. 
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Another limitation in the research relates to the finding that day programs are 
comparable to inpatient programs in terms of effectiveness, despite the less intensive 
nature of the former relative to the latter (Birchall et al., 2002; Stewart & Williamson, 
2004a; Williamson et al., 2001). However, in some studies this may be an artefact of 
the differences between patients attending day programs versus inpatient programs, 
with greater illness severity or lower motivation to change among the latter. For 
example, patients in outpatient programs, such as day programs, are reported to have 
higher levels of motivation to engage which may be one reason why day programs 
achieve the same outcomes as inpatient programs even though the former are less 
intensive (Crisp et al., 1991). It is also important to note that severity of illness is 
often not controlled for when comparing inpatient and day programs, which leads to 
difficulties when making comparisons between the two treatments. Inpatient 
admission can also involve involuntary patients (Hay et al., 2014: Matusek, & 
O’Dougherty Wright, 2010), which would also bias outcomes for inpatient 
admissions.  
A final noteworthy limitation to date is the fact that most research on day 
programs has focused on providing descriptions of these programs, with no clear 
understanding as to what are the effective elements of treatment that led to 
behavioural and cognitive change. Given the experience of Thornton et al., (2002), 
where a psychodynamic approach resulted in 95% of patients losing weight, it could 
be assumed that an effective ingredient of day programs should be sessions that focus 
on behavioural change, such as weight gain and meal therapy. However, the other 
factors that comprise a successful day program need further investigation in 
dismantling studies. The current wide variety between different programs makes it 
difficult to compare day programs and to establish what are the most effective 
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elements of day programs for patients with eating disorders (Lammers et al., 2007). 
As such, research is needed that evaluates the effectiveness of different types of day 
programs. For instance, treatment dose in day programs, including hours and meals 
per day, number of days per week and treatment length, needs to be evaluated. An 
Australian day program had patients attend a five-day per week program and then 
step down to a three-day per week program. However, the results of these two day 
programs were combined, making it difficult to determine what gains were made in 
treatment based on varying treatment dose (Willinge et al., 2010). This appears to be 
a common problem in the research, with some programs not specifying which 
component of treatment (e.g., day program, inpatient combined with day program, 
individual therapy) is being measured.  
A Review of Adolescent Eating Disorder Day Programs  
The aforementioned limitations of the research on adult day programs are 
further compounded in the context of adolescents with eating disorders given that 
past research has tended to focus on the treatment of adults in day programs. More 
recently, however, there have been an increasing number of adolescent day programs 
worldwide reported in the literature, and the results of these are beginning to be 
published. For example, there are currently a total of six-day programs for 
adolescents with eating disorders across Canada, although they have not all published 
their outcome data (Norris et al., 2013). Table 2.2 provides a description and 
evaluation of published research on adolescent day programs.  
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Table 2.2 
 
Overview of Published Day Patient Programs for Adolescents with Eating Disorders 
 
Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Australia 
 
The Sydney 
Children’s 
Hospital 
 
Goldstein et 
al., (2011). 
Days per week: 
three and a half 
days.  
Meals: two 
meals and two 
snacks per day.  
Length: 10 week 
cycles 
 
Criteria: adolescents with 
AN and EDNOS 
Content: CBT, motivational 
enhancement, distress 
tolerance, nutrition, meal 
therapy, art therapy and 
relapse prevention. It also 
included parent groups for a 
total of 4 hours per week 
and sibling sessions. 
Outcomes:  
- High completion rate of 92.9%.  
- Significant weight gain at end of 
treatment, and at a six month follow up.  
- At completion 58% of patients 
maintained their weight at or above the 
85% of EBW.  
- Significant improvements between pre- 
and post-treatment on the EDI scales of 
drive for thinness and perfectionism.  
Limitations:  
- Small sample size at follow up (17 
patients).  
- Ten patients were admitted as inpatients 
while attending the day program.  
Patients had relatively short duration of illness 
(average of about one year) prior to day program 
treatment.   
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Australia 
(cont.) 
 
The Southern 
Health 
Butterfly 
Eating 
Disorders Day 
Program  
Stevens, 
(2010). 
Program content 
and duration not 
stated.  
 
 
Focus: established in 2007 
to provide an alternative to 
inpatient admissions for 
young people 
Criteria: aged 12 to 25 years 
old. 
Content: not stated. 
 
Outcomes: 
- Preliminary results presented at a 
conference.  
- Improvement in eating disorder 
symptoms and reduced rates of relapse 
and inpatient re-admissions.  
- Cost effective compared with inpatient 
admissions.   
- Some patients chose not to attend due to 
the required time away from school or 
work.   
Limitations: 
- Data on outcomes has not been 
published.  
It is unclear whether the reduced rates of relapse 
are being compared with inpatient treatment or 
individual outpatient treatment.  
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Canada 
 
The Eating 
Disorder Day 
Treatment 
Program 
(EDDTP)  
Henderson 
et al., 
(2014). 
Days per week: 
five. 
Hours: 8am until 
6pm. 
Length: 12-14 
weeks. 
Number of 
patients: eight.  
 
 
Focus: step down program 
for those discharged from 
the inpatient program. 
Content: Maudsley FBT 
“informed” approach and 
includes group therapy 
sessions, nutritional support, 
meal therapy and parent 
sessions.  
Outcomes: 
- At discharge and 6 month follow up 
patients achieved medical stability 
(86.9% had a BMI over 19), reduction in 
eating disordered symptomology.  
Limitations: 
BMI is not an effective measure of medical 
stability, particularly in adolescents.  
 
The Eating 
Disorders Day 
Hospital 
program 
(EDDH)  
Grewel, 
Jasper, 
Steinegger, 
Yu, & 
Boachie 
(2014). 
Days per week: 
five. 
Length: 
individualised to 
suit each patient. 
Discharged 
when goal 
weight is 
achieved. 
Number of 
patients: eight.  
 
 
Criteria: medically stable, 
weight over 80% of EBW, 
aged 13 to 18 years 
Content: based on an 
adapted Family Based 
Therapy (FBT) approach 
and requires parents to 
attend sessions as well as be 
responsible for their child’s 
intake and eating disorder 
symptoms on weekends.  
Outcomes: 
- Those who were taking antidepressant 
medication and did not purge were more 
likely to complete the day program.  
- Drop out rate was 42%.  
- Start weight did not predict program 
completion. 
- Those who took longer to reach 100% of 
goal weight or exercised excessively 
stayed longer. 
Limitations: 
- All starting weights were high compared 
with other programs (over 80% of EBW).  
- Limited detail on outcomes.  
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Canada (cont.) 
 
Children’s 
Hospital   
Ngo & 
Isserlin, 
(2014). 
Days per week: 
four. 
Hours: 8am until 
4pm. 
Meals: two 
meals and two 
snacks per day.  
Length: based 
on individual 
need with an 
average of 65 
days.  
Number of 
patients: eight. 
 
Focus: normalisation of 
eating and improved body 
image. 
Criteria: includes inpatients 
and outpatients aged 13 to 
17 years.  
Content: based on a bio-
psycho-social framework 
with group sessions and 
individual sessions with 
family members.  
Outcomes: 
- No significant difference in demographic 
variables between completers and drop-
outs. 
- Percentage of EBW at admission did not 
predict successful outcome.  
Limitations: 
- Around 71% of patients failed to reach 
EBW. This may be due to current sample 
including more unwell patients who have 
failed or refused other treatment 
programs (e.g. FBT).  
- Data was collected over 10 years.  
 
Day program 
Girz, 
Robinson, 
Foroughe, 
Jasper, & 
Boachie 
(2013). 
Days per week: 
five. 
Meals: three 
meals and most 
snacks per day.  
Length: average 
of 149 days.  
 
 
Focus: Step up from 
outpatient.  
Criteria: Aged between 13 
to 18 years.  
Content: included group 
therapy with FBT sessions 
and also included weekly 
multi-family therapy 
sessions. 
 
Outcomes: 
- Mean illness duration was 2.5 years.  
- After 6 months of treatment all patients 
had achieved 99 to 100% of EBW.  
- Eating disordered symptoms, depression 
and anxiety scores significantly reduced.  
- Parents’ self-efficacy increased.  
Limitations: 
- Not all patients were underweight at the 
commencement of the program.  
- The sample size was only 17 patients.  
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
Spain 
 
The Day 
Hospital  
 
Lazaro et 
al., (2011). 
Days per week: 
five.  
Hours: 2pm til 
8:30pm 
Meals: two 
meals and one 
snack per day.  
Length: two 
months.  
 
 
Focus: weight gain and 
changing disordered eating 
behaviours. 
Criteria: adolescents aged 
13 to 18 years with AN or 
BN.  
Content: meal therapy, 
nutritional counselling, self-
esteem and social skills 
groups, as well as family 
meetings.  
 
Outcomes: 
- Improved self-perceptions of body 
appearance.  
- Increased social contact.  
- Improved levels of body satisfaction.  
Limitations: 
- The aim of the program was weight 
gain, however most patients were in 
the healthy weight range and the 
program produced only a one point 
BMI increase in the AN group.  
- Further data around the effectiveness 
of the program to change eating 
disordered cognitions and behaviours 
needs to be completed.  
- While the improvements in self 
esteem and social skills are positive, 
they could be taught in a group setting 
rather than a day program which may 
be less onerous on patients and more 
cost effective.   
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
United States 
of America 
 
Our Lady Of 
the Lake  
Stewart & 
Williamson, 
(2004a). 
Days per week: 
five 
Hours: 9:30am 
until 5:30 or 
6:30pm 
Meals: two 
meals per day  
Length: average 
is 50 days 
Number of 
patients: five to 
13  
 
Focus: weight gain.  
Criteria: ages ranging from 
10 to 60 years, weight 
between 85 and 92% of 
EBW.  
Content: CBT, group 
therapy, individual and 
family sessions, as well as a 
support group for parents 
and carers. 
  
Outcomes/limitations: 
- Research relating directly to the 
adolescent population has not been 
described. 
  
 
University of 
Michigan 
Comprehensive 
Eating 
Disorders 
Program (U-M 
CEDP) 
 
 
 
 
 
 
Hoste, 
(2015). 
Intensive 
outpatient 
program  
Days per week: 
three days. 
Hours: three 
hours per day.  
Meals: two 
meals and one 
snack per day  
 
 
 
 
Criteria: aged 8-17 years or 
18 to 24 years 
Content: FBT based 
Includes meal support, 
group therapy, family 
meetings and individual 
therapy.  
Outcomes:  
- Mean length of stay in the outpatient 
program was 11.5 days (range of 4-22 
days).  
- Significant increase in % of EBW 
from 82.1 to 93.1. 
- Significant improvement in eating 
disordered behaviours. 
- Improvement in mood for older 
patients.  
Limitations:  
- Small sample size which did not 
include all patients (preliminary 
results).  
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Treatment 
Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
United States 
of America 
(cont.)  
 
The Day 
Treatment 
Program 
(DTP)  
Dancyger, 
et al., 
(2003). 
Days per week: 
five.  
Hours: 9am to 
5pm.  
Length: open 
ended, average 
length of stay 
was 15 weeks.  
 
Criteria: any eating disorder 
and weight at or above 85% 
EBW.  
Focus: awareness and 
change of eating disordered 
pathology. Used to prevent 
hospitalisation or as a step 
down from hospital 
admissions.  
Content: supportive 
behavioural framework with 
a multidisciplinary 
approach. Included group, 
individual and family 
therapy with life skills 
programs, medical, 
psychiatric and nutritional 
support.  
Outcomes: 
- Included adolescent and young adult 
sample and despite the adult group 
having a longer duration of illness, 
there was no significant difference 
between the two groups at completion 
of the program.  
- Those who stayed longer in the 
program reported higher levels of 
depression and eating disordered 
cognitions at commencement.  
- Past duration of illness was negatively 
correlated with maturity fears.  
Limitations: 
- Only 49% of patients achieved the 
goals of the program and 13% 
required admission to the inpatient 
unit.  
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Facility 
References 
Treatment 
Dosage 
Program Content Outcomes 
United States 
of America 
(cont.)  
 
Child Partial 
Hospitalization 
Program for 
Eating 
Disorders 
(USA) 
Ornstein, 
Lane-
Loney, & 
Hollenbeak  
(2012).  
Days per week: 
five.  
Hours: six to 
eight per day.  
Length: average 
of 10.3 weeks.  
 
Criteria: an eating disorder 
which is impacting on 
functioning and medical 
health, aged 8 to 16 years.   
Focus: family-based 
approach to treatment and 
behavioural modification.  
Content: group based with 
at least one individual and 
family sessions. Attendance 
is reduced as patient gains 
weight and is transitioned 
back to school.  
 
 
 
 
 
Outcomes: 
- Patients were younger than most 
programs with a mean age of 12 years.  
- Significant increase in weight, 
improvement in eating cognitions, 
mood and anxiety.  
- Longer length of treatment predicted 
weight gain but not improvements in 
psychological assessment measures.  
- Medication use, demographic 
variables, prior length of illness and 
initial % of EBW did not predict 
outcomes.   
Limitations: 
- High rate of non completers (46%) 
which were excluded from data 
analysis. 
- Includes an outpatient program of 
three days per week for three hours 
per day, however no distinction 
around the outcomes for each 
program.  
Note. Studies are organised by country. 
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Summary of the outcome data for adolescent day programs. As shown 
in Table 2.2, from the few adolescent day programs that have been published, it 
appears that they range from three days per week to five days per week, with the 
majority being five days per week. All programs provide meal therapy and group 
therapy, either based on CBT or FBT frameworks. Program duration ranges from 
a minimum of six weeks to as long as is required by the patient (Girz et al., 2013; 
Goldstein et al, 2011; Grewel et al., 2014; Henderson et al., 2014; Herpertz-
Dahlmann et al., 2014; Hoste, 2015; Lazaro et al., 2011; Ngo & Isserlin, 2014; 
Stevens, 2010; Stewart & Williamson, 2004a). They are also used as a step up 
from outpatient treatment, or as a step down from inpatient treatment, and have 
been found to be as effective as inpatient admissions (Herpertz-Dahlmann et al., 
2014). Although all programs include weight gain as a treatment aim, they also 
include patients with both BN and AN (Girz et al., 2013; Goldstein et al, 2011; 
Grewel et al., 2014; Henderson et al., 2014; Herpertz-Dahlmann et al., 2014; 
Hoste, 2015; Lazaro et al., 2011; Ngo & Isserlin, 2014; Stevens, 2010; Stewart & 
Williamson, 2004a).  
The emerging research on adolescent day programs suggests that they are 
generally effective for weight gain (deGraft et al., 2013; Girz et al., 2013; 
Henderson et al., 2014; Herpertz-Dahlmann et al., 2014; Hoste, 2015) and that 
this weight gain is maintained at six-month follow-up (Goldstein et al., 2011). 
One exception was a program where the majority of patients failed to gain weight 
(Ngo & Isserlin, 2014). Adolescent day programs have also been found to lead to 
a significant reduction in eating disordered cognitions and improvements in body 
image perceptions (Girz et al., 2013; Goldstein et al., 2011; Henderson et al., 
2014; Lazaro et al., 2011). In addition, day programs have been shown to result in 
a reduction in anxiety and depression scores (Girz et al., 2013; Lazaro et al., 
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2011), and are cost-effective compared with inpatient admissions (Ngo & Isserlin, 
2014; Stevens, 2010).   
Limitations of research on adolescent day programs. Research focusing 
on day programs for adolescents with eating disorders encounters the same 
difficulties as the adult population. Given that adolescent day programs are an 
emerging area in the literature, the problems are intensified by a lack of research.  
Among the limitations is a lack of research pertaining to the optimum 
number of hours per day, days per week or length of time that a patient should 
attend a day program. In addition, most of the current studies only describe a 
small number of patients, which makes it difficult to generalise the outcomes and 
further replication is required.  
Akin to the adult research, there is a lack of research that compares day 
programs to alternative treatments, or that compares different types of day 
programs. Adult day programs generally use a CBT framework for group 
sessions. In contrast, day programs for adolescents are either CBT-based with 
parental information sessions or follow an FBT-based model with parents 
required to re-feed the adolescent at home. Yet, no comparisons of these various 
approaches to family involvement have been undertaken. As such, it is unclear in 
adolescent day programs what components facilitate changes in weight and eating 
disordered cognitions. It may be that parental involvement is the effective 
ingredient (e.g., the core components of FBT are producing change) and not the 
day program attendance. For example, Girz et al. (2013) found that the day 
program led to increased parental efficacy, however parental efficacy has also 
been shown to be a predictive factor in a patient’s recovery from AN in FBT 
treatment (Robinson, Strahan, Girz, Wilson, & Boachie, 2012). Therefore, day 
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program treatment for adolescents may actually be measuring parental capacity to 
support the adolescent rather than the actual content of the day program.  
Also similar to the adult literature is the fact that little is known about the 
predictors of day treatment outcome and drop-out in adolescent populations. This 
is a noteworthy limitation because, despite overall promising results obtained 
from day programs for adolescents with eating disorders, research also suggests 
that day programs are not effective for all patients. The results suggest that at 
most 87% (Henderson et al., 2014) of patients are able to return to a healthy 
weight and cease eating disordered behaviours, but at times as few as 29% of 
patients are weight restored at the end of day program treatment (Grewal et al., 
2014). Moreover, treatment drop-out is a problem for day programs (as with other 
forms of treatment for eating disorders), with studies reporting drop-out rates 
from adolescent day programs as high as 42% (Grewal et al., 2014). As such, 
identifying the predictors of outcome and treatment retention for adolescents with 
eating disorders participating in day programs is needed.  
Preliminary results on the predictors of outcome suggest that, contrary to 
the adult data, start percentage of EBW or BMI does not impact on clinical 
outcomes (Dancyger et al., 2003; Goldstein et al., 2011; Ngo & Isserlin, 2014; 
Ornstein et al., 2012). Starting weight in the adolescent age group may not be a 
predictor of outcome because adolescent day programs require a higher starting 
weight to be accepted into the program, and hence these studies cover a restricted 
range in body weight. For example, the day program reported by Dancyger et al., 
(2003) only accepted patients with a weight above 85% of EBW, whereas some 
adult day programs accept severely underweight patients with a BMI as low as 
13.5 (Abbate- Daga et al., 2009). Few studies in the adolescent age group have 
examined how factors other than starting weight or BMI impact on day program 
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outcomes. Only Ornstein et al. (2012) looked at prior length of illness and found 
that it was not predictive of the effectiveness of day program treatment, which is 
again inconsistent with the findings on adult patients. Prior length of illness may 
not be a predictor of outcome in the adolescent age group because, for most 
adolescents, the onset of the illness is relatively recent, thus again resulting in a 
restricted range. For example, Ornstein et al.,’ (2012) day program included 
adolescents with a mean age of 12 and their prior length of illness was a mean of 
12 months, compared with an adult day program where the mean length of illness 
was six years (Willinge et al., 2010).  
In addition to insufficient information on the predictors of outcome, 
research on predictors of drop-out is limited in the adolescent day program 
population. Indeed, only one study to date has investigated adolescent drop-out, 
and found that antidepressant medication use and lower levels of purging 
behaviours were associated with adolescent patients being more likely to complete 
their day program (Grewal et al., 2014). While not specifically reviewing 
predictors of drop-out, one study did note that there was no difference in 
demographic variables between those adolescents who dropped out of day 
program treatment compared with those who completed the program (Ngo & 
Isserlin, 2014). 
A final limitation in the adolescent day program research pertains to 
inadequate outcome measures, specifically, assessing whether day programs are 
effective in bringing about a return of menses. Failure to review return of menses 
at day program completion may be due to the short duration of some day 
programs. Limited research suggests that return of menses occurs in 47 to 65% of 
patients after day program attendance (Dempfle et al., 2013; Grewal et al., 2014; 
Herpertz-Dahlmann et al., 2014), and that menstruation was related to a higher % 
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of EBW at 12 month follow up (Dempfle et al., 2013). Given that return of 
menses is a sign of return to set weight, reversal of bone loss, and resumption of 
growth in adolescents (Dempfle et al., 2013; Le Grange, Doyle et al., 2012), it is 
therefore important to consider if adolescent day programs are achieving this 
important outcome at discharge and at follow up.  
Summary 
Treatment for AN traditionally required inpatient treatment, however an 
increase in research has shown that day programs for adults with AN are as 
effective as costly, long inpatient stays (Birchall et al., 2002; Crisp et al., 1991; 
Gerlinghoff et al., 1998; Kaplan et al., 1992; Kong, 2005). Research suggests that 
adult day programs are effective for weight gain, decreasing eating disordered 
cognitions and behaviours (Gerlinghoff et al., 1998; Kong, 2005; Piran et al., 
1989; Zeeck et al., 2004; Willinge et al., 2010), and can lead to improvements in 
general psychological and social functioning (Levitt & Sansone, 2003; Peake et 
al., 2005; Willinge et al., 2010). However, there are few studies reviewing longer-
term follow up and predictors of outcome and premature treatment termination.  
Adolescent day programs for AN are an emerging area, with the limited 
research conducted to date suggesting that adolescent day programs are as 
effective as inpatient admissions (Herpertz-Dahlmann et al., 2014), with 
significant weight gain, a reduction in eating disordered symptomatology (Girz et 
al., 2013; Goldstein et al., 2011; Henderson et al., 2014; Ornstein et al., 2012), 
and improvements in general psychological functioning (Henderson et al., 2014; 
Lazaro et al., 2011; Ornstein et al., 2012). Since the studies are few in number and 
may have small sample sizes, further research is needed to examine if day 
program attendance leads to positive outcomes for most AN patients, including 
weight restoration, return of menses, and reduced eating disordered cognitions and 
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behaviours. In addition, investigation of whether factors such as weight, eating 
disordered cognitions and behaviours, prior length of illness, and previous 
treatment impact on treatment outcome and drop-out are also needed in order to 
target day program participation to those adolescents where it will be most 
effective and improve the retention of those at risk of dropping out. 
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Chapter 3 
Study 1: The Effectiveness and Predictors of Outcome and Drop-out 
of a Day Program in Adolescents with Anorexia Nervosa 
 
Anorexia nervosa (AN) is a serious mental illness, which is highly 
debilitating in terms of its impact on psychological, social, and medical 
functioning (Gowers et al., 2010; Vitiello & Lederhendler, 2000). Traditional 
treatment for AN required inpatient treatment, which was often of lengthy 
duration and costly both to the patient and the health system (Zipfel et al., 2002). 
Over the last few decades there has been a shift from treating patients with AN in 
inpatient settings towards outpatient and day patient treatments. Regarding the 
latter, there has been a marked increase in the number of day programs offered for 
patients with eating disorders over the past two decades and the outcomes of these 
programs suggest that they are beneficial in the treatment of adults with eating 
disorders (Abbate-Daga et al., 2009; Thornton et al., 2009).  
Previously there was a lack of research focusing on adolescent day 
programs for eating disorders (Thornton et al., 2002). However, over the last few 
years there have been an increasing number of adolescent day programs published 
in the literature. Preliminary outcome data is similar to that reported in adult 
populations, with adolescent day programs found to be as effective as inpatient 
admissions (Herpertz-Dahlmann et al., 2014). Adolescent day programs have been 
found to produce significant weight gain and a reduction in eating disordered 
symptomatology (Girz et al., 2013; Goldstein et al., 2011; Henderson et al., 2014; 
Hoste, 2015; Ornstein et al., 2012). Day programs also support improvements in 
areas of general psychological functioning such as decreases in comorbid 
depression and anxiety, and improved self-esteem (Henderson et al., 2014; Lazaro 
et al., 2011; Ornstein et al., 2012). As with adult day programs, there are a limited 
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number of follow-up studies for adolescent day programs. However, these initial 
findings suggest that weight gain is maintained or continued six to 12 months 
after day program completion (Herpertz-Dahlmann et al., 2014; Girz et al., 2013; 
Goldstein et al., 2011). A further limitation of the research to date is its inattention 
to menstrual status. Only a few previous studies have assessed menstrual status 
and found that approximately 47-65% of patients menstruated after day program 
treatment (Dempfle et al., 2013; Grewal et al., 2014). As such, research is needed 
to determine whether adolescent day programs can effectively restore 
menstruation in those patients who commenced the program with amenorrhoea, in 
addition to weight restoration, a reduction in eating disorder cognitions and 
behaviours, and improvement in general psychosocial functioning.  
Despite the generally positive results, adolescent day programs have not 
been found to benefit all (or even most) patients in terms of a full remission, with 
13 to 71% of patients continuing to meet criteria for an eating disorder at 
discharge (Grewal et al., 2014; Henderson et al., 2014; Ngo & Isserlin, 2014). 
Thus a high research priority is identifying the factors that predict outcome, with a 
view to assisting treatment selection and modifying day programs to best suit 
patients’ needs. However, there is limited research investigating predictors of 
outcome in the adolescent group, particularly why some programs fail to produce 
weight restoration. From the few studies that have examined predictors of 
outcome in adolescent day programs, results suggest that at least some of the 
factors that influence outcome are contrary to those found in adult day programs. 
For instance, percentage of expected body weight (EBW) or body mass index 
(BMI) at commencement of an adolescent day program does not appear to impact 
outcomes (Dancyger et al., 2003; Goldstein et al., 2011; Ngo & Isserlin, 2014; 
Ornstein et al., 2012), which is contrary to the finding in adults which suggests 
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those adult patients who start a day program with a lower BMI are less likely to 
do well in day program treatment (Howard et al., 1999; Zipfel et al., 2000). These 
findings may be related to the relatively recent onset of the illness in adolescents, 
however further replication is needed.  
Ngo and Isserlin (2014) suggest that their day program was not successful 
in terms of weight gain due to previous failed attempts at treatment and patients 
presenting with severe eating disorders. Since few studies have reviewed the 
impact of prior treatment, length of illness or illness severity at commencement of 
an adolescent day program on outcome, the role of these factors remains unclear. 
Ornstein et al. (2012) found that duration of illness did not predict outcome, 
although this may have been due to the young age of patients in their study (8 to 
16 years). In terms of illness severity, Dancyger et al., (2003) reported that higher 
levels of eating disordered cognitions at commencement of day program treatment 
were related to remaining in the day program for longer. In summary, it is 
important to review if factors such as EBW, eating disordered cognitions and 
behaviours, prior length of illness, and previous treatment impact on treatment 
outcome in order to target day program participation to those adolescents where it 
will be most effective.  
As well as needing further clarification regarding the predictors of 
outcome, research is also required to understand the predictors of drop-out from 
adolescent day programs. Treatment drop-out is a problem for day programs, with 
studies reporting drop-out rates from adolescent day programs as high as 42% 
(Grewal et al., 2014). Yet few studies have examined predictors of program 
completion in the adolescent population. Initial results suggest that start weight 
does not predict program completion, while antidepressant medication use and 
lower levels of purging behaviours may be associated with lower drop-out rates in 
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the adolescent population (Grewal et al., 2014). Clearly, further research is needed 
to establish which factors predict drop-out from adolescent day programs so that 
patients at risk of prematurely terminating treatment can be targeted.  
Aims and Hypotheses of the Present Study 
While there is considerable evidence to support the effectiveness of adult 
day programs for treating individuals with eating disorders, the use of adolescent 
day programs to treat eating disorders is an emerging area and further outcome 
data are needed. Moreover, there is only limited (and conflicting) data regarding 
the predictors of treatment outcome and drop-out from day programs for 
adolescents. Thus the current study aims to add to the research on the outcomes 
and predictors of day program treatment for adolescents with eating disorders.  
Based on the positive results of previous research on adolescent day 
programs, it is hypothesised that day program treatment will result in significant 
weight gain, return of menses (in females with amenorrhoea), a reduction in 
eating disordered cognitions and behaviours, and an improvement in general 
psychosocial functioning. Based on the results of other adolescent day programs it 
is hypothesised that EBW at commencement of day program and duration of 
illness will not be predictors of treatment outcome. However, there is limited 
research in the adolescent day program population addressing the impact of age 
and eating disordered cognitions on outcome and drop-out, and if % of EBW or 
prior illness duration predict drop-out rates. Therefore, based on research 
involving the adult population, it is expected that lower % of EBW at 
commencement of treatment will predict higher drop-out rates.  
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Method 
Participants  
Inclusion criteria to participate in the study were: medical stability (as 
assessed by the patient’s General Practitioner based on criteria by Baran, Weltzin 
& Kaye [1995]), diagnosis of AN (binge/purging subtype or restricting subtype) 
or Eating Disorder Not Otherwise Specified (EDNOS; if weight or menses criteria 
were not met for AN) (APA, 2000), adolescent or young adult (still living at 
home), and willingness to participate. Due to a lack of easily accessible inpatient 
treatment facilities, BMI was not an inclusion/exclusion criterion. Hence patients 
with low BMIs were accepted into the day program provided they were medically 
stable and had been given clearance from a medical professional.  
Diagnosis was determined by a clinical interview conducted by 
experienced clinicians prior to starting the day program to ensure that patients met 
diagnostic criteria for AN or EDNOS using the fourth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV-TR; APA, 2000). Patients 
who met criteria for bulimia nervosa or binge eating disorder were excluded from 
participating in the study. However, using BMI as a basis for diagnosis in 
adolescents is limited given research suggesting that BMI in adolescents is not 
indicative of physical health (Trocki, Theodoros, & Shepherd, 1998). While 
percentiles are more accurate in this regard, there are differences in the way 
researchers calculate Ideal Body Weight (IBW) or Expected Body Weight 
(EBW). Most studies use the criterion of 85% of EBW as the cut-off for the 
underweight range, although there is a lack of clarity regarding how IBW or EBW 
is calculated (Le Grange, Doyle et al., 2012; Thomas, Roberto, & Brownell, 
2009). The current study utilised percentage of EBW calculated as BMI/50
th
 
percentile BMI for age, sex, and height x 100 (Faust et al., 2013). 
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Participants in the present study were 39 patients who were admitted 
consecutively to the day program over a period of 3.5 years. Drop-out was defined 
as those patients who disengaged from the day program before an agreed 
termination (i.e., between the patient, parents, and treating team), regardless of the 
number of weeks attended. 
The study received ethical approval from both the ACT Health and the 
Australian National University Human Research Ethics Committees 
(documentation pertaining to ethical clearance is contained in Appendix B). 
Program Description 
The Canberra Eating Disorders Program (EDP) is a public outpatient 
eating disorders unit which provides assessment and treatment to patients with 
any eating disorder in the Australian Capital Territory and surrounding areas of 
New South Wales. The EDP is staffed by three full-time psychologists and social 
workers, a manager, part-time consultant psychiatrist, dietitian, and teacher.  
The EDP day program was modelled on the three-day per week day 
program at the Peter Beumont Centre for Eating Disorders (Thornton et al., 2002). 
It was an open group for patients with AN and subthreshold AN (EDNOS), and 
included a maximum of six patients at any one time. The program ran three days 
per week, ranging from 3.5 to 5.5 hours per day (hours were increased on days 
when tutoring was provided by a school teacher) and with three meals per day 
being provided. There was no set length of treatment, however the program ran on 
10-week terms, which was a practical consideration that enabled the program to 
coincide with school terms rather than an evidence-based one. Program duration 
was individualised depending on patient progress, and was reviewed and agreed 
upon by a multidisciplinary team and also by the patient and parents.  
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Utilising an Enhanced Cognitive Behavioural Therapy approach (CBT-E; 
Fairburn, 2008), the program aimed to achieve weight restoration or maintenance 
(for those who were not underweight), normalisation of eating behaviours and 
attitudes, cessation of compensatory behaviours, return of menses, and improved 
psychosocial functioning. Table 3.1 provides a description of the groups provided 
to patients. Patients were also provided with an hour of individual therapy. 
Patients’ parents were invited to attend the weekly individual sessions with their 
child; however, additional parental sessions were not provided.   
 
Table 3.1 
 
Group Sessions Provided at the EDP Day Program 
 
Name Content 
Meal therapy Supervision and support at meal times 
Challenging “feared” foods 
 
Weighing 
 
Weekly weight checks 
Aim of 500 grams to 1 kilogram per week weight 
gain  
 
Nutrition 
 
Meal planning 
Nutrition education and counselling 
 
Review and planning 
 
Behavioural experiments  
Goal setting  
 
Psychological therapy 
 
CBT-E including psychoeducation, body image, 
perfectionism, interpersonal effectiveness, mood 
regulation and self esteem 
Art therapy 
 
Exercise 
 
Promote balanced exercise 
 
Tutoring 
 
School work 
 
 
Measures  
The data collection occurred at the commencement and completion of 
treatment, and included sex, age, weight, height, % of EBW, duration of illness in 
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months (as calculated by parental report of the onset of symptoms), diagnosis, 
amenorrhoea, and number of weeks in the day program. It also included the 
measures described below.  
Health of the Nation Outcome Scales (HoNOS). The HoNOS assesses 
the behaviour, impairment, symptoms, and social functioning of people with a 
severe mental illness (Wing et al., 1998; Wing, Curtis & Beevor, 1996). It was 
developed to be applicable to adults across a variety of diagnoses and settings. 
The HoNOS is a clinician-rated outcome measure and consists of 12 items that 
cover a wide range of health and social domains, such as psychiatric symptoms, 
physical health, functioning, relationships, and housing. Each item is scored from 
0 (‘no problems’) to 4 (‘severe problems’), with a maximum total score of 48 and 
higher scores indicating greater severity of symptoms and impairment. The 
HoNOS has been used for patients with eating disorders (Bilenberg, 2003; 
Stevens, 2010).  
A version of the HoNOS has been created for young people known as the 
Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA 
[Gowers et al., 1999]). The clinician-rated HoNOSCA is a 15-item measure, with 
the first 12 items being similar to the HoNOS and used to calculate the total score. 
The final three items relate to the child’s environment including school 
attendance, and concerns regarding parental lack of information regarding mental 
illness and access to services (Bilenberg, 2003). Only the first 12 items of the 
HoNOSCA relating to clinical features were used in the present study to allow for 
comparison with the HoNOS.  
The HoNOS and HoNOSCA have been shown to be easy to administer 
and have demonstrated good reliability, validity, sensitivity to change (Brann, 
Coleman, & Luk, 2001; Gowers et al., 1999; Gowers, Levine, Bailey-Rogers, 
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Shore, & Burhouse, 2002; McClelland, Trimble, Fox, Stevenson & Bell, 2000), 
and internal consistency (Cronbach’s alphas ranging from 0.59 to 0.76 [Oiesvold 
Bakkejord & Sexton, 2011; Pirkis et al., 2005]). They have also shown good 
predictive validity relating to patient readmission rates and ongoing levels of 
contact with the service (Kisely, Campbell, Cartwright, Cox, & Campbell, 2010). 
The HoNOS and the HoNOSCA are widely used across Australia, New Zealand, 
Canada, and the United Kingdom (Kisely et al., 2010; Pirkis et al., 2005). 
Eating Disorder Inventory-3 (EDI-3). The EDI–3 (Garner, 2004) is a 
standardised self-report measure of eating disorder symptoms and associated 
psychopathology which can be used from age 13 years to adulthood. It includes 
91 items which combine to create 12 subscales, six composite scores, and three 
response style indicators (inconsistency, infrequency, and negative impression). 
The subscales include: Drive for Thinness, Bulimia, Body Dissatisfaction, Low 
Self-Esteem, Personal Alienation, Interpersonal Insecurity, Interpersonal 
Alienation, Interoceptive Deficits, Emotional Dysregulation, Perfectionism, 
Asceticism, and Maturity Fears. The composite scores include: the Eating 
Disorder Risk Composite (made up of the Drive for Thinness, Bulimia, and Body 
Dissatisfaction subscales), Ineffectiveness, Interpersonal Problems, Affective 
Problems, Overcontrol, and General Psychological Maladjustment. The EDI-3 
provides norms for clinical samples and has been shown to be a reliable and valid 
measure of eating disordered and associated symptomatology (Clausen, 
Rosenvinge, Friborg, & Rokkedal, 2011; Cumella, 2006; Mizes, Heffner, 
Madison, & Varnado-Sullivan, 2004).  
Procedure  
Prior to commencement of the day program, patients and parents attended 
an initial assessment, which included a clinical interview and administration of 
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the outcome measures (copies of consent and information forms are included in 
Appendix C). The self-report (EDI-3) and clinician-rated (HoNOS or HoNOSCA) 
outcome measures were re-administered when the patient completed their day 
program treatment. Not all patients provided complete self-report measures at 
commencement due to refusal (n = 8), and at completion of the day program due 
to refusal or missing follow-ups (n = 20). As such, the results presented do not 
always include the full sample.  
Statistical Analysis 
To assess outcome, pre-treatment scores on continuous measures were 
compared with post-treatment scores using paired t-tests. Percentage of change 
from pre- to post-treatment for categorical variables was examined using 
McNemar’s test. Predictors of treatment outcome were examined using regression 
analysis, while an exploratory analysis (due to small sample size) examined 
predictors of treatment drop-out using logistic regression analysis. SPSS version 
22 was used for all analyses, with the two-tailed significance level set at p < .05. 
Results 
Characteristics of the Sample  
A total of 39 patients started the day program and, of these, 34 patients 
continued until an agreed upon discharge. Five female patients dropped out of 
treatment. Table 3.2 shows the characteristics of the sample of patients at 
commencement of the day program. At the pre-treatment assessment, 10 patients 
met DSM-IV-TR criteria (APA, 2000) for AN restricting type, three patients met 
criteria for AN binge/purge subtype, and 26 patients met criteria for EDNOS due 
to not meeting the weight and/or menses criteria for AN. All patients would meet 
the DSM-5 criteria for AN or Atypical AN (APA, 2013). Thirteen patients were 
underweight (less than 85% of EBW for BMI for age and sex), 22 patients were 
 75 
between 85% and 99% of EBW for age and sex, and four patients were at 100% 
of EBW for age and sex (despite having lost weight).  
 
Table 3.2  
Description of the Sample at Commencement of the Day Program 
Characteristic M SD 
 
Age 
 
15.7 
 
1.73 
 
% EBW  
 
87.15 
 
9.34 
   
Duration of illness (months) 
 
14.1  8.43 
Number of weeks attended 
 
14.36 10.42 
Characteristic n % 
 
Amenorrhoea  
 
 
25 
 
67.6 
  
Menstruating 7 18.9 
 
On oral contraceptive  
 
5 
 
13.5 
 
Female  
 
37 
 
 
94.9 
Male  2 5.1 
 
AN -Restricting subtype 
 
10 
 
25.6 
 
AN –Binge/purge subtype 
 
3 
 
7.7 
 
EDNOS  
 
 
26 
 
66.7 
Note. EDNOS: Eating Disorder Not Otherwise Specified. EBW: Expected body weight.  
N = 39 (except for Amenorrhoea, Menstruating and On oral contraceptive, where N = 37) 
 
 
Treatment Outcome 
There was a significant increase in percentage of EBW from 
commencement of the day program (M = 87.15, SD = 9.34) compared with 
completion of the day program (M = 93.03, SD = 9.65), t(33) = 3.47, p = .001. 
The mean increase was 5.88 with a 95% confidence interval ranging from 2.44 to 
9.32 and the eta squared statistic (.27) indicated a large effect size. Given that 
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some patients did not need to gain weight, paired samples t tests were also 
completed with only those who needed to gain weight. Of these 13 patients who 
were less than 85% of EBW at pre-treatment, eight (61.5%) were at 85% of EBW 
or more at post-treatment, and this increase was significant, with pre-treatment 
EBW (M = 78.28, SD = 5.40) increasing significantly to post-treatment EBW (M 
= 89.42, SD = 11.81), t(13) = 3.90 , p = .002. The mean increase was 11.13 with a 
95% confidence interval ranging from 4.98 to 17.29 and the eta squared statistic 
(.32) indicated a large effect size. However, four patients (10.3%) lost weight 
during treatment, with the amount of weight loss ranging from 2.2kgs to 5.95kgs.  
For female patients, only 18.9% of patients menstruated at the start of day 
program. By the completion of the day program, 62.2% of patients were 
menstruating, and McNemar’s Test showed that this change was significant, p < 
.001.  
There was a significant change in patients HoNOS/CA clinician-rated 
scores from pre- (M = 13.02, SD = 6.88) to post-treatment (M = 6.94, SD = 5.58), 
t(33) = 4.45, p < .001. The mean decrease was 6.08 with a 95% confidence 
interval ranging from 3.3 to 8.87 and the eta squared statistic (.38) indicated a 
large effect size. However, three patients (7.7%) experienced an increase in the 
HoNOS/CA scores, indicating that the clinician perceived the patient’s severity to 
have increased after treatment.  
Pre- and post-treatment EDI-3 composite scores including the Eating 
Disorder Risk Composite (EDRC), Ineffectiveness, Interpersonal Problems, 
Affective Problems, Over Control, and General Psychological Maladjustment 
were also compared. As can be seen in Table 3.3, the EDRC showed a significant 
reduction from pre- to post-treatment, t(18) = 2.46, p = .024. The mean decrease 
was 17.68 with a 95% confidence interval ranging from 2.59 to 32.78 and the eta 
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squared statistic (.25) indicated a large effect size. The Over Control composite 
scale also reduced significantly from pre- to post-treatment, t(18) = 2.17, p = .043. 
The mean decrease was 7.84 with a 95% confidence interval ranging from 0.27 to 
15.41 and the eta squared statistic (.21) indicated a large effect size. No other 
scale scores were significantly different from pre- to post-treatment. 
Table 3.3 
Means and Standard Deviations for the Composite Scales from the Eating 
Disorder Inventory (EDI-3)  
 Pre-treatment Post-treatment 
M SD M SD 
Eating Disorder Risk 
Composite (EDRC) 
150.58* 22.01 132.89* 32.73 
Ineffectiveness 93.31 17.35 89.95 19.14 
Interpersonal Problems 96.47 18.42 97.79 21.52 
Affective Problems 100.37 16.46 93.74 18.72 
Over Control 101.79* 16.27 93.95* 15.85 
General Psychological 
Maladjustment 
451.05 60.43 427.05 77.13 
Note. n = 19.   * p < .05 
 
Predictors of % of EBW at Completion of the Day Program  
Multiple regression analysis was used to predict the impact of starting % 
of EBW, age, duration of illness, and eating disordered symptoms (measured by 
the EDI-3 EDCR score at commencement) on EBW at completion of the day 
program. As Table 3.4 shows, higher % of EBW and younger age at 
commencement were significant predictors of higher EBW at completion.  
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Table 3.4  
Results of the Multiple Regression Analysis for EBW at Completion of the Day 
Program  
Item Coefficient 
Standard 
error 
t value p 
 
Duration of illness  
 
-.215 
 
.102 
 
-1.83 
 
.078 
 
EBW at commencement 
 
.437 
 
.125 
 
3.69 
 
.001 
 
Age 
 
 
-.498 
 
.775 
 
-4.09 
 
.000 
EDI-3 EDRC at commencement -.164 .057 -1.37 .181 
Note. EBW: Expected body weight. EDI EDRC: Eating Disorder Inventory-3 Eating Disorder 
Risk Composite. R
2
 = .701, Adjusted R
2
 = .655.  n = 31 
 
Predictors of Drop-Out From the Day Program  
Logistic regression analysis was used to predict the factors which may 
have increased the likelihood of drop-out. The results are exploratory in nature 
given that only five patients (12.8%) prematurely dropped out of the day program. 
Percentage of EBW and duration of illness at commencement were analysed to 
see if they predicted treatment non-completion due to the inconsistencies in 
previous research involving predictors of drop-out. The full model containing all 
predictors was significant, X
2
 (2, N = 39) = 7.03, p = .030, indicating that the 
model was able to identify treatment non-completers. The model as a whole 
explained between 16.5% (Cox & Snell R Square) and 30.8% (Nagelkerke R 
Square) of the variance in drop-out rates and correctly classified 89.7% of cases. 
As shown in Table 3.5 only % of EBW made a unique significant contribution to 
the model, indicating that those with a higher % of EBW at commencement of the 
day program were 1.17 times more likely to drop-out of the program.  
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Table 3.5  
Results of the Logistic Regression Analysis Predicting Drop-out from the Day 
Program  
 B S.E. Wald df p 
Odds 
Ratio 
95% C.I. for     
Odds Ratio 
       Lower Upper 
 
Starting 
% of 
EBW 
 
.160 
 
.078 4.23 1 .040 1.17 1.01 1.37 
 
Illness 
duration  
.048 .045 1.15 1 .283 1.05 .961 1.15 
Note. EBW: Expected body weight. 
 
Discussion 
The current study aimed to replicate and extend previous research 
examining the outcomes of day program treatment, as well as the predictors of 
outcome and drop-out, for adolescents with eating disorders. The results provide 
additional support for the effectiveness of day program treatment as well as 
support for the role of higher body weight and younger age in predicting higher 
body weight at the end of treatment, but with higher body weight associated with 
a greater likelihood of dropping out of treatment. 
Findings of the Present Study 
In terms of outcome, the results supported the benefits of the day program 
for the goal of weight gain or weight maintenance for patients. At the completion 
of the day program, there was a significant increase in weight for patients, 
including those who were underweight at commencement. Almost 80% of 
patients were discharged from the day program with a weight at or above 85% of 
EBW. This is consistent with past research in adults demonstrating that day 
programs lead to an increase in BMI (Gerlinghoff et al., 2004; Kong 2005; Zeeck 
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et al., 2004), and is at the upper end of the results reported for other adolescent 
day programs. For example, other day programs which are open ended and have a 
similar treatment length (an average length of stay of around 10-15 weeks), 
reported 58% to 84% of patients being discharged with their weight at or above 
85% of EBW (Dancyger et al., 2003; Goldstein et al., 2001). The weight gain 
results and high percentage of patients who were discharged at or above the 85% 
EBW in the current study may reflect relatively high starting weights. They may 
also reflect high levels of motivation to change (either on the part of the young 
person or the parents) given that day program attendance was voluntary and those 
adolescents or families who did not wish to engage were offered individual 
therapy.  
The day program also aimed to restore menses in those patients who 
started the program with amenorrhoea. At the commencement of day program 
only 18.9% of female patients menstruated and by the end of the day program this 
figure had risen to approximately 63%. This change was significant, and it 
suggests that some physical restoration occurred for a majority of patients through 
their day program attendance. This finding is similar to that reported in other 
adolescent day programs (Dempfle et al., 2013; Grewal et al., 2014; Herpertz-
Dahlmann et al., 2014), where 47-65% of patients menstruated at completion of 
the program. Return of menses was not discussed in other adolescent day 
programs where EBW was considered a sign of returning to physical health. This 
is concerning given that EBW does not always reflect a return to physical health 
(Trocki et al., 1998). Thus the current findings extend previous research in 
supporting the effectiveness of day program treatment for this important outcome 
variable. 
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Contrary to the significant increases in weight indices from pre- to post-
treatment, the findings on psychological change were inconsistent. There was 
evidence of a significant reduction in core eating disordered cognitions and 
behaviours as indexed by the EDI-3 Eating Disorder Risk Composite, which 
combines the subscales of Drive for Thinness, Bulimia, and Body Dissatisfaction. 
This finding indicates that the participants perceived a reduction in their eating 
disordered thoughts and behaviours by completion of the day program. This result 
is consistent with that obtained by Goldstein et al. (2011) who reported a 
significant reduction in the EDI-3 Drive for Thinness subscale among adolescents 
after day program completion. A significant reduction in the EDI-3 composite 
score Over Control was also found by the end of day program treatment in the 
current study. The reduction in the Over Control score indicates that patients 
perceived themselves as less perfectionistic and displayed reduced behaviours 
related to suffering and self sacrifice for the pursuit of perfectionism. This change 
is also consistent with a study that found reduced perfectionism in adolescent 
patients by day program completion (Goldstein et al., 2011). 
In contrast, there was no evidence of a significant reduction in the other 
composite measures of the EDI-3, namely, Ineffectiveness, Interpersonal 
Problems, Affective Problems, and General Psychological Maladjustment. These 
findings may reflect the fact that considerable time is needed for change in these 
psychological constructs. For example, Girz et al. (2013) found that change on 
psychological measures only occurred after three to six months, while some 
patients in the current study only attended the day program for two weeks, with a 
mean attendance of 3.5 months.  
The aim of improving general psychosocial functioning was achieved and 
reflected in a reduction of HoNOS and HoNOSCA scores from the 
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commencement to completion of day program treatment. The improvement in 
patient’s overall psychosocial functioning may have been due to the day program 
including groups such as distress tolerance and assertiveness and communication, 
which were targeted at improving overall psychological and social functioning. 
These results are in contrast to the EDI-3 composite scores of Ineffectiveness, 
Interpersonal Problems, Affective Problems, and General Psychological 
Maladjustment which did not improve significantly after day program attendance. 
These contradictory results may represent differing opinions of change in 
psychological functioning (the clinician rated HoNOS/CA compared with the self-
report EDI-3). These discrepant findings underscore potential differences in the 
perceptions of patients and clinicians, and suggest that, although they have been 
absent to date, research on day programs for adolescents would benefit from the 
inclusion of clinician-based measures. 
In addition to assessing treatment outcome, the present study also sought 
to identify predictors of outcome. Among these, higher EBW at the 
commencement of the day program was found to be a significant predictor of 
higher EBW at completion. This is supported by recent research in adolescent 
inpatient admissions that suggests that BMI percentile at admission predicted 
BMI percentile at discharge and follow-up (Focker et al., 2015; Steinhausen, 
Grigoroiu-Serbanescu, Boyadjieva, Neumarker, & Metzke, 2009). Specific to day 
programs research has found that admission weight did not predict end weight in 
adolescent day programs (Dancyger et al., 2003; Goldstein et al., 2011; Ngo & 
Isserlin, 2014; Ornstein et al., 2012). Previous studies of adolescents that have not 
found a relationship between weight at the commencement and completion of day 
program treatment may have had a restricted range of weight at commencement 
which resulted in the non significant findings (e.g., Dancyger et al., [2003] 
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required a starting weight of 85% of EBW to commence day program treatment). 
The findings of the current study are consistent with research on adults finding 
that lower BMI at commencement predicts poorer outcome from day program 
treatment (Howard et al., 1999; Zipfel et al., 2000).  
In addition to pre-treatment EBW, patient age was also a significant 
predictor of EBW at completion of the day program, with younger patients 
achieving a higher EBW at the end of the day program. This finding is consistent 
with one study that found adolescent age at admission to be a predictor of BMI 
percentile at discharge (Focker et al., 2015). However, there is limited research 
regarding the impact of age on day program outcomes, especially in adolescents. 
Yet it is clear that there are differences in the presentation and treatment of eating 
disorders in adults compared with older and younger adolescents (Ornstein et al., 
2012). For instance, younger adolescents report lower levels of motivation to 
change than adults (Goddard et al., 2013; Ngo & Isserlin, 2014) and therefore 
most day programs (including the current study) offer sessions where parents can 
attend or parent groups (e.g., Goldstein et al., 2011). Thus the increase in EBW at 
completion for the younger age group may reflect higher levels of parental control 
in the younger age group, which can improve treatment outcomes. In this regard, 
Family Based Treatment (FBT) is most effective in those under age 19 (Lock & 
Le Grange, 2013). Given that these considerations are speculative, further 
research is needed regarding the mechanisms by which adolescent age impacts on 
the effectiveness of day program treatment.  
In contrast to pre-treatment EBW and age, there was no evidence of the 
EDRC composite score of the EDI-3 at commencement of treatment predicting 
day program outcome in terms of weight restoration. This suggests that the level 
of eating disordered cognitions and behaviours at commencement of an adolescent 
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day program does not impact on weight at completion. There is limited research 
regarding the impact of severity of illness on adolescent day program outcomes. 
In contrast to the results of the current study, higher levels of eating disordered 
cognitions at commencement of a day program were found in a previous study to 
be associated with patients attending for a longer length of treatment (Dancyger et 
al., 2003), which may have in turn resulted in higher weight at completion. It may 
therefore have been the longer length of treatment, rather than higher eating 
disordered cognitions, that predicted higher weight.  
There was a trend (p = .078) towards a shorter duration of illness 
predicting a higher EBW at treatment completion, which may have resulted from 
limited power. If such a finding is replicated in larger studies on adolescent 
samples it would be consistent with the adult literature where shorter duration of 
illness predicts better outcomes (Howard et al., 1999; Williamson et al., 2001).  
The present study also sought to examine potential predictors of treatment 
drop-out as another index of outcome. Drop-out rates from adolescent day 
programs vary greatly, with previous studies reporting drop-out rates from as low 
as 7.1% (Goldstein et al., 2011) to as high as 42% (Grewel et al., 2014). The 
current program had a drop-out rate of 12.8%. The high day program completion 
rate obtained in the current study may have been due to the relatively higher levels 
of motivation of the patients given that treatment was voluntary and less 
motivated patients may have attended individual therapy.  
The present study sought to increase awareness of the factors which 
pertain to drop-out. Those patients with a higher % of EBW at commencement of 
day program were 1.17 times more likely to drop-out of day program treatment. 
These findings are in direct contrast to the adult literature which suggests that low 
starting weight predicts drop-out (Jones et al., 2007). This inconsistency may 
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reflect the fact that a primary focus of the current day program was weight gain; 
hence those patients who were attending the day program for weight maintenance 
may have found the program less tailored to their needs which increased the 
likelihood of prematurely discontinuing treatment.   
Limitations of the Present Study and Directions for Future Research 
While the findings of this study highlight the effectiveness of an 
adolescent day program in achieving weight gain or maintenance, as well as a 
return of menses, in those with AN, there are some important limitations to 
consider. First, the current sample is not necessarily comparable to previous day 
program samples, making comparisons difficult. For example, due to a lack of 
readily available inpatient services, 10 patients started the day program with a 
BMI or percentage of EBW that may have been considered too low to engage in 
the treatment. This feature of the sample must be borne in mind when interpreting 
the findings, particularly those that are inconsistent with previous research such as 
the role of lower body weight in predicting improved weight outcomes and a 
lower likelihood of dropping out. 
A second noteworthy limitation is that the sample size was small, and 
missing data further reduced this number. The small sample size (and its 
implications for power) mean that the results of the day program need to be 
interpreted with caution (especially the marginally significant finding regarding 
illness duration and treatment outcome) and further investigation and replication 
is needed. Nevertheless, while data collection in clinical settings is often 
inconsistent, such research provides a valuable insight into ‘real world’ treatment 
where patients are not excluded for issues such as comorbidity, suicidality or low 
weight (Norris et al., 2013).  
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A third limitation is that the current study did not include any follow up of 
patients after completion of the program. Thus while the findings highlight the 
effectiveness of an adolescent day program by treatment completion, follow up of 
patients at least one year later would provide evidence that the gains achieved in 
the day program were maintained over the longer term.  
Finally, the fact that the present study, like the bulk of the research on day 
programs, is not a controlled trial means that it is unclear as to how the current 
program directly compares to other promising treatments for adolescents with 
eating disorders, such as FBT. Such comparisons constitute a high priority for 
future research in order to identify the most effective treatments for this 
population. 
Summary 
Taking into account the small sample size of this study, the findings 
provide further support for day programs for adolescents with AN and related 
disorders in terms of weight, core eating disorder cognitions and behaviours, and 
general psychosocial functioning (at least as assessed by clinicians). The low 
drop-out rate in the current and other day programs indicates that adolescents can 
tolerate this treatment modality (Goldstein et al., 2011; Stevens, 2010). Yet there 
are limited and conflicting findings regarding the predictors of outcome and drop-
out from day program treatment for adolescents, with findings from the present 
study suggesting the relevance of higher pre-treatment weight and younger patient 
age in impacting on higher weight outcomes, and lower pre-treatment weight on 
completion rates. Future research should continue to evaluate the effectiveness of 
day programs (especially in comparison to other treatment approaches) and 
evaluate the predictors of outcome and drop-out so as to provide the most 
effective treatment options to adolescent patients with eating disorders.   
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Chapter 4 
Treatments for Adolescents with Eating Disorders: Family Based Treatment 
Chapter Overview  
This chapter will review the historical origins of Family Based Treatment 
(FBT), and discuss the core components of the model and phases of treatment. 
The chapter will then examine the evidence base for FBT, including strengths, 
adaptations to the model, and the limitations of FBT and the current research base. 
Family Based Treatment (FBT) 
There is emerging evidence that FBT for adolescents with anorexia 
nervosa (AN) should be recommended as the first line treatment (Eisler, Lock, & 
Le Grange, 2010; Lock, 2011; Stiles-Shields, Hoste, Doyle, & Le Grange, 2012). 
The use of FBT or ‘Maudsley Family Therapy’ as it is also known, became 
widespread after it was manualised in 2001 (Lock et al., 2001). Current research, 
including randomised controlled trials, suggest that FBT is the most effective 
treatment for adolescents with AN, particularly in those under 19 years of age and 
with an illness duration of less than three years (Eisler et al., 2000; Le Grange et 
al., 2004; Lock, Couturier, & Agras, 2006; Murray & Le Grange, 2014; Russell, 
Szmukler, Dare, & Eisler, 1987).  
FBT is based on the assumption that parents are the best resource to bring 
their adolescent with AN back to full health, given their unparalleled knowledge 
of their child, and their dedication to their child’s wellbeing. The notion that the 
family is in some way to blame for the development of the AN is strongly 
opposed. FBT aims to restore the child’s weight and physical health, promote 
adolescent responsibility around eating, and encourage normal adolescent 
development free of AN. In short, FBT seeks to empower parents to use all of 
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their expertise as parents to support their child back to full health and cease all 
AN behaviours (Lock et al., 2001).  
History of Family Therapy in the Treatment of Anorexia Nervosa  
Family therapy has been used in the treatment of AN with varying degrees 
of success over the past 30 years. Previously, family therapy to treat AN involved 
the family attending treatment whereas FBT views the parents as a resource to 
help the adolescent fight AN. Despite this difference, FBT draws on some of the 
theoretical foundations of other types of family therapy (Rhodes & Wallis, 2009).  
Structural family therapy. The use of structural family therapy in the 
treatment of AN was first developed by Minuchin et al., (1975). It came from an 
adapted version of their work with antisocial boys and their families. This 
approach assumed that the precursor to AN was a family style characterised by 
rigidity, enmeshment, over-involvement, and conflict avoidance, which was 
combined with a focus on physical functioning in the child and using the child as 
a mediator of conflict. In this view, AN develops in early adolescence as a way to 
change the family dynamics and patterns of interaction which are beginning to 
deteriorate due to the developmental needs of the emerging adolescent. Once the 
adolescent has developed AN, the parents refocus their attention and vigilance on 
the child, who is now more dependent, and AN becomes part of the adolescent 
and family identity. Indeed, AN functions to stabilise family dynamics. In this 
view of the illness, the parents were not to blame, but the constellation of 
dynamics known as the ‘psychosomatic family’ was viewed as necessary for the 
development of AN. The aim of treatment was to change the way the family 
functioned and decrease the importance of and interaction with the illness. It was 
thought that once the family took an active role in changing the problematic 
eating patterns, the parental team would realign which would create a reduction in 
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conflict avoidance and the enmeshed parenting styles. FBT uses elements of 
structural family therapy including the family meal, elevating parents into the 
parental position, highlighting intergenerational boundaries, encouraging direct 
communication between family members, pushing for change, and therapist 
modelling in session (Lock et al., 2001; Rhodes & Wallis, 2009).  
Systemic family therapy. Systemic family therapy was developed by the 
Milan group and placed an emphasis on intergenerational coalitions (Selvini 
Palazzoli, Boscolo, Cecchin, & Prata, 1980; Selvini Palazzoli, 1974). They took 
the view that the family of the adolescent with AN seeks to maintain homeostasis 
in the face of the adolescent trying to develop their own identity. In response to 
this, it was proposed that families then develop rigid and mechanistic patterns of 
interaction. Family therapy focused on assisting the families to observe their own 
patterns of interaction and, through this observation, to make changes. The 
therapist took the view that the family interactional style was unintentionally due 
to the parents trying to be protective rather than as a result of dysfunction. Akin to 
systemic family therapy, FBT takes a non-blaming position, uses circular 
questioning to promote change, and allows the family to take their own direction 
as ‘experts’ of their family (Lock & Le Grange, 2013).  
Narrative therapy. Narrative therapy rejected the view that AN was 
related to family functioning and instead took the approach that societal pressures 
encouraged the illness identity in those with AN. Treatment therefore focused on 
externalising the illness and allowing the patient to recognise and reject the voice 
of AN. Parents were also told to help the adolescent distinguish his/her voice and 
beliefs from that of the illness (White & Epston, 1990). FBT takes the 
externalisation of AN from narrative therapy, however narrative therapy did not 
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include a focus on weight gain or normalising eating (Lock & Le Grange, 2013; 
Rhodes & Wallis, 2009).  
Development of FBT  
Traditionally adolescents with eating disorders were included in adult 
studies and provided with the same treatment options as adults (Gowers & 
Bryant-Waugh, 2004). The development of FBT from the Maudsley Hospital in 
London led to a treatment created solely for adolescents with AN, which focused 
on including the family in treatment (Lock et al., 2001). As described above, FBT 
combines some of the theoretical and intervention underpinnings from different 
types of family therapy. However, FBT is distinctive in that it has been subjected 
to a number of treatment trials (Le Grange & Eisler, 2008; Rhodes & Wallis, 
2009). Paradoxically, since the research into the effectiveness of FBT has grown, 
research into the family therapies from which FBT was developed have been 
found to be inaccurate (Eisler, 2005). For example, research has shown that there 
is no particular family style or dysfunctional family which is related to the 
development of an eating disorder, and that the families of adolescents with AN 
are more similar to control groups than to other groups with psychiatric 
conditions. Moreover, any family dysfunction that is present could be a 
consequence (rather than a cause) of living with a serious psychiatric illness in a 
family member (Eisler, 1995; North, Gower, & Byram, 1995). 
As such, FBT moves the focus of treatment from the dysfunctional or 
problematic family to working with the family and harnessing its strengths (Eisler 
et al., 2010). FBT does not focus on aetiology or the body image disturbance of 
AN; instead, it aims to create change by exposing the adolescent to feared foods 
and weight ranges, and restructuring the family system and improving mood and 
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cognitions through weight restoration (Eisler, 2005; Hildebrandt, Bacow, 
Markella, & Loeb, 2010; Lock & Le Grange, 2013; Loeb & Le Grange, 2009).  
Core Components of FBT 
FBT combines both aspects of past family therapy and a number of current 
theoretical assumptions to treat adolescents with AN. The manual lists five core 
components to treatment including parental control, parental consistency, 
externalising the illness, restructuring the family, and sibling support (Lock & Le 
Grange, 2013).  
Parental control and parental consistency. In FBT, the therapist takes 
the view that the causes of AN are unknown or unclear and therefore, early in 
treatment, the focus is not on aetiology. FBT also resists the view that the family 
are in some way to blame for the AN; instead, the family are encouraged to 
dismiss any feelings of guilt. This allows the parents to refocus their attention on 
re-feeding the adolescent, fighting AN, and being a resource to support their child 
through recovery. It is thought that the parents have dismissed their natural 
instincts and allowed a level of accommodation to AN due to the strength and 
persistence of the AN. Parents are viewed in a positive light and it is assumed that 
they have the motivation and capacity to support their child’s recovery. Parents 
are also supported to work together as a consistent parental team in eliminating 
AN behaviours (Lock & Le Grange, 2013; Murray, Wallis, & Rhodes, 2012; 
Rhodes & Wallis, 2009). Research has found that prompts from parents do lead to 
increased eating in adolescents with AN (White et al., 2015).  
Externalising the illness. Separating AN from the adolescent and instead 
externalising AN as the problem, unites the family towards a common enemy and 
allows them to focus their energy on fighting AN. Externalisation also reduces 
blame towards the adolescent who may be perceived to be causing problems for 
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the family. The therapists use of externalising language models a way to deal with 
high expressed emotion within the family (e.g., critical comments), which may 
otherwise be directed at the adolescent. This is a particularly important component 
given that high levels of parental criticism are related to higher drop-out rates (Le 
Grange, Eisler, Dare, & Russell, 1992; Szmukler, Eisler, Russell, & Dare, 1985).  
Restructuring the family. In the early stages of FBT, the focus is entirely 
on ceasing AN behaviours and treating the illness. Any family conflicts that do 
not directly impede weight gain are not addressed until weight is restored. 
However, it is likely that changes will be made to the family structure and 
dynamics through the process of re-feeding. For instance, the parental alliance 
will need to strengthen to fight AN, and the communication within the family will 
improve. The adolescent will also be aligned with the sibling subsystem as parents 
take charge of the family to support the adolescent to eat (Lock & Le Grange, 
2013; Murray, Wallis et al., 2012; Rhodes & Wallis, 2009).  
Sibling support. Support from siblings, particularly as parents take on the 
difficult task of re-feeding, was thought to help reduce distress and anxiety in the 
adolescent with AN. However, to date there is minimal support for this intuitive 
notion. For instance, the presence or absence of siblings during FBT sessions does 
not appear to directly impact on outcome (Ellison et al., 2012; Eisler et al., 2000; 
Le Grange et al., 1992). In addition, one study reviewed each of the five core 
components of manualised FBT in predicting weight gain, and found a lack of 
evidence for the notion of the benefits of sibling support (Ellison et al., 2012). 
Specifically, at the end of each session, the clinician rated parental adherence to 
the five key areas. It was found that greater adherence to the components of 
parental control, parental consistency, externalising the illness, and restructuring 
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the family were associated with greater weight gain in the adolescent. However, 
sibling support did not predict weight gain.  
Phases of Treatment in FBT  
FBT involves three distinct phases to support the adolescent’s return to 
full health and recovery from AN: re-feeding, returning control of eating back to 
the adolescent, and focusing on the development of a healthy identity and 
‘normal’ family life. Although these are clearly defined in the treatment manual 
(Lock & Le Grange, 2013), in day-to-day practice these phases often overlap.  
Phase 1: Re-feeding the adolescent. In phase one of FBT, the focus is on 
treating the AN and re-feeding the adolescent. It is usually the longest phase, 
ranging from 10 to 15 sessions in the 20-session model set out in the manual 
(Lock & Le Grange, 2013). The aim of phase one is to bring about weight 
restoration, usually to at least 90% of expected body weight (EBW), with rapid 
weight gain of 250 grams to one kilogram per week encouraged. Parents are 
required to support their adolescent at meal times, take back responsibility for 
food choices, and present the adolescent with meals that will result in weight gain. 
If the adolescent also engages in compensatory behaviours, then the parents are 
encouraged to monitor the adolescent to cease all compensatory behaviours. Each 
session, the adolescent is weighed and the direction of weight change (loss or 
gain) will set the agenda for the rest of the session. Re-feeding and ceasing AN 
behaviours takes precedence over all other areas of the adolescent’s life and 
family functioning.  
Notwithstanding the aforementioned lack of empirical evidence to date for 
the sibling component, siblings are encouraged to provide support for the 
adolescent while parents take charge of re-feeding. This aims to allow for 
 94 
structural change within the family; the parents are realigned as the parental team 
and the adolescent is realigned with his/her siblings.   
Additional components include the therapist spending time alone with the 
adolescent with AN prior to the commencement of the family session in order to 
enhance the therapeutic alliance between the adolescent and the therapist. The 
family are also provided with psychoeducation regarding the effects of AN, 
particularly the medical complications, in an effort to increase the intensity and 
rate of weight gain. Treatment of any co-morbid illnesses, such as anxiety and 
depression, is seen as secondary to the need to terminate self-starvation.  
The family meal. The family meal is usually included as the second 
session, where the family are asked to bring a meal to the session. The aim of the 
family meal is to encourage the parents to increase the child’s dietary intake so as 
to consume more than the AN will allow (Lock & Le Grange, 2013; Rhodes, 
2003).    
The family meal was originally part of Minuchin’s approach to treating 
AN with family therapy (Minuchin et al., 1975). Minuchin and his colleagues 
would begin family therapy sessions with a meal to allow the observation but also 
the challenging of family patterns. Parents were encouraged to take charge of food 
restriction and to stop avoiding conflict. This promoted parents back into the 
parental role and freed the adolescent from AN. Re-feeding and weight gain were 
important, however parents were encouraged to focus on the adolescent’s bodily 
functions for only a short period of time. Later on parents were also encouraged to 
allow eating patterns to return naturally and focus on other issues such as spousal 
conflict.  
In FBT the family meal allows the therapist and the family to review the 
ground taken by AN in the family home. It also provides an opportunity for the 
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therapist to coach the parents to have their adolescent eat extra amounts of a 
challenging food (Godfrey et al., 2015). Parents are also coached to notice and 
challenge any AN behaviours (e.g., cutting food into small pieces) during the 
meal. The family meal allows the parents to feel successful at feeding their child 
and fighting the AN, and it demonstrates to the adolescent that there is no choice 
in recovery because the parents are determined to overcome the AN (Eisler et al., 
2010; Lock & Le Grange, 2013; Rhodes & Wallis, 2009). Interestingly, the family 
meal may not actually impact on outcome, with a separated model of FBT where 
the parents and adolescent are seen separately and therefore the family meal is not 
completed, proving just as effective as the standard version (Eisler et al., 2000; Le 
Grange et al., 1992). 
Phase 2: Negotiations for a new pattern of relationships. Phase two of 
FBT occurs when the adolescent has gained weight (usually to 90-95% of EBW), 
and is able to eat without parental persuasion (Eisler et al., 2010; Lock & Le 
Grange, 2013; Murray, Griffiths, & Le Grange, 2014; Rhodes, 2003; Rhodes & 
Wallis, 2009). This phase usually lasts for two to three months, with sessions held 
on a fortnightly basis. The adolescent continues to be weighed each session, with 
continued weight gain expected albeit at a more gradual rate. By this phase, it is 
expected that the family feels more in control of the AN and the adolescent is not 
displaying any AN behaviours. Thus the focus of phase two is to shift towards the 
adolescent with AN assuming greater responsibility for food and eating, including 
being responsible for meal choices, food preparation, increased variety of food 
selections, and eating with peers at a developmentally appropriate level. The 
adolescent is encouraged to reconnect with peers and reengage in previous social 
and recreational activities. Parents are encouraged to return to their everyday lives 
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and re-focus on their relationship now that the crisis and intense re-feeding phase 
is over. 
Phase 3: Adolescent issues and termination. The final phase occurs 
when control of eating has been returned to the adolescent, weight restoration is 
complete and menses (if absent) has returned (Eisler et al., 2010; Rhodes, 2003; 
Rhodes & Wallis, 2009). It usually consists of two to three sessions held four to 
six weeks apart. The focus of phase three is to restart the ‘normal’ adolescent 
developmental trajectory, which was deviated from as a result of AN. Given that 
physical health and safety have been re-instated, adolescent issues can now be 
explored. The family is supported in communicating in relation to, and problem-
solving, these issues, with parents encouraged to allow developmentally 
appropriate independence. If other comorbid illnesses or family or couple issues 
exist, then they are addressed in phase three, either by the therapist or with 
appropriate referral. At termination, the family are asked to review the progress 
they have made throughout the course of treatment, both as a family and as 
individual family members, and to identify strategies for relapse prevention (Lock 
& Le Grange, 2013). 
Review of the Evidence Base for FBT  
Early treatment studies, prior to the manualised version of FBT being 
widely disseminated, evaluated various forms of family therapy that were similar 
to FBT, and lent support to the use of family based approaches in the treatment of 
AN (Ball & Mitchell, 2004; Geist, Heinmaa, Stephens, Davis & Katzman, 2000; 
Robin et al., 1999). FBT proper has been subjected to a number of randomised 
controlled trials (RCTs) for adolescents with eating disorders, with the first being 
conducted prior to the publication of the manual. This first RCT compared FBT to 
supportive individual therapy and included 80 patients (57 with AN and 23 with 
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BN) aged between 14 and 55 years (Russell et al., 1987). All patients were also 
admitted for a 10-week admission prior to the commencement of the trial. FBT 
was found to be more effective than individual therapy, and led to 90% of patients 
achieving 85% or more of EBW and 60% of patients experiencing a return of 
menses. After examining the difference in outcomes for different ages, it was 
found that FBT was most suitable for adolescents with an illness duration of less 
than three years, where the illness began before the age of 19 years. At a five-year 
follow-up study it was found that FBT was again superior to individual therapy 
(Eisler et al., 1997). Of the adolescents in the FBT treatment group, 90% had a 
good outcome (based on the Morgan-Russell outcome criteria where a good 
outcome is defined as weight within 15% of EBW, menstruation, and no bingeing 
or purging), whereas 50% of those in the individual therapy group continued to 
experience eating disordered symptoms. However, the version of FBT undertaken 
in the study differed slightly from the manualised version (Lock & Le Grange, 
2013), with only the first two phases of treatment undertaken. In addition, the 
study included hospitalisation prior to commencing FBT for all patients, and the 
adolescent sample only reflected the outcomes of 11 patients who received FBT. 
Therefore, the results need to be interpreted with caution (Strober, 2014).  
The next two trials examined different forms of FBT, comparing conjoint 
family therapy (CFT) with a separated family therapy (SFT) where the adolescent 
and parents were seen separately (Eisler et al., 2000; Le Grange et al., 1992). In 
both studies, the therapies achieved positive outcomes, with 60% of patients 
showing significant improvement in psychological functioning and reduction in 
eating disorder symptoms. Patients in CFT showed greater psychological 
improvements, whereas SFT led to greater eating disordered symptom reduction, 
and the authors suggest that these results may be related to parents in the 
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separated model continuing to focus on changing eating disordered behaviours 
once the adolescent was weight restored, whereas the conjoint sessions created 
discussions around adolescent development.  
There have subsequently been a number of RCTs in adolescents with AN 
comparing different types of FBT, FBT to other types of family therapy, or FBT 
to a control (placebo or active) group. In one RCT investigating different versions 
of FBT, optimum length of treatment was reviewed (Lock, Agras, Bryson, & 
Kraemer, 2005). A short term version of 10 sessions of FBT over six months was 
compared with the standard long term version of 20 sessions over 12 months, in 
adolescents with AN. There was no significant difference in outcomes between 
the groups, which continued at the two- to six-year follow-up (Lock, Couturier, & 
Agras, 2006), indicating that the short course of treatment was just as effective as 
the long course. At follow-up, the combined recovery rates of the short and long 
term groups were positive, with 89% of adolescents with weights above 90% 
EBW, 91% menstruating, and 74% with Eating Disorder Examination (EDE) 
scores in the normal range. 
Another study randomly allocated adolescents with AN to either FBT or 
Adolescent Focused Therapy (AFT; also referred to as insight oriented individual 
psychotherapy; Lock et al., 2010). AFT is an individual therapy which focuses on 
ceasing eating disordered symptoms through increased awareness and tolerance of 
emotions, self efficacy and adolescent development. The study had a strict 
remission criterion of weight gain greater than 95% of EBW and one standard 
deviation from the mean on the EDE, which may have contributed to its lower 
recovery rate compared to other studies using more lenient definitions. At the end 
of treatment there was no significant difference in full remission between 
treatments, with FBT showing full remission rates of around 42% and almost 23% 
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for AFT. FBT was more effective than AFT for partial remission (89% compared 
to 67% respectively), higher BMI percentile, and degree of reduction in EDE 
scores at end of treatment. At the six- and 12-month follow-ups, FBT was more 
effective for full remission compared to AFT. AFT also had higher relapse rates 
and hospitalisations than FBT.  
Several studies have compared FBT with individual therapies. The most 
recent research review found that taken together, the research on FBT suggests 
that at the end of treatment, the outcomes produced by FBT were similar to other 
individual therapies (Couturier, Kimber, & Szatmari, 2013). However, at six- to 
12-month follow-ups, FBT was significantly better than individual therapy 
suggesting that FBT may be better at maintaining treatment gains. 
Results from a number of case series have also shown that the manualised 
version of FBT is effective. This approach produced good outcomes in younger 
children aged 9 to 12 years (Lock, Le Grange, Forsberg, & Hewell, 2006), and 
weight gain over 20 sessions with an average EBW increasing from 87.6% to 
95.2% at end of treatment (Ellison et al., 2012). It was also successful at restoring 
menses in females who previously had secondary amenorrhoea once weight 
restored to an average of almost 95% of EBW (Faust et al., 2013). After a mean of 
17 sessions, adolescents had a significant increase in percentage of EBW, with 
56% achieving a good outcome (>85% EBW and menses), 33% having an 
intermediate outcome (>85% EBW and intermittent menses), and only 11% 
having a poor outcome (<85% EBW and no menses). Overall, these findings 
indicated that FBT produced favourable outcomes in approximately 90% of 
adolescents (Le Grange, Binford, & Loeb, 2005).  
Given the disadvantages associated with inpatient treatment highlighted in 
Chapter 2, it is important to note that FBT is effective at preventing 
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hospitalisation (Eisler et al., 2000; Lock et al., 2005), as well as reducing the 
length of stay in hospital and the number of readmissions to hospital (Le Grange, 
Lock et al., 2012; Madden et al., 2014; Rhodes & Madden, 2005; Wallis, Rhodes, 
Kohn, & Madden, 2007).  
Importantly for establishing treatment effectiveness (and not only 
efficacy), FBT has been disseminated in a number of settings and shown to 
produce similar outcomes as those found in RCTs, with 75-85% of adolescents 
achieving good outcomes (Couturier, Isserlin, & Lock, 2010; Loeb et al., 2007; 
Paulson-Karlsson, Engstrom, & Nevonen, 2008).  
Predictors of outcome. Many studies have sought to evaluate the 
predictors of outcome in FBT in an attempt to identify the factors which produce 
the most change. Establishing parental control over the behavioural features of 
AN is a crucial component of FBT, and it has been shown to be the single most 
significant predictor of favourable treatment outcome (Ellison et al., 2012). Even 
the parents’ belief in their ability to help their child to recover impacts outcome. 
That is, in one study higher parental self efficacy predicted reduced adolescent 
eating disordered cognitions and increased mood at the end of treatment, and 
higher fathers’ self efficacy predicted lower anxiety scores (Robinson, Strahan, 
Girz, Wilson, & Boachie, 2012). 
Furthermore, it could be assumed that younger adolescents would do 
better in FBT due to higher levels of parental control in the younger age group, 
and some research suggests that age is a predictor of outcome, with older 
adolescents less likely to recover by the end of treatment (Le Grange, Lock et al., 
2012; Lock, Couturier, Bryson & Agras, 2006). However, other research suggests 
that age of the adolescent is not a predictor of outcome in FBT (Lock et al., 2005), 
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with no difference in outcome for younger children or adolescents compared with 
older adolescents (Le Grange et al., 2005; Lock, Le Grange et al., 2006).  
Therapeutic alliance has been shown to be a good predictor of outcome. 
One study showed that a stronger mother-therapist alliance led to greater 
adolescent weight gain, however a stronger father-therapist alliance was 
surprisingly associated with significantly less weight gain, and may be due to 
therapists inferring that responsibility for feeding is traditionally the mother’s role 
within the family (Ellison et al., 2012). Other research has found that a positive 
therapeutic relationship with both the adolescent and parents reduces drop-out 
rates and improves early weight gain (Pereira, Lock, & Oggins, 2006). However 
with time, behavioural change (such as weight gain) becomes an important factor 
in maintaining the therapeutic relationship and producing positive outcomes, 
suggesting a bidirectional relationship between therapeutic alliance and change. 
It is clear that early weight gain improves recovery rates (Lock, Couturier, 
Bryson et al., 2006; Pereira et al., 2006). One study found that a gain of at least 
2.88% of EBW by session four predicted treatment success (Doyle, Le Grange, 
Loeb, Celio Doyle, & Crosby, 2010).  
Research investigating the severity of symptoms in predicting treatment 
outcome has yielded highly inconsistent findings. While early weight gain 
predicts outcome (Doyle et al., 2010), pre-treatment weight (i.e., percentage of 
EBW) has not been found to predict EBW at termination (Loeb et al., 2007). Yet 
other research suggests that the severity of eating disordered symptoms at pre-
treatment does impact treatment outcome, although greater symptom severity has 
been found to variously predict better or worse outcomes. Supporting the former, 
one study found that those adolescents with higher scores on the EDE Shape 
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Concern and Restraint subscales as well as the overall global score at the 
commencement of FBT were more likely to have a return of menses at treatment 
completion (Faust et al., 2013). In support of the latter, another study found that 
lower starting body weight and amenorrhoea predicted worse outcomes (Eisler et 
al., 2000). Those adolescents who display more eating disordered behaviours and 
stronger eating disordered cognitions may require longer interventions given 
research demonstrating that they achieve better outcomes with the full 20 sessions 
rather than a shortened 10-session program (Lock et al., 2005). These more 
severely affected adolescents may also achieve better outcomes in FBT than AFT 
(Le Grange, Lock et al., 2012). Some research suggests that the binge/purge type 
of AN leads to worse outcomes (Le Grange, Lock et al., 2012), however others 
argue that the presence of purging, did not impact outcomes (Lock et al., 2005). In 
short, there is conflicting data regarding the effects of symptom severity and type 
on treatment outcome. 
The evidence concerning the impact of past duration of illness on outcome 
is also mixed. Some studies have found that it does not predict outcome (Lock et 
al., 2005), while others have shown that a longer duration of illness leads to worse 
outcomes (Doyle et al., 2010; Le Grange, Lock et al., 2012; Pereira et al., 2006). 
It has also been found that those who had no previous treatment had better 
outcomes (Eisler et al., 2000).  
Finally, the role of co-morbid psychopathology has been investigated. This 
research reveals that adolescents with comorbid psychiatric disorders have lower 
remission rates and worse outcomes than those who do not have a comorbid 
disorder (Eisler et al., 2000; Lock, Couturier, Bryson et al., 2006).  
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Predictors of drop-out. Drop-out rates in FBT vary but are generally 
recorded as being around 10-15% in the standard form of FBT (Ellison et al., 
2012; Le Grange & Lock, 2005; Le Grange et al., 2005). Drop-out rates in 
dissemination studies may be slightly higher around 14-25% (Couturier et al., 
2010; Loeb et al. 2007).  
Research examining predictors of drop-out has identified several potential 
factors that may be relevant. Paralleling the findings from research on treatment 
outcome, both comorbidity and parental control have been found to be associated 
with drop-out. Specifically, those with a comorbid psychiatric illness were more 
likely to drop-out of treatment (Lock, Couturier, Bryson et al., 2006), while higher 
rates of drop-out were associated with lower levels of parental control during 
treatment (Ellison et al., 2012). Treatment duration may also be pertinent, with 
those families who were randomised to a longer length of treatment (12 months 
instead of six months) found to be more likely to drop-out (Lock, Couturier, & 
Agras, 2006).   
The complex nature of AN means that FBT therapists are required to work 
with a team of professionals including psychiatrists, paediatricians, and general 
practitioners. It appears that a unified treatment team improves outcomes for 
adolescents in FBT, with those cases where the treating team had poor cohesion 
and inconsistency being associated with higher drop-out (Murray, Griffiths, & Le 
Grange, 2013).  
Research has also identified several factors which do not appear to impact 
on retention rates in FBT. Pereira et al., (2006) found that severity of illness (as 
measured by the EDE subscale scores) did not predict drop-out from treatment. 
Age, gender, percentage of EBW, and eating disordered cognitions at pre-
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treatment (as measured by the EDI-3 Eating Disorder Risk Composite score) also 
did not significantly predict drop-out from treatment (Ellison et al., 2012).  
Summary of the outcome data for FBT. Many studies have been 
completed reviewing the effectiveness of FBT including RCTs, open trials, case 
studies, dissemination studies, mediator and moderator studies, and meta-analyses 
(Fisher, Hetrick, & Rushford, 2010). Taken together, these studies indicate that in 
adolescents with AN, FBT is more effective than other forms of treatment, with 
between 50-75% of adolescents weight restored at the end of treatment, although 
most will not have resumed menses (Couturier et al., 2013; Downs & Blow, 2013; 
Fisher et al., 2010; Le Grange, 2005; Murray et al., 2012). At follow-ups ranging 
from one to five years, the number of adolescents who have recovered will 
increase to 60-90%. FBT is more successful in yielding weight gain and reduced 
behavioural pathology compared to reduced eating disordered cognitions, with 
40-74% of adolescents experiencing measurable reductions in eating disordered 
cognitions (Couturier et al., 2010; Lock, Couturier & Agras, 2006; Lock et al., 
2010). Further investigation is required to review what changes are needed to the 
FBT model to create greater cognitive change in more adolescents. More 
generally, further research is needed to clarify the predictors of outcome and 
treatment retention in ‘real world’ studies of FBT compared with other forms of 
outpatient treatment.  
Adaptations of FBT  
Since it was originally published, the manualised version of FBT has been 
adapted into various formats with varying degrees of success.  
FBT for adolescents with BN. There is emerging evidence that FBT is an 
effective treatment in adolescents with BN (Le Grange, Crosby, Rathouz, & 
Leventhal, 2007; Le Grange, & Lock, 2007; Le Grange, Lock, Agras, Bryson, & 
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Booil, 2015; Le Grange, & Schmidt, 2005; Stiles-Shields et al., 2012). FBT for 
adolescents with BN is similar to FBT for AN, however the adolescent is 
encouraged to take more responsibility for symptom reduction by keeping track of 
and trying to reduce the frequency of binges and purging (Le Grange & Lock, 
2007). 
Adaptations to the manualised model. There have also been 
modifications to the manualised version of FBT to better support families, 
particularly those who are geographically isolated, such as intensive family 
therapy ranging from one to two weeks (Rockwell, Boutelle, Trunko, Jacobs, & 
Kaye, 2011). For example, a two-week residential program based on the 
principles of FBT is offered to families with adolescents stepping down from 
inpatient admissions (Wallis et al., 2013). The aim in this program is to shift the 
focus of refeeding from hospital staff to parents, increase parental capacity, and 
reduce hospital readmission rates, particularly in the group of families who may 
have failed using outpatient FBT. There is also some evidence that providing 
greater parental support, through parent-to-parent consultations (Rhodes, Baillie, 
Brown, & Madden, 2008) or online support groups (Binford Hopf, Le Grange, 
Moessner, & Bauer, 2013), as an adjunct to FBT is beneficial.  
FBT for adults. Given the effectiveness of FBT in the adolescent 
population, studies have evaluated if it can be transferred to young adults with 
eating disorders. The initial RCT found that adolescents achieved better outcomes 
with FBT than adults (Russell et al., 1987). However, there is emerging evidence 
that FBT may be at least as effective as other treatments for adults with AN. A 
case series found that FBT produced weight gain in patients with AN and a 
reduction in eating disordered cognitions (Chen et al., 2010), and an RCT found 
that FBT produced superior outcomes compared to the control group in adults, but 
 106 
no difference when compared with psychoanalytic therapy (Dare, Eisler, Russell, 
Treasure, & Dodge, 2001). However, no long term follow-up of FBT in the adult 
population has been completed.  
Multiple family based treatment (MultiFBT). Since the development of 
standardised FBT, research has been conducted into the use of FBT in a multi 
family context in the hope that this would improve outcomes in those who had not 
responded well to the manualised treatment (Le Grange & Eisler, 2008; Rhodes & 
Wallis, 2009). Multiple family therapy has been used successfully in other areas 
where it was thought that bringing families together would improve 
communication within and between families, with families learning from the 
experiences of others and thereby creating new interactional patterns (Lacquer, La 
Burt, & Morong, 1964). 
MultiFBT for AN aims to reduce the sense of isolation and helplessness 
that some families feel, create new perspectives, and promote change and 
recovery. The structure of MultiFBT is similar to the manualised approach, with 
the focus initially on parents taking control of re-feeding their adolescent, helping 
to cease AN behaviours, and then later focusing on returning responsibility to the 
adolescent and dealing with adolescent issues (Asen, 2002; Dare & Eisler, 2000; 
Eisler et al., 2000). The MultiFBT approach also focuses on restoring the family 
interactions that have been interrupted by AN (Whitney & Eisler, 2005). While 
there is limited evidence for MultiFBT for AN, and the available research has 
entailed small sample sizes, preliminary results are promising with data showing 
good patient outcomes, a reduction in drop-out rates compared to standard FBT, 
and higher satisfaction by parents, patients, and staff compared to standard FBT 
(Dare & Eisler, 2000; Schmidt & Asen, 2005; Scholz & Asen, 2001; Scholz, Rix, 
Scholz, Gantcher, & Thomke, 2005).  
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FBT based day programs. FBT has also been adapted for use in day 
programs for adolescents with eating disorders (e.g. Hoste, 2015). Patients attend 
a day program with group therapy and meal support during the day, and in the 
evenings and on weekends parents are required to take responsibility for the 
adolescents intake and support them to cease compensatory behaviours. Parents 
and siblings are usually required to attend stand-alone FBT sessions in addition to 
the adolescent attending the day program. Programs may also include parent or 
sibling support groups or multi-family therapy. Most programs do not provide 
details as to whether the day program is during phase one of FBT or if it continues 
for the entire one year of FBT treatment.  
Although only a small number of FBT-based day programs have been 
published, the results are promising, with reduced eating disordered cognitions 
and weight gain at the end of day program treatment (Girz et al., 2013; Grewel et 
al., 2014; Henderson et al., 2014; Hoste, 2015; Robinson et al., 2012; Ornstein et 
al., 2012). However, drop-out rates are high (42-46%) compared with the 
standardised version of FBT (15-25%) perhaps because of the time intensity of 
day program or because the FBT day program is usually offered to those who are 
struggling with traditional FBT (Ellison et al., 2012; Grewel et al., 2014; Loeb et 
al., 2007; Ornstein et al., 2012).  
Strengths of FBT  
In addition to the positive outcomes achieved by standard FBT, and 
emerging evidence for its variants, FBT has several noteworthy advantages. One 
strength of FBT is that it is a manualised treatment which can easily be 
disseminated. A review of eating disorder treatment services for adolescents 
across Canada found that 91% of programs provide FBT for patients with AN 
(Norris et al., 2013).  
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The manualised version of treatment has also been reported as being 
acceptable and effective by patients and their parents, and 84% would recommend 
FBT (Krautter & Lock, 2004). In the past, many families reported feeling 
disempowered and disenfranchised by AN (Whitney & Eisler, 2005), however the 
opposite is true in FBT, with parents encouraged to develop a sense of control in 
their child’s treatment (Murray et al., 2012). This enhancement of parental control 
has implications for relapse prevention in that teaching parents to identify and 
then stop the signs and behaviours of AN also creates an environment where 
parents are able to support sustained wellness even when contact with the treating 
team has ended (Lock & Le Grange, 2013; Loeb & Le Grange, 2009). Once 
adolescents have recovered using FBT, relapse rates are extremely low, at less 
than 10% (Eisler et al., 2007; Lock, Couturier, & Agras, 2006).  
A corollary of enhanced parental control is that recovery is less dependent 
on the adolescent’s intrinsic motivation to change. Adolescents consistently report 
even lower levels of readiness to change eating disordered symptoms compared 
with adults (Goddard et al., 2013), which makes individual therapy difficult. FBT 
has the distinct advantage of not relying on the adolescent being motivated to 
change and instead uses the parents as the driving force for change (Lock & Le 
Grange, 2013).  
Limitations of FBT and its Research Base  
Despite evidence of the notable strengths of FBT, there exist key 
limitations of FBT and its research base. Among these limitations is the fact that 
the research on FBT may have resulted in an overstatement of its benefits 
(Strober, 2014). When reviewing the recovery rates from FBT and only taking 
into account those who achieve full weight restoration, return of menses, and a 
change in eating disordered cognitions, the outcomes are much less favourable 
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than previously presented. For example, Lock et al., (2010) found that only 42% 
of adolescents achieved full remission from AN after FBT, and while Le Grange 
et al., (2005) report that around 90% of adolescents in their study had positive 
outcomes, actually only 56% experienced full recovery from AN. Specifically, 
while many studies report that FBT is effective at weight restoration, this is 
usually after an inpatient admission, or when the adolescent is not severely 
underweight. For instance, one of the first RCTs re-fed patients to 90% of EBW 
in hospital prior to starting FBT (Russell et al., 1987) and it is common for other 
programs to discharge adolescents to begin outpatient FBT only after they are 
weight restored to 80% of EBW (Rhodes & Madden, 2005). It could be argued 
that these weight-restored patients are not representative of outpatient practice, 
where adolescents may present as severely underweight and only be hospitalised 
if they are medically unstable. Hospital admissions during FBT may also inflate 
the findings attributed to FBT. In some studies a large portion of patients are 
hospitalised during treatment; in the study by Lock et al. (2005), for example, 
23% of patients were hospitalised during FBT, with their data included in the 
results. One study found that those patients who commenced treatment at a lower 
EBW gained weight faster in a RCT than in a clinical setting (Accurso, 
Fitzsimmons-Craft, Ciao, & Le Grange, 2015), further highlighting the need for 
research investigating the effectiveness of FBT in treating adolescents on an 
outpatient basis who are at very low weights (Strober, 2014). In addition, most 
studies also report exclusion criterion that do not match ‘real world’ practice (e.g., 
one study excluded a patient for frequent suicidal ideation; Loeb et al., 2007). 
Furthermore, many of the RCTs and some dissemination studies include 
the original authors of the manual as therapists or use therapists who have been 
trained by them. Using only therapists trained by the authors of the manual limits 
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the generalisability of the results obtained since it is uncertain if the results are 
related to the effectiveness of the manualised treatment, which can then be 
replicated and disseminated, or instead reflect the skill and experience of the 
therapists (Strober, 2014). As such, further dissemination studies are needed 
where the original authors of the manual have not trained the therapists.  
Combined, the above factors may have inflated the outcomes that can be 
attained using FBT in ‘real-world,’ outpatient settings. The effectiveness of FBT 
alone (i.e., without hospitalisation for weight restoration) in these real-world 
settings is a key research priority. A somewhat related limitation of the FBT 
research is that the sample sizes are generally very small, with an average of 20 
adolescents in each treatment, which again challenges the generalisability of the 
findings.  
The research base on FBT is also limited in providing insufficient clarity 
regarding the optimum length of treatment. RCTs have been based on the original 
manual and usually follow the format of 20 sessions over 12 months (Lock et al., 
2010; Lock & Le Grange, 2013). There is some evidence that a shorter course of 
10 sessions over six months is just as effective as the 12-month course of FBT 
(Lock et al., 2005), although this may be related to the fact that most research into 
FBT has included patients who are partially weight restored and therefore do not 
require a longer treatment length; this research is therefore not representative of 
the full spectrum of AN severity. Over half of the adolescents who completed 
FBT reported feeling that they required more treatment than offered in the time-
limited protocol (Krautter & Lock, 2004). Yet, since longer treatment length may 
lead to higher rates of drop-out (Lock, Couturier, Bryson et al., 2006), 
establishing whether shorter treatments are sufficient, at least for some patients, is 
an important area of research. It may be that those adolescents who commence 
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treatment at a lower weight or have stronger eating disordered cognitions require a 
longer treatment duration.  
A key deficiency in the research is that FBT has not been compared to a 
comprehensive range of evidence-based treatments for adolescent AN. For 
instance, there have also been no clinical trials comparing the effectiveness of 
FBT with inpatient admissions, or alternative outpatient programs such as 
specialised eating disorder day programs (Loeb & Le Grange, 2009).  
While research has shown that FBT is more effective than the limited 
range of treatments to which it has been compared, particularly at longer-term 
follow-ups, FBT does not lead to recovery for all patients. For example, in a 
number of RCTs FBT was superior to alternative treatments, however, FBT only 
led to full remission in less than half of the adolescents at the end of treatment and 
at the 12-month follow-up (Le Grange et al., 2007; Lock et al., 2010).  
Limited outcomes from FBT are particularly evident in terms of an 
insufficient reduction in eating disordered cognitions (Couturier et al., 2010; 
Lock, Couturier & Agras, 2006; Lock et al., 2010). This may be a methodological 
artefact given that studies may not adhere to the manualised version of FBT. For 
example, many studies report treatment completion as attending the first two 
phases of FBT or 10 sessions (Couturier et al., 2010; Lock et al., 2005; Lock, 
Couturier & Agras, 2006), even though the manual clearly defines three phases 
over 20 sessions (Lock & Le Grange, 2013). This early termination of treatment 
may not allow for sufficient time for cognitive change to occur. However, the 
limited cognitive change resulting from FBT may also be an inherent limitation of 
this approach as it does not target psychological change such as reducing a fear of 
weight gain or body image disturbance (Lock & Le Grange, 2013; Loeb & Le 
Grange, 2009). Thus further research is needed to review if FBT, administered 
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with a high degree of fidelity to the manual, can produce cognitive change for 
adolescents with AN.  
In addition to limited cognitive change, FBT has been criticised for not 
targeting a broader range of problems. For instance, while many families report 
that FBT is an acceptable treatment, they also report that they feel the need for the 
treatment to focus on issues other than AN (Krautter & Lock, 2004). The need to 
treat comorbid conditions is a view shared by therapists (Couturier et al., 2013). 
Research has suggested that psychiatric comorbidity in adolescents increases the 
drop-out rate and reduces the likelihood of good outcomes in FBT (Le Grange, 
Lock et al., 2012; Lock et al., 2005), yet this comorbidity is not targeted in 
treatment.  
One of the criticisms of FBT is that it may not be effective for all families, 
such as in those families where family members are highly critical towards the 
adolescent, although parents of adolescents with AN have been shown to have 
lower levels of expressed emotion towards the adolescent, compared with some 
other psychiatric disorders (Le Grange et al., 1992; Szmukler et al., 1985; 
Vaughn, & Leff, 1976). High levels of expressed emotion in families of 
adolescents with AN have been shown to lead to higher drop-out rates and poorer 
outcomes for those who do remain in treatment (Eisler et al., 2000; Le Grange et 
al., 1992; Le Grange, Hoste, Lock, & Bryson, 2011; Szmukler et al., 1985). 
However, the separated model of FBT (SFT) where the adolescent and parents are 
seen separately, has been shown to improve outcomes in families with high 
expressed emotion (Eisler et al., 2000), suggesting that this adapted version of 
FBT may be effective for these families. Other families in which FBT may have 
limited effectiveness are those where parental anxiety is high or assertiveness is 
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lacking given that parental control has been shown to be the most significant 
predictor of favourable treatment outcome in FBT (Ellison et al., 2012).   
Finally, while the FBT manual encourages the dissemination of this 
approach, there are also barriers to dissemination. Research suggests that many 
practitioners are wary of manualised therapy, and FBT is no exception to this with 
fidelity to the manualised version of FBT variable, particularly in the later phases 
of treatment (Couturier et al., 2010). Moreover, 95% of therapists have been 
found to desire further training in FBT. Therapists also report many barriers to 
practicing FBT, ranging from a lack of support from their organisation to 
believing that AN as an illness requires more intensive treatment (Couturier et al., 
2013; Kimber et al., 2014; Murray, Thornton, & Wallis, 2012). Thus the 
implementation of FBT into a service may not be straightforward (Wallis et al., 
2007).  
Summary  
FBT is based on the assumption that parents are the best resource to 
support their adolescent with AN back to full health. FBT aims to restore the 
child’s weight and physical health, promote adolescent responsibility around 
eating, and encourage normal adolescent development free of AN.  
FBT is currently the most effective treatment for adolescents with AN, 
particularly in those under 19 years of age and with an illness duration of less than 
three years (Eisler et al., 2000; Le Grange et al., 2004; Russell et al., 1987). It is 
most effective at weight restoration and reducing behavioural symptoms, although 
some adolescents are able to achieve full remission with FBT including a 
reduction in eating disordered cognitions. Although there have been a number of 
research trials including FBT, further investigations reporting adolescent 
outcomes from different treatment sites are needed, including areas where 
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adolescents are not excluded for comorbidity or risk issues, where weight gain is 
not achieved with the aid of inpatient admissions, and where the therapists have 
not been directly trained by the original developers of FBT (Fisher et al., 2010; 
Lock et al., 2010; Murray et al., 2014). It is also of benefit to evaluate if more 
sessions result in full recovery including greater cognitive change, given the 
limited impact of FBT in this regard. Furthermore, there are inconsistencies in the 
research regarding the factors that predict outcome (such as the level of eating 
disordered symptoms at the commencement of FBT and amenorrhoea), and 
limited understanding of the factors which predict treatment completion, 
highlighting the need for further clarification of these issues.  
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Chapter 5 
Study 2: The Effectiveness and Predictors of Outcome and Drop-out of 
Family Based Treatment in Adolescents with Anorexia Nervosa 
 
A growing evidence base suggests that Family Based Treatment (FBT) 
should be the first line outpatient treatment for adolescents with Anorexia 
Nervosa (AN; Eisler et al., 2010). Studies suggest that FBT is particularly 
effective for weight gain and physical restoration in those adolescents under the 
age of 19 years with an illness duration of less than three years (Russell et al., 
1987). After FBT, adolescents remain well at one to five year follow-ups (Eisler 
et al., 1997; Lock, Couturier, & Agras, 2006; Lock et al., 2010). FBT has been 
effective at creating return of menses at treatment completion and follow-up, with 
60-90% of adolescents having achieved return of menses several years post-
treatment (Eisler et al., 1997; Faust et al., 2013; Lock, Couturier, & Agras, 2006). 
FBT has also been disseminated in a variety of settings, and in different 
populations such as young children and young adults (Couturier et al., 2010; Loeb 
& Le Grange, 2009; Lock, 2011; Loeb et al., 2007; Paulson-Karlsson et al., 2008).  
In contrast to the positive results for weight restoration and physical 
recovery at the end of treatment, the evidence for cognitive changes is not as 
robust. Overall, results suggest that a reduction in eating disordered cognitions 
after FBT is limited, with an average of 50% of adolescents reaching full 
remission after FBT (Lock & Le Grange, 2014). Some studies report that only 40-
74% of adolescents experience a measurable reduction in eating disordered 
cognitions after completing FBT (Couturier et al., 2010; Lock, Couturier & Agras, 
2006; Lock et al., 2010). FBT does not directly target psychological change in 
AN, such as reducing a fear of weight gain or body image disturbance (Lock & Le 
Grange, 2013; Loeb & Le Grange, 2009), and this may limit the cognitive change 
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produced by FBT. A lack of cognitive change after FBT may also be the result of 
early termination of treatment (e.g., completing only a few sessions or less than 
the full three phases of treatment; Couturier et al., 2010; Lock et al., 2005; Lock, 
Couturier, & Agras, 2006), resulting in insufficient time for a reduction in eating 
disordered cognitions to occur. Thus further research is needed to review if FBT, 
administered with a high degree of fidelity to the manual and/or with a longer 
length of treatment, can produce a reduction in eating disordered cognitions for 
adolescents with AN. 
Despite evidence of the notable strengths of FBT, there is some suggestion 
that the research on FBT may have resulted in an overstatement of its benefits 
(Strober, 2014). Specifically, FBT studies have failed to report drop-out numbers 
in the results or have varying definitions of drop-out. Given that the manual 
outlines three clear phases of FBT (Lock & Le Grange, 2013), it could be argued 
that drop-out should include any patient who has not completed all three phases of 
treatment. In contrast, many studies report treatment completion as only needing 
to complete the first two phases of FBT or 10 sessions (Couturier et al., 2010; 
Lock et al., 2005; Lock, Couturier, & Agras, 2006). Furthermore, most studies 
report exclusion criteria that do not match ‘real world’ practice (e.g., one study 
excluded a patient for frequent suicidal ideation; Loeb et al., 2007). These factors 
may contribute to an inflated view of the outcomes that can be attained using FBT 
in real-world, outpatient settings. The effectiveness of the full three phases of 
FBT as an outpatient treatment, in these real-world settings, is thus a key research 
priority. 
Also requiring further investigation is clarification regarding the factors 
that predict treatment outcome from FBT. One study found that those adolescents 
with lower starting weight, amenorrhoea, and previous treatment had poorer 
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outcomes following FBT (Doyle et al., 2010; Eisler et al., 2000; Pereira et al., 
2006). In contrast, displaying more eating disordered behaviours and cognitions 
was a predictor for return of menses at treatment completion but also required a 
longer course of treatment so that it is unclear if it was the higher level of eating 
disorder symptoms or the longer treatment duration that was associated with a 
better outcome (Faust et al., 2013; Lock et al., 2005). In addition, there are 
inconsistent findings in terms of whether longer duration of illness has an impact 
on outcomes. Le Grange, Lock et al., (2012) found that those adolescents with a 
longer duration of illness were less likely to recover by treatment completion, and 
others have also shown that a longer duration of illness leads to worse outcomes 
(Doyle et al., 2010; Pereira et al., 2006), while Lock et al., (2005) found that 
duration of illness did not moderate outcome between short or long treatment 
lengths. It is unclear why the inconsistencies given that the studies all had a 
similar mean age of patient with approximately a 12-month history of the illness, 
and further investigation into the impact of illness duration on outcomes is 
needed.  
Age of the adolescent at commencement of FBT has also been considered 
as a potential predictor of outcome. Some research suggests that age is a non-
specific predictor of outcome, with older adolescents less likely to recover by the 
end of treatment (Le Grange, Lock et al., 2012; Lock, Couturier, Bryson et al., 
2006). However other research suggests that age of the adolescent is not a 
predictor of outcome in FBT (Le Grange et al., 2005; Lock et al., 2005; Lock, Le 
Grange et al., 2006), with no difference in outcome for younger children or 
adolescents compared with older adolescents (Le Grange et al., 2005; Lock, Le 
Grange et al., 2006). There is a clear need for further research to clarify if age of 
the adolescent is a predictor of outcome in FBT.   
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As well as predictors of outcome, research has begun to focus on 
identifying the factors which lead to drop-out. Given the above-mentioned 
problems with definitions of drop-out or treatment completion, drop-out rates in 
FBT vary but are generally recorded as being approximately 10-15% (Ellison et 
al., 2012; Le Grange & Lock, 2005). Studies have found that drop-out rates are 
increased among those with a comorbid psychiatric illness (Lock, Couturier, 
Bryson et al., 2006), when treatment professionals are not aligned with the model 
(Murray et al., 2013), and when families were randomised to a longer length of 
treatment (Lock, Couturier, & Agras, 2006). Conversely, drop-out decreased 
when parents have more control over the illness (Ellison et al., 2012). There are 
also a number of factors which did not impact on retention rates in FBT, including 
the severity of illness (Ellison et al., 2012; Pereira et al., 2006), age, gender, and 
percentage of EBW at admission (Ellison et al., 2012). However, many studies 
exclude those families who have dropped out of treatment when reviewing 
outcomes (Fisher et al., 2010; Murray et al., 2014). Therefore, further 
investigation into factors which may impact drop-out such as age, past duration of 
illness, eating disordered cognitions, starting weight, and length of treatment need 
to be conducted.  
In summary, FBT is most effective at weight restoration and reducing 
behavioural symptoms, although some adolescents are able to achieve full 
remission with FBT including a reduction in eating disordered cognitions. 
Although there have been a number of research trials evaluating FBT, further 
investigations reporting adolescent outcomes from different treatment sites is 
needed, including areas where adolescents are not excluded for comorbidity or 
risk issues, where weight gain is not achieved with the aid of inpatient admissions, 
and where treatment is delivered by more varied therapists. Also requiring further 
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research is determining whether completing the full three phases of the 
manualised FBT, with no limit on the number of sessions, results in full recovery 
including greater cognitive change. Moreover, the predictors of outcome and 
drop-out (e.g., age of the adolescent, past duration of illness, eating disordered 
cognitions, starting weight, and length of treatment) from FBT require further 
clarification given the inconsistencies characterising this research.  
Aims and Hypotheses of the Present Study 
The current study aims to add to the research on the outcomes and 
predictors of treatment outcome and drop-out from FBT for adolescents with AN 
in a real-world setting. Based on the results of previous research, it is 
hypothesised that completion of all three phases of FBT will result in significant 
weight gain, return of menses (in females with amenorrhoea), a reduction in 
eating disordered cognitions, and an improvement in general psychosocial 
functioning. Given the research in past FBT studies, it is expected that lower 
starting weight at commencement of treatment will lead to poorer outcomes and a 
longer length of treatment. Previous studies have reported inconsistencies when 
reviewing if prior length of illness and age at treatment commencement impacts 
on outcomes and therefore no predictions will be made. Age of the adolescent, as 
well as past duration of illness, number of sessions, eating disordered cognitions, 
and starting weight will also be examined as predictors of outcome. Past research 
reviewing predictors of drop-out in FBT has yielded inconsistent results, and has 
included varying definitions of drop-out. Therefore, no definitive hypotheses 
around predictors of drop-out are made for the current study. Instead, the factors 
of percentage of EBW, illness duration, age, and eating disordered cognitions at 
commencement of FBT will be explored as potential predictors of drop-out.  
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Method 
Participants  
Participants in the present study were 45 adolescents with eating disorders 
who engaged in FBT at the Canberra Eating Disorders Program. Inclusion criteria 
to engage in FBT were: medical stability, diagnosis of AN (binge/purging subtype 
or restricting subtype) or EDNOS (if weight or menses criteria were not met for 
AN). Diagnosis was determined by a clinical assessment interview conducted by 
experienced clinicians using the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR; APA, 2000). Using the current DSM-5 criteria, all 
patients would have met criteria for AN or Atypical AN (APA, 2013). The current 
study utilised percentage of EBW (% of EBW) calculated as BMI/50
th
 percentile 
BMI for age, sex and height x 100 (Faust et al., 2013). Due to a lack of easily 
accessible inpatient treatment facilities, % of EBW was not an inclusion/exclusion 
criterion. Hence patients with low % of EBW were accepted into outpatient 
treatment provided they were medically stable and had been given clearance from 
a medical professional. Drop-out was defined as those families who did not 
complete the full three phases of FBT (regardless of the number of sessions 
attended), as defined by the treatment manual (Lock & Le Grange, 2013). The 
study received ethical approval from both the ACT Health and the Australian 
National University Human Research Ethics Committees (refer to Appendix B, 
and copies of the consent and information forms are included in Appendix C). 
Program Description 
The Canberra Eating Disorders Program (EDP) is a public outpatient 
eating disorders unit which provides assessment and treatment to patients with 
any eating disorder in the ACT and surrounding NSW. All clinicians were 
provided with the manual (Lock et al., 2001), and attended a two-day workshop 
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on FBT. FBT provided to adolescents and their families was based on the 
standard manualised version of FBT (Lock & Le Grange, 2013), however there 
was no limit on the number of sessions.  
Measures  
The data collection occurred at the commencement and completion of 
treatment, and included sex, age, weight, height, % of EBW, duration of illness 
(months), diagnosis, amenorrhoea, and number of sessions attended. It also 
included the measures briefly described below. However, see Chapter 3 for a full 
description of the measures.  
Health of the Nation Outcome Scales (HoNOS). The HoNOS is a 
clinician-rated measure which includes 12 items to assess the behaviour, 
impairment, symptoms, and social functioning of people with mental illness, with 
higher scores indicating greater severity of symptoms and impairment (Wing et 
al., 1998; Wing, Curtis & Beevor, 1996). The Health of the Nation Outcome 
Scales for Children and Adolescents (HoNOSCA) is used for children and 
adolescents and includes an additional three items which assess the child’s 
environment including school attendance, concerns regarding parental lack of 
information around mental illness or access to services (Gowers et al., 1999). 
However, to allow for comparison with the HoNOS, only the first 12 items of the 
HoNOSCA were used. Both the HoNOS and HoNOSCA have been used for 
patients with eating disorders (Bilenberg, 2003; Stevens, 2010). 
Eating Disorder Inventory-3 (EDI-3). The EDI–3 (Garner, 2004) is a 
standardised self-report measure which provides objective scores of eating 
disordered symptoms and associated psychopathology. The EDI-3 produces 12 
subscale scores, six composite scores and three response style indicators 
(inconsistency, infrequency, and negative impression).  
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Procedure  
Prior to commencement of FBT, patients and parents attended an initial 
assessment, which included a clinical interview and administration of the outcome 
measures. The self-report (EDI-3) and clinician-rated (HoNOS or HoNOSCA) 
outcome measures were re-administered when the patient completed treatment. 
Not all patients completed self-report measures at commencement due to refusal 
(n = 4), and being too young (n = 3), and at completion of treatment due to refusal 
(n = 3), missing follow-ups (drop-out; n = 14), and age (n = 3). As such, the self-
report measures presented do not always include the full sample.  
Statistical Analysis 
The study included both completer and intention-to-treat analyses. To 
assess outcome, pre-treatment scores on continuous measures were compared with 
post-treatment scores using paired t-tests, and effect size was calculated using 
Cohen’s d. Percentage of change from pre- to post-treatment for categorical 
variables was examined using McNemar’s test. To allow for clinically relevant 
interpretation of the outcome, the Morgan-Russell outcome criteria (Morgan & 
Russell, 1975) were used. These include three criteria, namely, ‘good outcome’ 
(weight within 15% EBW, menstruation, no bingeing or purging), ‘intermediate 
outcome’ (weight within 15% EBW, no bingeing or purging but amenorrhoea), 
and ‘poor outcome’ (weight below 85% EBW, bingeing/vomiting once per week 
or more). Predictors of treatment outcome were examined using regression 
analysis, while an exploratory analysis (due to small sample size) examined 
predictors of treatment drop-out using logistic regression analysis. SPSS version 
22 was used for all analyses, with the two-tailed significance level set at p < .05 
for all analyses. 
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Results 
Characteristics of the Sample  
A total of 45 patients engaged in FBT and of those 14 (31.1%) ended 
treatment prematurely (without completing all three phases of FBT). Treatment 
was not limited to 20 sessions and instead followed the core components and three 
phases of FBT outlined in the manual (Lock & Le Grange, 2013). The number of 
sessions was dependent on the goals of each phase being achieved, (e.g. weight 
gain in phase one may have taken longer than the 10-15 sessions outlined in the 
manual) and therefore treatment ranged from four to 57 sessions. No therapeutic 
techniques beyond those outlined in the manual were provided.   
Fifteen patients were underweight (less than 85% of EBW for BMI for age 
and sex), 24 patients were between 85% and 99% of EBW for age and sex, and 
six patients were at 100% of EBW for age and sex (despite having lost weight), 
with weights ranging from 69.95% of EBW to 104.7% of EBW. A total of 11 
patients (24.4%) were hospitalised for medical stabilisation prior to commencing 
FBT. Despite the small sample size, independent t-tests were completed to 
determine whether there were any significant differences between those who were 
hospitalised for medical stabilisation prior to commencing FBT and those who 
were not hospitalised, with the results showing no significant difference for % of 
EBW at commencement of treatment, t(43) =.679, p = .501, or at treatment 
completion, t(43) = -.042, p = .967.  Table 5.1 shows the characteristics of the 
sample of patients at commencement of treatment. 
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Table 5.1  
Description of the Sample at Commencement of FBT 
Characteristic M (SD) Range 
 
Age (years) 
 
14.96 (1.89) 
 
8-18 
 
% of EBW  
 
89.0 (8.44) 
 
69.95-104.7 
   
Duration of illness (months) 
 
11.31 (6.69) 3-26 
Characteristic n % 
 
Amenorrhoea  
 
 
29 
 
70.7 
Menstruating 9 22 
 
On oral contraceptive  
 
3 
 
7.3 
 
Female  
 
41 
 
91.1 
 
Male  
 
4 
 
8.9 
 
AN -Restricting subtype 
 
27 
 
60.0 
 
AN –Binge/purge subtype 
 
5 
 
11.1 
 
EDNOS  
 
13 
 
28.9 
Note. EDNOS: Eating Disorder Not Otherwise Specified, EBW: Expected body weight. 
N = 45 (except for Amenorrhoea, Menstruating and On oral contraception, where N = 41) 
 
Treatment Outcome 
For those who completed treatment (n = 31), FBT led to weight gain with 
overall percentage of Expected Body Weight (% of EBW) post-treatment scores 
(M= 101.03, SD= 6.73) increasing significantly from pre-treatment scores (M= 
87.92, SD= 8.79), t(30) = -9.46, p < .001, and with 26 (83.8%) adolescents who 
completed treatment finishing with an EBW at or above 95% of EBW. The mean 
increase was 13.11 with a 95% confidence interval ranging from 10.28 to 15.93 
and the eta squared statistic (.75) indicated a large effect size. However, those 
who dropped out of treatment (n = 14) did not gain a significant amount of 
weight, with no significant difference between pre-treatment % of EBW (M= 
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91.50, SD= 7.29) and % of EBW at drop-out (M= 92.39, SD= 9.50), t(13) = -.569, 
p = .579. In addition, five (35.7%) of the 14 who dropped out of treatment lost 
weight. Including both those who completed treatment and those who dropped 
out, 30 (66.7%) adolescents ended their treatment with an EBW at or above 95% 
of EBW. 
Including the full sample of female patients, at commencement of FBT, 
only 9 adolescents (22%) menstruated, but at termination of FBT, 32 adolescents 
(78%) menstruated. McNemar’s Test showed that this change was significant, p < 
.001.  
Based on the Morgan-Russell outcome criteria, at the termination of FBT 
(excluding 3 [7.3%] patients on the contraceptive pill), 85.7% of adolescents 
experienced a ‘good outcome’ (weight within 15% EBW, menstruation, no 
bingeing or purging), 7.1% had an ‘intermediate outcome’ (weight within 15% 
EBW, no bingeing or purging but amenorrhoea), and 7.1% experienced a ‘poor 
outcome’ (weight below 85% EBW, bingeing/vomiting once per week or more). 
It is important to note that 10 (22.2%) adolescents commenced treatment 
satisfying the criteria for a ‘good outcome’ (n = 4 of those who completed 
treatment; n = 6 of those who dropped out of treatment). Nevertheless, the change 
from adolescents classified as having a ‘good outcome’ from pre- to post-FBT 
was significant (p < .001.) according to McNemar’s Test.  
There was a significant change in HoNOS/CA clinician-rated scores for 
those who completed FBT, with significant reductions from pre-treatment (M= 
10.41, SD= 5.09) to post-treatment (M= 3.39, SD= 3.65), t(30) = 6.89, p = .001. 
The mean decrease was 7.03 with a 95% confidence interval ranging from 4.94 to 
9.11 and the eta squared statistic (.61) indicated a large effect size. However, 
those who dropped out of treatment did not improve on HoNOS/CA scores, with 
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no significant difference between pre-treatment (M= 11.85, SD= 4.55) and post-
treatment scores (M= 13.00, SD= 7.41), t(13) = -.547, p = .593. 
As shown in Table 5.2, for those who completed treatment, pre- and post-
treatment EDI-3 composite scores all improved significantly after FBT, including 
the Eating Disorder Risk Composite (EDRC), Ineffectiveness, Interpersonal 
Problems, Affective Problems, Over Control, and General Psychological 
Maladjustment. A total of 18 out of 21 (85.7%) adolescents had a reduction in 
their EDRC raw score at completion of FBT. No post-treatment EDI-3s were 
completed by those who dropped out of FBT. 
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Table 5.2 
Descriptive Statistics and t-test Results for the Eating Disorder Inventory (EDI-3) Composite and Subscale Scores.  
 Pre-treatment Post-treatment   
95% CI for 
Mean Difference 
 
Cohen’s d 
  
 M SD M SD n t df 
 
Eating Disorder Risk 
Composite (EDRC) 
 
149.04 
 
28.19 
 
117.04 
 
24.93 
 
21 19.67, 44.32 
 
0.59*     5.41* 
 
20 
Ineffectiveness 96.34 19.22 80.47 18.28 23 5.62, 26.11 0.32* 3.21* 22 
Interpersonal Problems 103.37 17.81 89.16 17.27 24 
6.21, 22.20 
0.37* 
3.67* 
23 
Affective Problems 98.82 17.50 87.00 19.96 23 4.27, 19.37 0.32* 3.24* 22 
 
Over Control 
 
96.95 
 
15.07 
 
86.04 
 
14.02 
 
23 
 
3.27, 18.54 
 
0.29* 
 
2.96* 
 
22 
 
General Psychological 
Maladjustment 
 
454.50 
 
58.66 
 
388.70 
 
71.09 
 
20 
28.53, 
103.06 
 
0.42* 3.69* 
 
19 
Note. * p < .05 
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Predictors of % of EBW in FBT   
Multiple regression analysis was used to predict the impact of starting % 
of EBW, age at commencement, length of illness, eating disordered cognitions 
(measured by the EDI-3 EDCR score at commencement), and number of sessions 
attended on % of EBW at termination of FBT (including those who completed 
and dropped out of treatment). As Table 5.3 shows, all factors explain 31.6% of 
the variance in % of EBW at termination of FBT treatment. Of these factors, a 
higher % of EBW at commencement and greater number of sessions attended 
made a significant contribution to higher post-treatment % of EBW, with a 
marginally significant contribution by lower EDI-3 EDCR scores at treatment 
commencement.  
Table 5.3  
Results of the Multiple Regression Analysis for % of EBW at Termination of FBT.  
 Coefficient 
β 
Standard 
error 
t value p 
 
Age at commencement 
 
 
-.007 
 
.698 
 
-.048 
 
.962 
Number of sessions 
 
.360 
 
.093 2.44 .021 
Duration of illness  -.026 .191 -.177 .861 
% of EBW at commencement 
 
.540 .150 3.67 .001 
EDI-3 EDRC at commencement -.287 .045 -1.97 .058 
Note. % of EBW: percentage of expected body weight. EDI-3 EDRC: Eating Disorder Inventory-3 
Eating Disorder Risk Composite.  
R
2
 = .414, Adjusted R
2
 = .316.   
N = 36 
 
Predictors of Drop-Out From FBT  
Logistic regression analysis was used to predict the factors which may 
have increased the likelihood of drop-out. Percentage of EBW, age, duration of 
illness, and eating disordered cognitions (measured by the EDI-3 EDRC score) at 
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commencement were analysed to see if they predicted treatment non-completion. 
The full model containing all predictors was significant, X
2
 (4, N = 36) = 21.86, p 
< .001, indicating that the model was able to identify treatment non-completers. 
The model as a whole explained between 45.5% (Cox & Snell R Square) and 
64.3% (Nagelkerke R Square) of the variance in drop-out rates and correctly 
classified 88.9% of cases. As shown in Table 5.4, EDI-3 EDRC scores and % of 
EBW at treatment commencement made unique significant contributions to the 
model, indicating that those with a higher EDRC score at commencement of FBT 
were 1.15 times more likely to drop-out of treatment and those with a higher 
starting % of EBW were 1.2 times more likely not to complete the full three 
phases of FBT.  
Table 5.4  
Results of the Logistic Regression Analysis Predicting Drop-out from FBT.  
 β  S.E. Wald df p Odds 
ratio 
95% C.I. for 
odds ratio 
       Lower Upper 
Age (at 
commencement) 
 
-
.481 
.495 .944 1 .331 .618 .234 1.63 
% of EBW (at 
commencement) 
 
.184 .093 3.92 1 .048 1.2 1.0 1.44 
EDRC (at 
commencement) 
 
.141 .057 6.04 1 .014 1.15 1.02 1.29 
Duration of 
illness 
-
.042 
.084 .250 1 .617 .959 .813 1.13 
Note. % of EBW: Percentage of expected body weight. EDRC: EDI-3 Eating Disorder Risk 
Composite. 
N = 36 
 
 
Discussion 
The current study aimed to replicate and extend previous research 
examining the outcomes and predictors of outcome and drop-out for FBT among 
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adolescents with AN. The results provide support for FBT leading to physical 
restoration, reduced eating disordered symptoms, and improved psychosocial 
functioning. The findings also indicated that a greater severity of eating 
disordered cognitions and higher % of EBW at commencement of FBT increased 
drop-out, while commencing FBT at a higher % of EBW, experiencing a lower 
severity of eating disordered cognitions, and attending more FBT sessions 
predicted a greater % of EBW at completion of treatment.  
Findings of the Present Study 
In terms of outcome, 66.7% of the entire sample (treatment completers and 
drop-outs) ended their course of FBT with an EBW at or above 95% of EBW. The 
results supported the benefits of FBT leading to weight restoration for those 
adolescents who completed the full three phases of FBT, with 83.8% of 
adolescents who completed treatment finishing with an EBW at or above 95% of 
EBW. These results are consistent with other studies, for example, those obtained 
by Lock, Couturier, Bryson et al., (2006) where at follow up of 83% of the 
original treatment sample after completing FBT, 89% of adolescents were at or 
above 90% of EBW. These results also suggest that for those who complete 
treatment, FBT is effective for weight restoration even without the aid of 
hospitalisation for weight restoration. However, it is important to note that the 
current study included 24% of patients who had a hospitalisation for medical 
stabilisation prior to commencing FBT. This is despite the fact there were no 
significant differences in % of EBW at commencement or completion of FBT 
between those who were hospitalised and those who were not.  
In contrast, those who dropped out of treatment (n = 14, 31.1%) showed 
no significant increase between EBW at commencement of FBT and EBW at the 
point when they prematurely terminated therapy (with five of these patients losing 
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weight during their course of FBT). Given that the first phase of FBT is heavily 
focused on weight gain, these results may suggest that those who were not gaining 
weight assumed that treatment was failing and therefore terminated therapy. This 
idea is consistent with research demonstrating that a weight gain of at least 2.88% 
of EBW by session four predicts treatment success (Doyle et al., 2010), and that 
early weight gain improves recovery rates (Lock, Couturier, Bryson et al., 2006; 
Pereira et al., 2006). 
As well as the positive outcomes for treatment completers in terms of 
weight restoration, the current study sought to determine if FBT is effective for 
return of menses and this was confirmed. At commencement of FBT, only 9 
female adolescents (22%) menstruated but at termination of FBT, 32 adolescents 
(78%) had a return of menstruation. This is consistent with past studies which 
have shown that FBT leads to return of menses in approximately 60-90% of 
adolescents (Eisler et al., 1997; Faust et al., 2013; Lock, Couturier, & Agras, 
2006; Russell et al., 1987). While some of these percentages included results after 
a period of follow-up (e.g., Russell et al., 1987; Eisler et al., 1997), the results 
from the current study suggest that return of menses is possible for the majority of 
adolescents during the course of FBT.  
In addition to weight gain and return of menses, the study reviewed 
adolescent outcome based on the Morgan-Russell outcome criteria. By 
termination of FBT, 85.7% of the full sample (i.e., treatment completers and drop-
outs) experienced a ‘good outcome,’ 7.1% had an ‘intermediate outcome’ and a 
further 7.1% experienced a ‘poor outcome.’ This is in contrast to other studies 
which have shown lower recovery rates such as 56% of patients achieving a ‘good 
outcome,’ 33% with an ‘intermediate outcome’, and 11% with a ‘poor outcome’ 
(Le Grange et al., 2005). The higher rates of a ‘good outcome’ reported in this 
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study may reflect the high number of adolescents who commenced treatment 
already in the ‘good outcome’ category, including those who dropped out of 
treatment. It does highlight the limitations of the Morgan-Russell criteria which 
rely heavily on physical symptoms. Thus there is a need for other factors such as 
behavioural and cognitive changes to be taken into account when defining 
outcomes.  
Given the emphasis on the physical changes achieved as a result of FBT, 
the current study also aimed to investigate whether or not FBT is effective in 
improving overall psychological functioning for adolescents. The HoNOS/CA 
clinician-rated scales indicated that those who completed FBT displayed 
improved overall psychological functioning. These improvements were also 
supported by the self-report EDI-3 scales of Ineffectiveness, Interpersonal 
Problems, Affective Problems, Over Control, and General Psychological 
Maladjustment, which were all significantly reduced at treatment completion. The 
results of these measures indicate that FBT led to improved overall psychiatric 
and social functioning for those who completed the treatment. Previous research 
has also found that completion of FBT can lead to improvements in social 
functioning (Couturier et al., 2010; Paulson-Karlsson et al., 2008). In contrast to 
the positive results achieved by treatment completers, those who dropped-out of 
treatment had no change in their HoNOS/CA scores. This indicates that the 
clinician perceived those who dropped out of treatment not to have made any 
significant improvements in overall psychological functioning.  
In addition to the positive changes seen in psychological and social 
function for those who completed FBT, the study demonstrated that there was a 
significant reduction in core eating disordered cognitions and behaviours as 
indexed by the EDI-3 Eating Disorder Risk Composite (EDRC) among those who 
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completed treatment (treatment non-completers did not complete the EDI-3 at 
termination of FBT and therefore their results could not be analysed). The EDRC 
combines the subscales of Drive for Thinness, Bulimia, and Body Dissatisfaction. 
As well as the change being significant, a total of 85.7% of adolescents who 
completed FBT had a reduction in their EDRC score which suggests they 
perceived an improvement in their eating disorder cognitions. This rate is higher 
than reported in other studies, where a reduction in eating disordered cognitions 
was seen in 40-74% of adolescents (Couturier et al., 2010; Lock, Couturier, & 
Agras, 2006; Lock et al., 2010). The typically low levels of cognitive change 
observed in other studies may have been due to premature termination of 
treatment or not completing the full three phases of FBT. For example, Couturier 
et al., (2010) considered completion of FBT as completing the first two phases of 
treatment or attending more than 10 sessions. The lack of completion of the final 
phase of FBT or shorter treatment in past studies may have resulted in insufficient 
time for a reduction in eating disordered cognitions to occur. The current results 
highlight the need to retain adolescents in treatment so that they complete all three 
phases of FBT if cognitive change is to occur.   
As well as assessing weight, menstrual, and psychosocial outcomes, the 
present study sought to identify predictors of outcome. It was found that % of 
EBW and (marginally) EDRC at treatment commencement, and number of FBT 
sessions attended were unique predictors of % of EBW at termination of FBT. 
Lower eating disordered cognitions and behaviours at commencement led to 
higher % of EBW at completion, which may have been significant with a larger 
sample. This finding may be due to the fact that less eating disordered symptoms 
at commencement of FBT is likely to make weight restoration and the re-feeding 
phase of FBT easier.  
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Overall, however, % of EBW at commencement and number of sessions 
made the most significant contribution to predicting % of EBW at termination of 
FBT in the current study. Those who commenced treatment at a higher EBW were 
more likely to terminate FBT at a higher EBW, and this may have occurred 
because they had less weight to gain. This is consistent with other research that 
suggests lower starting weight leads to poorer outcomes (Doyle et al., 2010; Eisler 
et al., 2000; Pereira et al., 2006). The current study also found that those 
adolescents who attended more sessions were more likely to have a higher % of 
EBW at termination of FBT. This is in contrast to other studies that have found a 
short term version of FBT to be just as effective as the 20 session version of FBT 
(Lock et al., 2005; Lock, Couturier, & Agras, 2006). This discrepancy may have 
been due in part to the fact that patients in the current study did not undergo a 
period of inpatient weight restoration and therefore benefited from an extended 
period of FBT. Additionally, the present study differs from those of Lock and 
colleagues by the fact that it was undertaken in a clinical, rather than a research, 
setting. Since underweight patients have been shown to gain weight faster in 
RCTs compared with clinical settings (Accurso et al., 2015), patients in the 
current study may have benefited from a longer course of treatment to reach 
EBW. Allowing FBT to continue past the standard 20 sessions may be a 
consideration for outpatient settings where inpatient weight restoration is not 
possible prior to the commencement of FBT. This is a view shared by some 
adolescents, with over half reporting that they required more treatment than 
offered in the time-limited protocol (Krautter & Lock, 2004). 
It appears that a shorter duration of illness was not a significant predictor 
of a higher % of EBW at termination of FBT. The findings of the current study 
reflect the results of previous research which suggest that past duration of illness 
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may not have a direct impact on outcomes (Doyle et al., 2010; Lock et al., 2005; 
Pereira et al., 2006). The mean duration of past illness in the current study of 11 
months was similar to that reported in other studies of adolescents which ranged 
from 8 to 12 months (Couturier et al., 2010; Le Grange, Lock et al., 2012; Lock et 
al., 2010). This restricted range in illness duration may have contributed to the 
non-significant findings. In addition, the current results suggest that age did not 
significantly predict % of EBW at termination of FBT. This is in contrast to 
previous findings where age was a non specific predictor of outcome, with older 
adolescents less likely to do well in FBT (Le Grange, Lock et al., 2012; Lock, 
Couturier, Bryson et al., 2006). The reasons for these inconsistent results are 
unclear (given that the patients in the current study had similar mean age and 
duration of illness as other studies [e.g. Le Grange, Lock et al., 2012]), but may 
have been due to the limited analysis in the study which only reviewed age as a 
predictor of % of EBW at completion. Future research should review if age is a 
predictor of various types of outcome such as weight, menses and eating 
disordered thoughts and cognitions. 
The present study also sought to examine potential predictors of treatment 
drop-out from FBT. Partially replicating the predictors of outcome, eating 
disordered cognitions and behaviours (measured by the EDI-3 EDRC score) at 
treatment commencement made a unique contribution to predicting treatment 
drop-out. More specifically, higher EDRC scores at commencement were 
associated with a greater likelihood of terminating treatment prematurely. This is 
in contrast to other research which has found that severity of the illness did not 
impact retention rates in FBT (Ellison et al., 2012; Pereira et al., 2006), and 
suggests that those with higher eating disordered symptoms have difficulty 
tolerating the treatment and are more likely to drop-out of treatment. The findings 
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in this study may reflect the lack of inpatient admissions for weight restoration 
(compared to medical stability), which would result in some symptom reduction 
prior to commencing FBT. Many of the past studies have included prior weight 
restoration through hospitalisation (e.g., Russell et al., 1987) and future research 
should focus on examining if prior inpatient weight restoration can increase 
retention rates in FBT for those with severe eating disordered cognitions and 
behaviours.  
Another predictor of drop-out was % of EBW at commencement of 
treatment, with those who commenced treatment at a higher % of EBW being 
more likely to terminate treatment prematurely. This is an interesting finding 
given that starting with a higher % of EBW predicted a higher % of EBW at post-
treatment, but it seems it leads to higher drop-out rates, with those who dropped 
out of treatment having a higher starting % of EBW than those who completed 
treatment (mean 91.50 vs. 87.92, respectively). Previously, % of EBW was 
thought not to have an impact on completion rates (Ellison et al., 2012). It has 
been assumed in past studies that those who drop-out of treatment have a ‘poor 
outcome’ (Strober et al., 2014), however in the current study many of those who 
did not complete the full three phases of FBT commenced treatment in the ‘good 
outcome’ category. Treatment drop-out may actually reflect a lack of a sense of 
urgency in phase one to gain weight and may mean that the patient or parents are 
less likely to comply with the goals of FBT and find it difficult to tolerate the 
treatment. Reviewing treatment outcomes and acceptability of FBT for those with 
Atypical AN, where weight maintenance rather than re-feeding is necessary, 
would help to clarify if treatment acceptability for FBT is lower among those not 
requiring weight restoration.  
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In contrast, age and duration of illness were not significant predictors of 
drop-out from FBT. This is consistent with other studies suggesting they did not 
have an impact on completion rates (Ellison et al., 2012). These results may 
reflect the fact that in the current study, as in the Ellison et al. (2012) study, the 
patients were under 18 years of age with a short illness duration, both of which 
are viewed as the optimum target group for FBT (Lock & Le Grange, 2013; 
Russell et al., 1987). This may result in clinicians selecting this group for 
treatment, resulting in a restricted range in age and illness duration so that they do 
not predict retention rates. 
Limitations of the Present Study and Directions for Future Research 
While the findings of this study highlight the effectiveness of FBT for 
weight restoration, return of menses, reduction in eating disordered cognitions, 
and an improvement in overall psychiatric and social functioning for those who 
completed the full three phases of treatment, there are some important limitations 
to consider. Firstly, while the study showed that successfully completing all three 
phases of FBT led to cognitive change or a reduction in eating disordered 
cognitions, the sample did not include EDI-3s from all adolescents. This was due 
to the fact that some adolescents refused to complete the EDI-3, some missed 
follow up sessions as a result of prematurely terminating therapy, and some 
adolescents/children were too young to complete the EDI-3. Not having EDI-3 
data for the full sample may have biased the results as some adolescents may have 
refused to complete the EDI-3 due to still experiencing a high level of eating 
disordered cognitions. This concern is underscored by the findings that higher 
EDI-3 scores at treatment commencement predicted a greater likelihood of 
premature drop-out, meaning that those adolescents with the greatest cognitive 
disturbance were not included in the analyses assessing cognitive change. 
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Moreover, the mean illness duration of patients was less than a year, 
which may have impacted on the severity of eating disordered cognitions being 
experienced. Therefore the positive results concerning cognitive change found in 
the current study may actually reflect, at least in part, prior illness duration rather 
than treatment effectiveness. Further investigations into cognitive change in FBT 
should be conducted to determine if the high rates of cognitive improvement 
found in this study can be replicated with a complete sample size and with 
varying rates of prior illness duration. 
A second noteworthy limitation is that the sample size was small, and 
results of a small sample size combined with missing data (and its implications for 
power) should be interpreted with caution. The ‘real world’ nature of this study 
means that the clinicians were not blind to the completion status of patients when 
undertaking clinician-rated outcome measures and stringent statistical measures 
usually associated with RCTs, such as inter-rater reliability, were not possible. 
While data collection in clinical settings is often inconsistent, the small sample 
size indicates that further investigation and replication is needed in these ‘real 
world’ treatment settings. In addition, it is important to note that because this was 
a ‘real world’ sample of patients, it included 24.4% of patients who had 
previously been hospitalised for medical stabilisation prior to commencing FBT. 
While these patients were hospitalised for medical stabilisation and not for weight 
restoration, the hospital admission may have had an effect on treatment. For 
example, the hospital admission may have increased the intensity in phase one of 
FBT and motivated parents in the re-feeding of their child. In addition, EBW at 
commencement of treatment was relatively high, with only one third of patients 
being underweight at commencement of FBT, which may have contributed to the 
positive results. Further investigation regarding how prior hospitalisation (whether 
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for medical stability or weight restoration) and EBW at commencement of FBT 
impacts on treatment outcome and drop-out is needed.  
Thirdly, only a limited number of predictors of outcome and terminating 
treatment prematurely were analysed in the present study, indicating that future 
research would benefit from examining additional constructs. For instance, past 
research has shown that settings where the treating team had poor cohesion and 
inconsistency led to higher drop-out rates (Murray et al., 2013). The EDP does not 
have medical staff as part of the unit and relies on external providers such as GPs 
and paediatricians to provide medical monitoring. Therefore, problems with 
collegial alliance between the treating team and the medical professionals may 
have also increased drop-out rates in the current study.  
Another limitation of the present study is that it did not include a longer-
term follow-up of the adolescents. While the current findings highlight the 
effectiveness of FBT for those who completed all three phases of treatment, a 
longer-term follow-up would provide evidence that the gains are maintained, or 
that there is continued improvement, as found in past research (Eisler et al., 1997; 
Lock, Couturier, & Agras, 2006).  
Finally, the present study altered the manualised version of FBT by 
allowing an unlimited number of sessions.  Past studies have also altered the 
manualised definition of treatment completion for FBT, for example, considering 
completion of FBT as completing the first two phases of treatment or attending 
more than 10 sessions (Couturier et al., 2010; Lock et al., 2005; Lock, Couturier 
& Agras, 2006). While treatment in the current study adhered to the main 
concepts and three phases of FBT outlined in the manual, allowing patients and 
families to continue treatment until they chose to end treatment rather than 
completing the standard 20 sessions, means that the findings of the study may not 
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reflect the effectiveness of the manualised version of FBT. In addition, the present 
study did not report on the findings of a comparison group. It is important to 
consider how the outcomes achieved in FBT compare to other treatments offered 
for adolescents. While a few RCTs have been completed comparing FBT to other 
forms of individual therapy (e.g., Lock et al., 2010), further investigation is 
needed comparing FBT in ‘real world’ treatment settings to other forms of 
outpatient therapy such as individual therapy and day programs.  
Summary 
Taking into account the small sample size of this study, the missing data, 
and the adaptation of the manualised version of FBT by allowing an unlimited 
number of sessions, the findings provide preliminary support for the notion that 
completion of all three phases of FBT leads to improvements for adolescents with 
AN in terms of weight restoration, return of menstruation, core eating disorder 
cognitions and behaviours, and general psychosocial functioning. There have been 
conflicting results regarding predictors of outcome and drop-out from FBT, with 
the present study suggesting that commencing FBT at a higher % of EBW and 
experiencing a lower severity of eating disordered cognitions, as well as attending 
more FBT sessions predict a greater % of EBW at termination of FBT, while a 
greater severity of eating disordered cognitions and higher % of EBW at 
commencement of FBT increases the likelihood of terminating treatment 
prematurely. Future research should continue to evaluate the effectiveness of FBT 
in ‘real world’ settings, especially compared with other outpatient adolescent 
treatments.  
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Chapter 6 
Study 3: The Effectiveness of a Day Program Compared with Family Based 
Treatment for Adolescents with Anorexia Nervosa 
 
Family Based Treatment (FBT) is currently recommended as the first line 
treatment for adolescents with Anorexia Nervosa (AN; Eisler et al., 2010). This 
recommendation is based on promising results suggesting that FBT is efficacious 
in the adolescent population and this is particularly true for those under the age of 
19 years with an onset of less than three years (Russell et al., 1987). FBT has been 
shown to be effective for weight restoration, return of menses, and physical 
recovery (Eisler et al., 1997; Faust et al., 2013; Lock et al., 2006; Lock et al., 
2010), and can lead to a reduction in eating disordered cognitions for some 
patients (Couturier et al., 2010; Lock, Couturier, & Agras, 2006; Lock et al., 
2010). FBT has also been disseminated in a variety of settings, and in different 
populations such as young children and young adults (Couturier et al., 2010; Loeb 
& Le Grange, 2009; Lock, 2011; Loeb et al., 2007; Paulson-Karlsson et al., 2009).  
Despite the above-mentioned promising results, there is currently a lack of 
research comparing FBT to other forms of intensive outpatient treatment, such 
that the recommendation that it be considered first line treatment for adolescents 
with AN may be premature. To date, FBT has been investigated in adolescents 
with AN comparing different types of FBT, FBT to other types of family therapy, 
or FBT to other types of individual therapy. For instance, the first RCT compared 
FBT to supportive individual therapy, where FBT was found to be more effective 
than individual therapy at completion and again at a five-year follow-up (Eisler et 
al., 1997; Russell et al., 1987). Another study found that, compared to another 
form of individual therapy (Adolescent Focused Therapy), FBT was more 
effective for full remission at six- and 12-month follow-ups (Lock et al., 2010). 
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Subsequently, a review by Couturier et al., (2013) found that FBT produces 
outcomes similar to individual therapy at the end of treatment, however is more 
effective at six- to 12-month follow-ups.  
Further research comparing FBT to a more comprehensive range of 
evidence-based treatments for adolescent AN is lacking, in particular, day 
programs. Given that AN is one of the most serious psychiatric illnesses with high 
mortality rates, especially when intervention in the early stages is not provided or 
not effective (Bulik et al., 2007; Harris & Barraclough, 1998), finding the most 
efficacious treatments should be a research priority. Reviews of studies for AN 
suggest that further research is needed across the various forms of 
psychotherapeutic interventions, particularly those that include a multidisciplinary 
treating team (Bulik et al., 2007).  
The need to evaluate FBT relative to other approaches is further 
underscored by some limitations with FBT. For instance, many adolescents do not 
respond to FBT, with research demonstrating that for patients with higher levels 
of negative expressed emotion or for separated families, FBT results in higher 
rates of drop-out, lower rates of physical restoration, and longer treatment length 
(Eisler et al., 2000; Le Grange et al.,1992; Lock, Couturier, Bryson et al., 2006; 
Szmukler et al., 1985). The findings from Study 2 (see Chapter 5) also suggest 
that a greater severity of eating disordered symptoms and higher % of EBW at 
commencement of FBT increase the likelihood of terminating treatment 
prematurely. In addition, patients who attend more FBT sessions as well as those 
patients who commence FBT at a higher % of EBW, and experience a lower 
severity of eating disordered cognitions, could be expected to experience a greater 
% of EBW at completion of FBT. For most patients, FBT has also produced less 
than ideal rates of eating disordered cognitions at treatment completion (Le 
 143 
Grange & Lock, 2005; Couturier et al., 2010; Ellison et al., 2012; Lock et al., 
2010; Strober, 2014). Therefore, it is important to review FBT compared to other 
forms of intervention to offer an alternative treatment to those families for whom 
FBT is inadequate.  
In addition to the research comparing FBT to various forms of individual 
therapy, adaptations to the manualised version of FBT have been studied. The 
most common adaptations to the model are multifamily programs (Dare & Eisler, 
2000; Scholz & Asen, 2001; Scholz et al., 2005), or group based treatments such 
as dialectical behaviour therapy (DBT; Johnston, O’Gara, Koman, Wood Baker, 
& Anderson, 2015), and using FBT combined with another group based treatment 
option such as a day program (Girz et al., 2013; Grewel et al., 2014; Henderson et 
al., 2014; Robinson et al., 2012; Ornstein et al., 2012). In particular, FBT-based 
day programs involve adolescents attending a day program which includes group 
therapy and meal support, while the family also engages in traditional FBT. The 
initial studies indicate that the FBT-based day programs are effective for weight 
gain and producing a reduction in eating disordered cognitions. However, these 
day programs appear to have high drop-out rates (42-46%) compared with the 
standard version of FBT (15-25%; Ellison et al., 2012; Grewel et al., 2014; Loeb 
et al., 2007; Ornstein et al., 2012) and it is often unclear if they are used as a first 
line treatment or for those who have failed more traditional FBT. While FBT-
based day programs may be beneficial, research examining the effectiveness of 
FBT compared to traditional day programs is also needed.  
As with FBT, there is a lack of research comparing day programs to other 
outpatient treatments. The literature reviewing standard and FBT-based day 
programs for adolescents is an emerging area. The limited number of studies 
which have been published indicate that adolescent day programs are as effective 
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as inpatient admissions (Herpertz-Dahlmann et al., 2014), produce significant 
weight gain, result in a reduction in eating disordered symptomatology (Girz et 
al., 2013; Goldstein et al., 2011; Henderson et al., 2014; Ornstein et al., 2012), 
and lead to improvements in general psychological functioning (Henderson et al., 
2014; Lazaro et al., 2011; Ornstein et al., 2012). Day programs were initially 
developed as a way to reduce long inpatient admissions for patients with eating 
disorders and therefore most research has focused on comparing the effectiveness 
of day programs to inpatient admissions. Aside from comparing day programs to 
inpatient admissions, studies related to day programs for patients with eating 
disorders have either not included comparison groups (Zipfel et al., 2002) and/or 
have utilised small sample sizes (e.g., 40 patients in a randomised controlled trial 
by Kong [2005]), thereby making it difficult to ascertain the effectiveness of day 
program treatment relative to other evidence-based interventions for adolescent 
AN such as FBT.  
Aims and Hypotheses of the Present Study 
Given that a key deficiency in the research is that there have been no 
clinical trials comparing the effectiveness of FBT with day programs, the aim of 
the current study is to provide a first step in comparing the effectiveness of 
manualised FBT and day program treatments for adolescents with AN. Limited 
past research suggests that day programs are more effective than individual 
therapy, however there is currently no research comparing day programs to group 
based or family therapies. Based on limited research assessing FBT based day 
programs for adolescents, it is hypothesised that there will be no difference 
between the two treatments on outcome measures. The two treatments will be 
compared on a number of factors including drop-out rate, length of treatment 
(number of sessions or days attended), and changes in percentage of expected 
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body weight (% of EBW), return of menses (in females with amenorrhoea), eating 
disordered cognitions and behaviours, and general psychosocial functioning from 
the commencement to end of treatment.  
Method 
Participants  
The present study included adolescents who participated in treatment at 
the Canberra Eating Disorders Program over a period of seven years. This 
included 39 adolescents who participated in the day program (as described in 
Study 1, Chapter 3) and 45 adolescents who participated in FBT (as described in 
Study 2, Chapter 5). Inclusion criteria to participate in either treatment were: 
medical stability and diagnosis of AN (binge/purging subtype or restricting 
subtype) or EDNOS (if weight or menses criteria were not met for AN). 
Diagnosis was determined by a semi-structured clinical assessment interview 
conducted by experienced clinicians using the Diagnostic and Statistical Manual 
of Mental Disorders (DSM-IV-TR; APA, 2000). Using the current DSM-5 criteria, 
all patients would have met criteria for AN or Atypical AN (APA, 2013).  
Drop-out from the day program was defined as those patients who 
disengaged before an agreed termination (i.e., between the patient, parents, and 
treating team), regardless of the number of weeks attended. Drop-out from FBT 
was defined as those families who did not complete the full three phases of FBT 
(regardless of the number of sessions attended), as defined by the treatment 
manual (Lock & Le Grange, 2013).  
The study received ethical approval from both the ACT Health and the 
Australian National University Human Research Ethics Committees 
(documentation pertaining to ethical clearance is contained in Appendix B, while 
copies of the consent and information forms are included in Appendix C). 
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Design 
A non-randomised controlled trial study design was used. Randomisation 
to treatment type was not possible because the two treatments were offered 
consecutively at the Canberra Eating Disorders Program, with day program 
treatment being offered for the first 3.5 years and FBT being offered for the next 
3.5 years. Research has highlighted the need for ‘real world’ research trials in 
addition to randomised controlled trials in the AN population (Treasure & Kordy, 
1998). The therapists in both programs had varying experience in treating patients 
with eating disorders and were part of a multidisciplinary team that included 
social workers, occupational therapists and psychologists.  
Measures  
Data collection occurred at the commencement and completion of 
treatment, and included sex, age, weight, height, percentage of expected body 
weight (% of EBW; calculated as BMI/50
th
 percentile BMI for age, sex, and 
height x 100 [Faust et al., 2013]), duration of illness in months (calculated from 
when patients or family members reported the onset of the disorder), diagnosis, 
amenorrhoea, and number of day program days attended or number of FBT 
sessions attended.  
Several questionnaires were also administered including the Health of the 
Nation Outcome Scales (HoNOS [Wing, Curtis & Beevor, 1996]) or Health of the 
Nation Outcome Scales for Children and Adolescents (HoNOSCA [Gowers et al., 
1999]), and the Eating Disorder Inventory-3 (EDI-3). The HoNOS is a 12-item, 
clinician-rated measure to assess the behaviour, impairment, symptoms, and 
social functioning of people with a severe mental illness including patients with 
eating disorders and the HoNOSCA is a version for young people (Bilenberg, 
2003; Stevens, 2010; Wing et al., 1998). The EDI–3 (Garner, 2004) is a 
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standardised self-report measure of eating disorder symptoms and associated 
psychopathology. A full description of the outcome measures is contained in 
Chapter 3.  
Procedure  
Prior to commencement of either treatment program, patients and parents 
attended an initial assessment, which included a clinical interview and 
administration of the outcome measures. A description of the day program content 
is contained in Chapter 3, while a description of FBT is presented in Chapter 5. 
The self-report (EDI-3) and clinician-rated (HoNOS or HoNOSCA) outcome 
measures were re-administered when the patient completed treatment. In both the 
day program and FBT samples, not all patients completed the self-report measures 
at commencement due to refusal (day program, n = 8; FBT, n = 4) and age (FBT, 
n = 3). Again at completion of treatment, not all patients completed the self-report 
measures due to refusal and missing follow-ups (drop-out) (day program, n = 20; 
FBT, n = 17) and age (FBT, n = 3). Therefore the results of the self-report 
measures do not always include the full sample of each treatment program.  
Statistical Analysis 
The study included a completer and an intention-to-treat analysis. To 
assess outcome for categorical variables (return of menses at end of treatment and 
drop-out) percentages between treatment types were examined using the Chi-
square independence test. Length of treatment between the two groups was 
compared using independent t-tests. A series of two-way within-between subjects 
analysis of variance (ANOVAs) were performed for the full sample and then 
excluding drop-outs to assess the impact of treatment (day program or FBT) on % 
of EBW, HoNOS/CA scores and EDI-3 composite scores at pre- and post-
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treatment. SPSS version 22 was used, with the two-tailed significance level set at 
p < .05 for all analyses. 
Results 
Characteristics of the Sample  
A total of 39 patients participated in the day program and 45 patients and 
their families participated in FBT. At the pre-treatment assessment, for those in 
day program, 13 (33.3%) patients met DSM-IV-TR criteria (APA, 2000) for AN, 
and 26 (66.7%) patients met criteria for Eating Disorder Not Otherwise Specified 
(EDNOS) due to not meeting the weight and/or menses criteria for AN. For those 
in FBT, 32 (71.1%) patients met DSM-IV-TR criteria (APA, 2000) for AN, and 13 
(28.9%) patients met criteria for EDNOS due to not meeting the weight and/or 
menses criteria for AN. Table 6.1 shows the characteristics of both samples at 
commencement of the day program and FBT.  
Independent t-tests and chi square tests were completed to ensure there 
were no significant differences between the two groups on demographic and 
clinical characteristics at treatment commencement. There were no significant 
differences for any of the characteristics including menstruation at 
commencement (excluding males and those on the contraceptive pill), X
2
 (1, n = 
70) = .000, p = 1.0, phi = -.02; prior hospitalisation, X
2
 (1, n = 84) = .162, p = 
.687, phi = -.07; percentage of EBW at commencement of treatment, t(82) = -
.279, p = .781; age at commencement of treatment t(82) = 1.73, p = .087; duration 
of illness t(82) = 1.69, p = .095; and gender, X
2
 (1, n = 84) = .808, p = .681, phi = 
-.07.  
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Table 6.1  
Mean (SDs) Demographic and Clinical Characteristics at Commencement of the 
Day Program and FBT 
Characteristic M (SDs) 
 Day Program FBT 
Age 
 
15.7 (1.73) 14.96 (1.89) 
% of EBW  
 
88.48 (9.7) 89.0 (8.44) 
Duration of illness (months) 
 
14.1 (8.43) 11.31 (6.69) 
 n (%) 
Characteristic 
 
Day Program FBT 
Amenorrhoea  
 
25 (67.5) 
 
29 (70.7) 
Menstruating 
 
7 (18.9) 9 (22) 
On oral contraceptive  
 
5 (13.5) 3 (7.3) 
Female  37 (94.9) 
 
41 (91.1) 
Male  
 
2 (5.1) 4 (8.9) 
Weight < 85% of EBW 
 
13 (33.3) 15 (33.3) 
Weight between 85% and 99% of EBW 
 
22 (56.4) 24 (53.4) 
Weight > 99% of EBW 
 
4 (10.3) 6 (13.3) 
Hospitalisation prior to treatment 
 
12 (30.8) 11 (24.4) 
 N = 39 N = 45 
Note. EBW: Expected body weight. 
 
Treatment Outcome 
A Chi-square test for independence indicated that there was a significant 
difference between treatment groups for drop-out rates with a small effect size, X
2
 
(1, n = 84) = 3.99, p = .046, phi = -.218. Only five (12.8%) of the day program 
patients ended treatment prematurely, whereas 14 (31.1%) of FBT patients 
terminated treatment without completing the full three phases of FBT. Day 
program patients dropped out of treatment after an average of 4.2 days, whereas 
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those in FBT dropped out after an average of 10.8 sessions.  
When reviewing the full sample (i.e., both completers and drop-outs), 
there was a significant difference in the number of sessions attended for FBT (M 
= 18.77, SD = 13.6) compared with number of days attended in the day program 
(M = 26.8, SD = 20.6), t(64) = 2.07, p = .043, and Cohen’s value (d = .51) 
suggested a moderate effect size. When excluding those who dropped out of 
treatment, there was a trend towards a significant difference in the number of 
sessions attended for FBT (n = 31) (M = 22.35, SD = 13.9) compared with the 
number of days attended in the day program (n = 34) (M = 30.11, SD = 20.03), 
t(63) = 1.79, p = .077. In addition, for those who completed treatment, there was a 
significant difference in the number of weeks attended. Those patients in day 
program attended for less weeks (n = 34; M = 15.85, SD = 10.34) than those in 
FBT (n = 31; M = 40.22, SD = 20.20), t(43.77) = -6.033, p <.001, and Cohen’s 
value (d = -1.518) suggested a large effect size. 
For the full sample of female patients 62.2% % of the day program 
patients experienced menstruation at the end of treatment, and 78% of FBT 
patients menstruated. A Chi-square test for independence (with Yates Continuity 
Correction) indicated that this difference was not significant, X
2
 (1, n = 70) = .92, 
p = .33, phi = -.15. For those who completed treatment (and when excluding those 
on the contraceptive pill), Fisher’s Exact Probability Test showed that there was a 
significant difference (p = .025) in menstruation for females between the two 
treatment groups, with 96% of those in the FBT group menstruating at completion 
compared with 70.4% of the day program patients.  
A mixed within-between subjects ANOVA was conducted to assess the 
treatment types (day program and FBT) on % of EBW at pre- and post-treatment 
for both the full and completer samples. For the full sample, there was no 
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significant interaction between treatment type and change from pre- to post-
treatment for % of EBW, Wilks’ Lambda = .97, F(1, 82) = 2.91, p = .092; η2 = 
.03. There was a main effect for time, Wilks’ Lambda = .59, F(1, 82) = 55.77, p < 
.001; η2 = .41, showing that for both day program and FBT patients, % of EBW 
weight increased from pre- to post-treatment. The main effect for treatment type 
was not significant, F(1, 82) = 1.74, p = .191; η2 = .02, suggesting no difference 
for % of EBW between day program and FBT patients.  
For those who completed treatment (i.e., excluding drop-outs), there was a 
significant interaction between treatment type and change from pre- to post-
treatment for % of EBW, Wilks’ Lambda = .85, F(1, 63) = 10.67, p = .002; η2 = 
.145 (indicating a large effect size). The main effect for time was also significant, 
Wilks’ Lambda = .46, F(1, 63) = 73.71, p < .001; η2 = .54, as was the main effect 
for treatment type, F(1, 63) = 5.5, p = .022; η2 = .08. These results suggest that for 
those who completed treatment, where they commenced with similar % of EBW  
by the completion of treatment FBT patients finished with a higher % of EBW 
than day program patients. The mean % of EBW scores at the commencement and 
end of treatment in the day program and FBT conditions for both the full sample 
and completers are shown in Table 6.2.  
To review the impact of treatment type (day program and FBT) on 
HoNOS/CA scores at pre- and post-treatment for both the full and completer 
samples, a mixed within-between subjects ANOVA was completed. For the full 
sample, there was no significant interaction between treatment type and change 
from pre- to post-treatment on HoNOS/CA scores, Wilks’ Lambda = .97, F(1, 82) 
= .338, p = .563; η2 = .004. The main effect for treatment type was also not 
significant, F(1, 82) = .82, p = .368; η2 = .01, indicating no difference for 
HoNOS/CA scores between day program and FBT patients. There was a main 
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effect for time, Wilks’ Lambda = .71, F(1, 82) = 33.73, p < .001; η2 = .29, 
suggesting that for both day program and FBT patients, HoNOS/CA scores 
significantly decreased from pre- to post-treatment.  
For those who completed treatment (i.e., excluding drop-outs), there was 
no significant interaction between treatment type and change from pre- to post-
treatment on HoNOS/CA scores, Wilks’ Lambda = .99, F(1, 63) = .297, p = .588; 
η2 = .005. The main effect for time was significant, Wilks’ Lambda = .52, F(1, 
63) = 57.4, p < .001; η2 = .47, suggesting that for those who completed day 
program or FBT, HoNOS/CA scores significantly decreased from pre- to post-
treatment. The main effect for treatment type was also significant, F(1, 63) = 8.65, 
p = .005; η2 = .121, indicating a difference for HoNOS/CA scores between day 
program and FBT patients. Mean HoNOS/CA scores at the commencement and 
end of treatment in the day program and FBT conditions for both the full sample 
and completers are shown in Table 6.2.   
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Table 6.2 
Means (SDs) for % of EBW and HoNOS/CA Scores for the Full Sample and 
Treatment Completers for the Day Program and FBT at Pre-Treatment and Post-
Treatment  
 M (SD) 
 Pre-treatment Post-treatment  
Full Sample  Day Program  FBT Day Program FBT 
 
% of EBW 
 
 
88.48 (9.7) 
 
 89.03 (8.44) 
 
94.32 (9.46) 
 
98.34 (8.59) 
HoNOS/CA 12.3 (6.99) 10.86 (4.92) 6.82 (5.86) 6.37 (6.75) 
 Pre-treatment Post-treatment 
Treatment 
completers  
Day Program  FBT Day Program FBT 
 
% of EBW 
 
87.14 (9.34)  
 
87.92 (8.79) 
 
93.03 (9.65) 
 
101.03 (6.73) 
 
HoNOS/CA 13.02 (6.88) 10.41 (5.09) 6.94 (5.58) 3.38 (3.66) 
Note. % of EBW: Expected body weight. 
 
Mean EDI-3 scores (for the completer sample) at pre- and post-treatment 
in the day program and FBT groups are shown in Table 6.3. Only analyses on the 
completer sample were undertaken for the EDI-3 scores given that no EDI-3s 
were completed at the end of treatment for those who dropped out. To evaluate if 
there were significant differences between treatment groups for the EDI-3 Eating 
Disorder Risk Composite (EDRC) scores for those who completed treatment, 
mixed within-between subjects ANOVAs were completed. The interaction 
between treatment type and change from pre- to post-treatment on EDRC scores 
approached significance, Wilks’ Lambda = .90, F(1, 34) = .338, p = .06; η2 = 
.09, with a significant main effect for time, Wilks’ Lambda = .55, F(1, 34) = 
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28.04, p < .001; η2 = .45, and a trend towards a significant main effect for 
treatment type, F(1, 34) = 3.83, p = .059; η2 = .101. EDRC scores reduced for 
both groups across time, however FBT patients had lower EDRC scores at 
treatment completion compared with day program patients. In addition, the 
interaction between treatment type and change from pre- to post-treatment on 
EDI-3 General Psychological Maladjustment (GPM) scores was significant, 
Wilks’ Lambda = .85, F(1, 33) = 5.6, p = .024; η2 = .145, with a main effect for 
time, Wilks’ Lambda = .633, F(1, 33) = 19.15, p < .001; η2 = .37, but not for 
treatment type, F(1, 33) = 2.69, p = .110; η2 = .07, indicating that GPM scores for 
day program and FBT were similar at pre-treatment, but at post-treatment those in 
FBT had lower GPM scores.  
 
Table 6.3 
Means (SDs) for the Eating Disorder Inventory (EDI-3) Composite Scores of 
Eating Disorder Risk Composite (EDRC) and General Psychological 
Maladjustment (GPM) for the Day Program and FBT at Pre-Treatment and Post-
Treatment.  
 M (SD) 
 Pre-treatment Post-treatment  
 Day 
Program  
FBT Day 
Program 
FBT 
Eating Disorder Risk 
Composite (EDRC) 
150.58 
(22.01) 
149.04 
(28.19) 
132.89 
(32.73) 
117.04 
(24.93) 
General Psychological 
Maladjustment (GPM) 
451.05 
(60.43) 
454.50 
(58.66) 
427.05 
(77.13) 
388.70 
(71.09) 
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Discussion 
The current study aimed to compare the effectiveness of day program 
treatment and FBT for adolescents with AN. More specifically, the study aimed to 
compare the effectiveness of each program based on a number of physical 
measures including % of EBW and return of menses at the end of treatment, and 
on potential improvements in eating disordered cognitions and measures of 
general psychosocial functioning. The study also sought to compare if there were 
differences in premature termination of treatment between day program treatment 
and FBT.   
Findings of the Present Study 
The current study found that FBT was associated with a significantly 
higher rate of drop-out compared with day program treatment. Only 12.8% of day 
program patients ended treatment prematurely, whereas 31.1% of FBT patients 
terminated treatment before completing all three phases of FBT. The drop-out 
rates of the day program in the current study are consistent with other studies 
employing CBT-based day programs for adolescents, such as Goldstein et al., 
(2011) who reported a drop-out rate of 7.1%. In contrast, FBT-based adolescent 
day programs have reported drop-out rates as high as 42% (Grewel et al., 2014). 
Studies evaluating the use of FBT in specialist research settings report drop-out 
rates around 10-15% (Le Grange & Lock, 2005; Le Grange et al., 2005), however 
dissemination studies report higher drop-out rates of around 14-25% (Couturier et 
al., 2010; Loeb et al. 2007). These higher drop-out rates in dissemination studies 
are consistent with the premature termination rate of 31.1% in FBT in the current 
study. The significant difference between drop-out rates from the day program 
and FBT in the current study, in addition to the results of past studies, suggests 
that research is needed to clarify the patients and families for whom FBT may be 
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less well-suited and/or methods for optimising the delivery of FBT (at least when 
administered outside of specialist research settings) to reduce these elevated drop-
out rates. Tempering this positive aspect of day program treatment is its greater 
resource demand relative to FBT. That is, patients who completed FBT in the 
present study received a mean 22 hours contact hours with professionals, whereas 
day program treatment ranged from 3.5 to 5.5 hours per day for a mean of 30 days 
(105-165 hours), making it considerably more time intensive for staff. This is an 
important consideration when evaluating the two treatments.  
At the present stage of research, the reasons underlying the higher drop-
out rates for FBT relative to day program treatment are unclear. One possibility is 
that implementations of FBT outside of specialist research settings are comprised 
of patients who are more unwell and/or may be undertaken with less rigour. 
Results from Accurso et al., (2015) suggest that this may be the case, where 
patients who commenced treatment at a lower % of EBW gained weight slower 
when FBT was administered in a clinical setting rather than a RCT. Alternatively, 
research has suggested that FBT is not suitable for all families (Strober et al., 
2014), and factors such as high levels of negative expressed emotion and 
comorbid psychopathology may increase drop-out rates in ‘real-world’ treatment 
settings. Another possibility may be related to the age appropriateness of FBT. 
Recent research suggests that adaptations to the model are needed depending on 
the developmental stage of the adolescent (Dimitropoulos et al., 2015), although 
there was no evidence that age was related to drop-out from FBT in the current 
research program (see Study 2, Chapter 5). Clearly further research into treatment 
acceptability of FBT in particular is needed.  
In addition to drop-out rates, the current study aimed to determine if there 
were differences in treatment length between day program treatment and FBT. 
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The current study was unusual in that there was no maximum treatment length for 
either program, such that treatment could be extended depending on clinical need. 
The manualised version of FBT posits 20 sessions as standard (Lock & Le 
Grange, 2013). The results of the current study suggest that this may be 
insufficient for some adolescents with AN, given that 17 participants (37.8%) 
attended more than 20 sessions of FBT. While there is a lack of research 
regarding optimum treatment length for day program attendance (Zipfel et al., 
2002), patients in the current study attended a range of 3-89 days. This high level 
of variability suggests that it may be inadvisable to pre-determine the 
recommended length of day program treatment. When comparing treatment length 
between conditions using an intent to treat analysis, patients in the day program 
participated in significantly more days/sessions than those who participated in 
FBT. When comparing treatment length between conditions using an intent to 
treat analysis, patients in the day program participated in significantly more 
days/sessions than those who participated in FBT. Since this significant difference 
disappeared when conducting completer analyses, it may reflect the possibility 
that more unwell patients (who therefore required longer treatment) dropped out 
of day program treatment. 
In terms of outcome measures, a number of physical factors were assessed 
in comparing the two treatments including % of EBW and menstruation. For the 
intent to treat analyses conducted on the full sample, there were no significant 
differences between the two treatments on either % of EBW or return of menses, 
with both treatments resulting in significant improvements on these outcome 
measures. However, for those who completed treatment, FBT appeared to be more 
effective than day program treatment for both weight and menstruation at the end 
of treatment. The results of the current study showed that for females (excluding 
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those on the contraceptive pill) 96% of those who completed FBT experienced 
menstruation, whereas approximately 70% of day program patients menstruated. 
In addition, when reviewing those who completed treatment, patients in FBT 
ended with a higher mean % of EBW (M = 101% of EBW) than patients in the 
day program (M = 93% of EBW). This difference in post-treatment weight 
occurred even though patients in both treatments had comparable pre-treatment 
weights (M = 87% of EBW). Thus the more positive results of FBT cannot be 
attributed to these patients being less unwell (at least in terms of weight status) 
after the more unwell patients dropped out of treatment.  
The results from the current study are consistent with rates reported in past 
studies with day programs reporting return of menses in approximately 65% of 
adolescents (Grewal et al., 2014), and patients weight restored to around 85% of 
EBW at treatment completion (Dancyger et al., 2003; Goldstein et al., 2001). The 
results for treatment completers are also consistent with past studies of physical 
restoration in FBT, with 60-90% of adolescents experiencing a return of menses, 
and weight restoration to at or above 90% of EBW (Eisler et al., 1997; Faust et 
al., 2013; Russell et al., 1987).  
The finding that FBT (provided patients complete the treatment) may be 
more effective than day program treatment for weight restoration and a return of 
menses is perhaps not surprising given that the highest priority in phase one of 
FBT is a focus on re-feeding, weight gain, and physical restoration (Lock & Le 
Grange, 2013). The results may also reflect differences in treatment length with 
those who completed the day program attending an average of approximately15 
weeks, whereas those in FBT attended for an average of approximately 40 weeks, 
thus allowing greater time for weight restoration and resumption of menses to 
occur for those patients who attended FBT. These results may also reflect 
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differences in the meal supervision of each treatment. FBT involved parents 
supervising all meals, whereas day program treatment only included meal 
supervision by staff three days per week. It would be beneficial for future research 
to compare the results of an FBT based day program with a CBT based day 
program to develop a better understanding of the components that lead to 
improved outcomes; this design would help to demonstrate any additive benefits 
of parental supervision of meals while holding other aspects of the intervention 
more constant.   
The study also aimed to compare FBT and day program treatment on 
eating disorder specific and general measures of psychological functioning. The 
results suggested that when using either an intent to treat or a completer analysis, 
there was no significant difference between the clinician-rated HoNOS/CA scores 
of patients in day program treatment versus FBT, however there was a significant 
change in treatment time with both programs showing a reduction in scores from 
pre- to post-treatment. Thus clinicians perceived that both programs resulted in an 
overall comparable improvement in psychosocial functioning. That FBT was able 
to match day program treatment in this regard is an interesting finding given that 
FBT does not directly target the patient’s psychosocial functioning or co-morbid 
disorders (Lock et al. 2001), whereas the day program did provide groups such as 
distress tolerance and assertiveness and communication, which were directly 
targeted at improving overall psychological and social functioning.  
In addition to the clinician-rated measure of psychological functioning, the 
self-report EDI-3 composite General Psychological Maladjustment (GPM) score 
showed a significant difference between the patients who completed the day 
program and those who completed FBT. In the completer analysis, patients 
commenced treatment in both groups with similar scores on the GPM scale, but 
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FBT patients ended treatment with significantly lower scores than those in the day 
program. This finding suggests that FBT led to greater improvements in eating 
concerns and general psychological functioning as the GPM scale is considered an 
overall evaluation of eating disordered symptoms and psychological 
maladjustment (Garner, 2004). The improvement in scores in FBT suggests that 
those who completed the full program of FBT experienced positive changes in 
terms of feeling more socially connected, as well as improved self-esteem, ability 
to articulate their emotions, and general functioning. This is consistent with other 
research which has shown that patients report feeling more emotionally connected 
after engaging in FBT (Krautter & Lock, 2004). The greater improvements in 
GPM scores in the FBT relative to the day program group need to be considered 
with some degree of caution, however, given that these findings do not include 
those who dropped out of treatment and are inconsistent with the lack of a 
significant group difference in patients’ psychological functioning from the 
perspective of clinicians (as indexed via the HoNOS/CA). 
The EDI-3 Eating Disorder Risk Composite (EDRC), which combines the 
subscales of Drive for Thinness, Bulimia, and Body Dissatisfaction and is a more 
specific measure of eating disordered behaviours and cognitions, showed a 
marginally significant (p = .06) difference between patients who completed day 
program treatment and FBT, favouring a greater reduction in the latter group. If 
found to be significant in studies with higher power, this suggested finding of the 
relative benefits of FBT over day program treatment on the EDI-3 scales 
constitutes a somewhat unexpected result given that the day program, like most 
other eating disorder day programs (Abbate-Daga et al., 2009; Zipfel et al., 2002), 
provided treatment groups targeting factors such as mood regulation and 
interpersonal effectiveness to enhance psychological functioning. In contrast, FBT 
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does not directly target psychological change (Lock & Le Grange, 2013; Loeb & 
Le Grange, 2009), with the core components of FBT focused on weight related 
outcomes (Ellison et al., 2012). One possible interpretation of this finding is that 
much of the psychological disturbance seen in adolescents with AN may be 
secondary to their compromised medical state as starvation can lead to 
psychological disturbances including low mood, irritability and social withdrawal 
(Kalm & Semba, 2005). FBT may produce greater psychological change due to 
directly targeting starvation, as well as addressing the disturbance in family 
functioning stemming from the AN. 
Limitations of the Present Study and Directions for Future Research 
There are several important limitations of the study that must be 
acknowledged in interpreting the results. Firstly, the fact that the present study 
was not a randomised controlled trial means that there may have been other 
factors which influenced the outcomes and drop-out rates, rather than the specific 
treatments. For example, the current study did not collect a reason for drop-out 
and can only hypothesise that the reduced number of drop-outs in day program 
compared with FBT may reflect the treatment offered by the service at the time to 
patients and families. More specifically, it is possible that the day program was 
associated with lower drop-out rates because adolescents were offered the 
alternative option of individual therapy, resulting in those who commenced the 
day program having higher levels of commitment to this treatment modality and 
therefore being less likely to terminate treatment prematurely. In contrast, FBT 
was offered as the only treatment for adolescents, which may have resulted in 
some families commencing treatment due to feeling that there were no other 
treatment options rather than a high level of commitment to this approach. In 
addition, day program may have higher retention rates because patients can 
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potentially avoid meal therapy at home, whereas FBT requires parents to continue 
meal therapy outside of sessions. While the findings of the present study are 
beneficial as a starting point, randomised controlled trials comparing FBT and day 
program treatments are now warranted in order to remove the potential effects of 
non-treatment factors on drop-out rates or outcomes.  
A second noteworthy limitation is that the sample size in both treatment 
groups was relatively small. While sample size of the current study compares 
favourably with other studies (e.g., a review found that the mean sample size of 
treatment studies for AN is 23 patients [Bulik et al., 2007]), it was nevertheless 
small which has implications for power and the generalisability of the findings.  
Relatedly, while this non-randomised controlled trial presents evidence 
from ‘real world’ practice - an area lacking in both day program and FBT research 
- the nature of the study meant that there was missing data and incomplete follow 
up. This further reduced the sample size and means that the results of some 
outcome measures need to be interpreted with caution. The results of the EDI-3, 
in particular, may have been biased as they were not completed by all patients at 
treatment completion and therefore may represent a subsample of those who felt 
more positive after engaging in the treatment. The fact that FBT had a higher rate 
of drop-out than day program treatment may therefore have contributed to its 
more positive outcomes on the EDI-3. While this concern is mitigated by the 
finding that both groups were comparable on these measures at the 
commencement of treatment, it is still possible that the FBT completer sample 
constituted a healthier group on variables that were not measured (e.g., motivation 
to change which is known to predict lower eating disorder symptoms and reduced 
general psychopathology [Clausen, Lübeck, & Jones, 2013; Dray & Wade, 
2012]).  
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A fourth limitation is that the uncontrolled, rolling length of treatment in 
both treatment programs, which was determined by the clinician, patient and 
family, makes comparisons of the two treatments difficult. While those patients 
who completed day program attended more sessions than those who completed 
FBT, treatment in FBT lasted more than double the number of weeks that day 
program did, and therefore length of time may have impacted the outcomes. Also 
as previously mentioned, contact with the clinician in day program compared with 
FBT was unbalanced in terms of contact hours, and findings should take this into 
account.  
Finally, the current study did not include any longer-term follow up of 
patients after completion of either of the programs. Therefore, while the findings 
suggest that, if patients complete treatment, FBT produces greater improvements 
than day program treatment in the outcomes of expected body weight, 
menstruation, and some measures of psychosocial functioning, follow up of 
patients over the longer-term is needed to determine if these improvements are 
sustained over time. This is of considerable importance given the high rate of 
relapse in AN (Steinhausen, 2002). It is difficult to predict whether day program 
or FBT would result in lower rates of relapse given the limited follow-up studies 
conducted on adolescent day programs. However, there have been a number of 
follow-up studies with adult patients suggesting that gains made through FBT are 
maintained or improved two to six years later (Eisler et al., 1997; Lock et al., 
2010; Lock, Couturier, & Agras, 2006). In contrast, only one day program study 
for adolescents completed a follow-up, where weight gain was found to be 
maintained over six months (Goldstein et al., 2011).  Given the involvement of 
families in FBT and the high level of parental meal supervision compared with 
day program treatment, it is possible that day programs could result in higher rates 
 164 
of relapse compared with FBT. However, research involving longer term follow-
up is needed. 
Summary 
This preliminary study was the first to compare day program treatment and 
FBT in adolescents with AN. The findings suggest that while FBT may lead to 
higher rates of drop-out, if patients can be retained in treatment this treatment 
modality is associated with greater improvements than day program treatment in 
physical restoration and various measures of psychosocial functioning and eating 
disordered cognitions and behaviours. This is despite the fact that it is less 
demanding in its use of healthcare resources. Given the preliminary nature of this 
study, future research should continue to evaluate the effectiveness of outpatient 
treatments for adolescents, including day programs, FBT, and combined versions 
of both, to provide the most effective treatment options for adolescent patients 
with eating disorders.  
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Chapter 7 
Summary and Conclusion 
Chapter Overview 
The overarching aim of the current program of research was to provide 
further clarification of the most effective and acceptable outpatient interventions 
for adolescents with AN (including its subthreshold variants) in a ‘real-world’ 
clinical setting. More specifically, the research program sought to evaluate the 
effectiveness of day program treatment and Family Based Treatment (FBT) for 
adolescents with Anorexia Nervosa (AN), as well investigating the predictors of 
outcome and drop-out from these treatment modalities, and obtaining the 
perspectives of patients, parents, and siblings who have experienced both of these 
treatment approaches. This chapter will begin by providing a summary of the 
current state of research on day program treatment and FBT for adolescents with 
AN, before highlighting the key contributions of the present research program and 
directions for future research. 
Current Field of Research on Treatment for Adolescents with Anorexia 
Nervosa 
Recent decades have witnessed a reduction in inpatient admissions with 
the development of day program treatment for eating disorders. Day programs are 
now commonly used to support patients with AN (Piran, Langdon et al., 1989), 
providing meal support and therapy groups (Zipfel et al., 2002). Outcome data 
from day programs suggest that they are an effective way to treat patients with 
AN (Abbate-Daga et al., 2009; Thornton et al., 2009). Increasing research in the 
area of adolescent based day programs suggests that they are beneficial in 
producing significant weight gain and a reduction in eating disordered 
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symptomology (Girz et al., 2013; Goldstein et al., 2011; Henderson et al., 2014; 
Ornstein et al., 2012).  
As well as day program for adolescents, research suggests that Family 
Based Treatment (FBT) is a well-established, efficacious treatment for 
adolescents with AN (Lock, 2015). FBT is a manualised treatment for adolescent 
AN (Lock & Le Grange, 2013). FBT relies on the family, especially the parents, 
to support their adolescent to recover from AN. Research suggests that FBT is 
currently the most effective treatment for adolescents with AN, particularly for 
weight restoration and behavioural change (Eisler et al., 2000; Le Grange et al., 
2004; Russell et al., 1987). However, research suggests that results for eating 
disordered cognitions are less favourable, with only 40-74% of patients achieving 
a clinical reduction in eating disordered cognitions at treatment completion 
(Couturier et al., 2010; Lock, Couturier, & Agras, 2006; Lock et al., 2010). 
While much has been learned from the growing research base for day 
program treatment and FBT in adolescents with AN, there remain notable 
inconsistencies and gaps within the research. Among these is a need to identify 
the predictors of outcome and treatment retention for both the adolescent day 
program and FBT population. In addition, few studies have compared either day 
program treatment or FBT with other outpatient treatment modalities and none 
have directly compared these two approaches. Moreover, no studies have 
ascertained the perspectives of patients, parents, and siblings who have 
experienced both day program treatment and FBT, and as such are in a unique 
position to offer insight into these interventions. 
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Study 1: The Effectiveness and Predictors of Outcome and Drop-out of a Day 
Program in Adolescents with Anorexia Nervosa 
The first study aimed to contribute to the research on the outcomes and 
predictors of day program treatment for adolescents with eating disorders, despite 
the promising results obtained in previous research (e.g., Girz et al., 2013; 
Goldstein et al., 2011; Henderson et al., 2014; Herpertz-Dahlmann et al., 2014; 
Lazaro et al., 2011; Ornstein et al., 2012 ), the fact remains that the use of 
adolescent day programs to treat eating disorders is still an emerging area and 
further outcome data are needed. Moreover, there is only limited (and conflicting) 
data regarding the predictors of treatment outcome and drop-out from day 
programs for adolescents.  
The results of Study 1 provide further support for the use of day programs 
for adolescents with AN and its subthreshold presentations. Day program 
treatment was successful for physical restoration for most patients, with almost 
80% of patients achieving a weight at or above 85% of EBW at treatment 
completion, and 70% achieving return of menses. The findings around 
psychological change suggested that day program was beneficial for a reduction 
in self-reported core eating disorder cognitions and behaviours, and for general 
psychosocial functioning as assessed by clinicians. The day program also had a 
low drop-out rate which highlights that the vast majority of adolescents can 
tolerate this treatment modality. However, those patients in the day program chose 
to attend this treatment over individual therapy and therefore the low drop-out 
rates may reflect motivation to engage rather than the effectiveness of day 
programs in retaining patients.  
The findings of this study also highlighted the relevance of pre-treatment 
weight and patient age in impacting on outcome, with those who commenced 
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treatment at a higher % of EBW and younger age completing treatment with a 
higher % of EBW. Yet those who commence treatment with a higher % of EBW 
are also more likely to terminate treatment prematurely, suggesting that day 
program treatment should be modified to better engage this at-risk group. For 
example, rather than focusing on weight restoration, day programs could be 
modified to include a separate module focused on healthy eating and weight 
maintenance for those who do not require weight gain. Future research should 
continue to evaluate the factors that impact treatment outcomes and retention rates 
to better target treatment to those who are most at risk of poorer outcomes and 
drop-out. For example, minimal research as been undertaken on the issue of 
motivation to change as a predictor of treatment outcome in adolescents, although 
evidence from the adult literature indicates that greater readiness to change at the 
commencement of treatment generally predicts lower eating disorder symptoms at 
the end of treatment (Dray & Wade, 2012). 
While the findings of this study did indicate the effectiveness of an 
adolescent day program for those with AN, there are some important limitations 
to consider. A relatively small sample size, missing data and a lack of follow up 
indicated that the results need to be interpreted with caution and further 
investigation and replication is needed. Future research to evaluate the 
effectiveness of adolescent day programs in comparison to other outpatient 
treatment approaches would be especially beneficial.  
Study 2: The Effectiveness and Predictors of Outcome and Drop-out of 
Family Based Treatment in Adolescents with Anorexia Nervosa   
Although there have been a number of research trials evaluating FBT, 
Study 2 aimed to provide further investigation of adolescent outcomes from a 
‘real world’ treatment site, and where the full three phases of the manualised FBT, 
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with no limit on the number of sessions, were completed. The study also aimed to 
further evaluate rates of cognitive change in this population (given that the rates 
of cognitive change have not been as successful as those for weight restoration 
from FBT). This is particularly important in light of treatment being extended 
depending on clinical need, which may provide the necessary treatment dose to 
effect cognitive change. Finally, Study 2 sought to add clarification to the factors 
that predict outcome and drop-out.  
The results of Study 2 suggest that completion of all three phases of FBT 
leads to improvements for adolescents with AN in terms of weight restoration, 
return of menstruation, core eating disorder cognitions and behaviours, and 
general psychosocial functioning. The study also found that commencing FBT at 
a higher % of EBW and experiencing a lower severity of eating disordered 
cognitions and behaviours, as well as attending more FBT sessions, predicted a 
greater % of EBW at termination of FBT. Combined, these results suggest that 
alternative treatments to FBT (e.g., inpatient admission) or adaptations of FBT 
(e.g., day programs or family admissions) may be needed for patients who are 
more severely compromised in terms of their weight and eating disordered 
cognitions and behaviours, as well indicating that longer retention of patients in 
FBT is associated with an improved outcome. Further research should focus on 
reviewing if more sessions, or even an unlimited treatment length, leads to 
improved physical restoration and cognitive change.  
In terms of retaining patients in FBT, the results indicated that greater 
severity of eating disordered cognitions and behaviours and higher % of EBW at 
commencement of FBT increase the likelihood of terminating treatment 
prematurely. Suggestions for potentially increasing the retention of these at-risk 
patients could include the addition of individual or group therapy alongside FBT, 
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thereby reducing the focus on weight in phase one and instead targeting 
psychological change including reducing eating disordered cognitions and 
behaviours in the adolescent.  
It is important to note that Study 2 included a number of limitations which 
have a bearing on the interpretation of the results, such as an uncontrolled 
treatment length, relatively small sample size, missing data on self-report outcome 
measures, and a lack of follow up. In addition, the sample included a small 
number of patients who prior to commencing FBT, had been hospitalised for 
medical stability. Although this hospitalisation was not for weight restoration, the 
impact of prior admission on treatment outcome and drop-out in FBT requires 
further investigation. Furthermore, the study did not include a treatment 
comparison group; investigating the effectiveness of FBT compared with other 
outpatient treatments such as day program treatment would be especially useful in 
this regard.  
Study 3: The Effectiveness of a Day Program Compared with Family Based 
Treatment for Adolescents with Anorexia Nervosa  
Accordingly, given that a key deficiency in the literature is that there have 
been no clinical trials comparing the effectiveness of FBT with day programs for 
AN, the aim of Study 3 was to compare the effectiveness of manualised FBT and 
day program treatment for adolescents with AN. The generally positive outcomes 
obtained in Study 1 and 2 for day program treatment and FBT, respectively, 
indicate that it is timely for these two efficacious interventions to be directly 
compared. 
The findings of Study 2 suggest that FBT results in higher drop-out rates 
than day program treatment, and that day program treatment resulted in greater 
treatment length. When treatment drop-outs were included in the analyses, there 
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were no significant differences between day program treatment and FBT in terms 
of weight gain, return of menses, and clinician-rated levels of psychosocial 
functioning. In contrast, when drop-outs were excluded, FBT was associated with 
greater improvements than day program treatment in physical restoration for both 
weight and menstruation at the end of treatment. FBT was also superior to the day 
program for improving self-rated general psychological functioning and, 
marginally (p < .06), for eating disordered cognitions and behaviours. These more 
positive outcomes for FBT compared with day program treatment for those who 
complete treatment, together with the significantly higher rate of drop-out from 
FBT, indicate that identifying strategies for retaining patients in FBT is a high 
research priority. Given that patients and parents report wanting individual 
therapy in addition to FBT (Krautter & Lock, 2004), future research should 
evaluate the effectiveness of adding individual therapy in phase three of FBT in 
terms of improving retention rates. 
There are several important limitations of this study that must be 
acknowledged in interpreting the results (including small sample size, missing 
data, and the fact that it was not a randomised controlled trial) and these factors 
may have influenced treatment outcome and retention rates. In addition, both 
treatments included uncontrolled treatment length which may have impacted 
outcomes, and no follow up of patients was completed. Given the preliminary 
nature of this study, future research should continue to evaluate the effectiveness 
of outpatient treatments for adolescents, including day programs, FBT, and 
combined versions of both, to provide the most effective treatment options for 
adolescent patients with eating disorders.  
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Conclusion 
AN has one of the highest mortality rates of all psychiatric illnesses 
(Harris & Barraclough, 1998; Hoek, 2006), a finding that underscores the need to 
prioritise research investigating the most effective treatments for adolescents with 
AN. Taking into account the limitations of the studies, the results of the current 
program of research suggest that both day program and FBT are effective and 
acceptable treatments for adolescents with AN. The research provides support for 
both adolescent day programs and FBT in terms of producing physical restoration, 
an improvement in core eating disorder cognitions and behaviours, and general 
psychosocial functioning, even in a ‘real world’ clinical setting.  
The present findings also highlight the need to continue to evaluate the 
predictors of outcome and drop-out from both day program treatment and FBT 
with the aim of targeting treatment to those where it will be the most beneficial 
and potentially modifying these treatment modalities to improve outcomes and 
retention. In this regard, the current results suggest that patients with a lower 
weight at pre-treatment are at risk of a poorer outcome from both day program 
treatment and FBT, but that those with a higher weight at pre-treatment are at risk 
of prematurely terminating both treatments. Therefore future research needs to 
consider adaptations to the treatments, such as targeted individual therapy in 
addition to the program or combining FBT and day program, to better support 
these high risk patients and increase retention rates.  
In a direct comparison of day program treatment and FBT, the findings 
suggest that these interventions are comparable if drop-outs are included, with 
drop-out rates significantly higher in FBT compared with day program treatment. 
However, for patients who complete the full course of treatment, the results 
suggest that FBT is associated with greater improvements in physical restoration, 
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general psychological functioning, and eating disordered cognitions and 
behaviours relative to day program treatment. Study 4 (in Appendix A) suggests 
that reviewing the patient and family perspectives of both treatments also 
highlights that both FBT and day program treatment are generally acceptable 
interventions, with positive (and some negative) features, and that families feel 
that the two treatments may be complementary. Overall, the results of the current 
research program suggest that future research should focus on continuing to 
compare and combine day program treatment and FBT, and evaluate variants of 
both in order to maximise the effectiveness and acceptability of these treatment 
modalities for adolescents with AN and their families.  
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Study 4: A Qualitative Investigation of Day Program and Family Based 
Treatment in Anorexia Nervosa: Patient, Parent, and Sibling Perspectives 
Anorexia nervosa (AN) is characterised by self-induced weight loss 
(achieved by extreme weight control behaviours), a fear of weight gain, and a 
disturbance in the perception of one’s body image (APA, 2013). It is also one of 
the most serious and chronic illnesses to affect adolescents (Beumont & Touyz, 
2003). Despite the fact that AN has one of the highest mortality rates of all 
psychiatric illnesses (Harris & Barraclough, 1998; Hoek, 2006), treatment is often 
not sought (Hudson et al., 2007), and there are currently high drop-out rates in 
treatment (Mahon, 2000; Pike, 1998). These factors highlight the importance of 
understanding the patient and family perspective of treatment, with the aim of 
refining these treatments to optimally meet patient and family needs.  
Day programs are now commonly used to support patients with AN 
(Piran, Kaplan et al., 1989), providing meal support and therapy groups (Zipfel et 
al., 2002). Outcome data from day programs suggest that they are an effective 
way to treat adolescent patients with AN (Girz et al., 2013; Goldstein et al, 2011; 
Grewel et al., 2014; Henderson et al., 2014; Herpertz-Dahlmann et al., 2014; 
Hoste, 2015; Lazaro et al., 2011; Ngo & Isserlin, 2014; Stevens, 2010; Stewart & 
Williamson, 2004a).  Despite many studies reviewing the efficacy, cost 
effectiveness, and content of day programs (e.g., Abbate-Daga et al., 2009), there 
has been little research into the patient and/or family experience and acceptability 
of day programs. This lack of research is exacerbated in the adolescent population 
where day programs for eating disorders are an emerging area.  
There is currently a lack of research evaluating the overall experience of 
adolescent patients and parents after participating in day program treatment for 
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AN. The few studies that have been published often present the overall experience 
of attending a treatment service, which may include multiple treatment modalities, 
as well as the day program component (Clinton, Almlof, Lindstrom, Manneberg, 
& Vestin, 2014; Federici & Kaplan, 2008). This makes interpretation related to 
day programs difficult, however the results do suggest that patients find day 
program treatment helpful due to social support including support from staff and 
other patients, and learning to tolerate negative emotions. Thus more 
comprehensive and specific qualitative investigation concerning the parent, 
adolescent and family perspective relating to the experience of day program 
treatment is needed. 
More generally research reviewing the patient and parent experience has 
involved those participating in all treatment types, including inpatient and 
outpatient treatment, rather than after receiving a specific treatment modality. 
Results of these studies suggest that while parents are generally satisfied with 
treatment, adolescents have often reported negative perceptions of the need to 
attend treatment, perhaps due to the illness. Adolescents also reported that family 
involvement and therapist expertise in the area were important aspects of 
treatment (Bezance & Holliday, 2013; Clinton et al., 2014; Federici & Kaplan, 
2008; Halvorsen & Heyerdahl, 2007; Roots, Rowlands, & Gowers, 2009; 
Westwood & Kendal, 2012).  
Another evidence based treatment for adolescents with AN is Family 
Based Treatment (FBT). It is a well-established, efficacious treatment for 
adolescents with AN (Lock, 2015). FBT is a manualised treatment for adolescent 
AN (Lock & Le Grange, 2013) that relies on the family, especially the parents, to 
support their adolescent with AN back to full health. While there have been many 
studies evaluating the effectiveness of FBT, there are few qualitative studies 
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investigating patient and family member experiences of this treatment modality, a 
limitation that has been previously noted (Strober, 2014).  
One of the few qualitative studies reviewing the family experience of FBT 
was conducted by Krautter and Lock (2004). They reviewed the patient and 
parents’ experience once FBT was completed, and found that the majority of 
patients and parents described FBT as being an effective treatment in terms of 
leading to recovery from AN. Parents and patients described a number of factors 
which they considered to be the most helpful components of treatment, including 
the family spending time together, the re-feeding process, learning to separate the 
illness from the child, and building therapeutic rapport. When asking what they 
disliked about treatment, some parents and adolescents reported that there was 
nothing unhelpful about FBT, while others reported feeling that treatment was too 
short, focused exclusively on AN, lacked individual therapy, and that sibling 
involvement was unnecessary. Despite these factors, 84% of parents and patients 
combined, said they would recommend FBT to other people. Mothers had the 
most favourable perceptions towards FBT, with 94% suggesting that they would 
recommend FBT to another family, whereas 84% of fathers and 72% of 
adolescents would recommend FBT. Families also perceived a change in 
relationship dynamics between all family members after treatment, with 70% 
believing this change was positive.  
Subsequent research has supported these results regarding the generally 
high acceptability of FBT for adolescents with eating disorders (Paulson-
Karlsson, Nevonen, & Engström, 2006; Rhodes, Brown, & Madden, 2009; 
Zaitsoff, Doyle, Hoste, & Le Grange, 2008). The addition of attending a parent-
to-parent consultation as part of FBT was also viewed as a positive experience by 
parents, where they felt less isolated and more empowered (Rhodes et al., 2009). 
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However, these favourable results need to be interpreted with caution as often 
only those who have successfully completed treatment are willing to complete 
feedback forms, potentially biasing the results towards those who perceived the 
treatment in a favourable light. For instance, in the Krautter and Lock (2004) 
study, the sample only included 74% of families who had successfully completed 
the full course of treatment, and in addition another 12% of families who dropped 
out of treatment did not participate in the qualitative study.  
Another limitation is that many of these studies failed to consider the 
experience of siblings. While parents stated that they found sibling involvement to 
be unnecessary (Krautter & Lock 2004), adolescents in other studies have 
indicated that they would have preferred more sibling involvement in treatment, 
acknowledged that the illness marginalised their siblings (Lindstedt et al., 2015), 
and siblings have reported being provided with more knowledge as a positive 
(Withers et al., 2014). While the experience of the sibling in the caring role has 
been explored by other studies (e.g., Dimitropoulos, Klopfer, Lazar, & Schacter, 
2009), currently, there has been limited research into the sibling’s perspective of 
different treatment modalities and how these different treatments impact on 
siblings. One study has reviewed the sibling experience in FBT and found that 
siblings described it as a positive experience due to feeling engaged in treatment 
and improving connections within the family unit (Withers et al., 2014). Further 
investigation into how siblings perceive different treatments such as day program 
and FBT is required to gain a wider understanding of the family experience of 
treatment for AN in adolescents.  
It is also important to note, that despite the promising results of FBT 
shown in randomised controlled trials and the acceptability studies, 51% of 
participants in the Krautter and Lock (2004) study felt that they needed to have 
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more treatment once they had completed the 20 sessions of FBT. Results of other 
studies also suggest that for adolescents, FBT may not be considered an optimal 
dose or type of treatment. For example, adolescents have reported that they prefer 
individual sessions in addition to the family sessions (Lindstedt et al., 2015; 
Clinton et al., 2014; Halvorsen & Heyerdahl, 2007; Roots et al., 2009). More 
recently Lindstedt et al., (2015) reviewed the adolescent experience of receiving 
individual therapy and/or FBT for AN. Their results indicated that adolescents 
often felt forced into treatment and forced into including their families in the 
treatment. Nevertheless, they reported that parental involvement was a positive 
aspect of treatment that encouraged recovery outside of the treatment setting.  
Despite the limited number of qualitative investigations into the family 
experience of FBT, there have been a number of parents who have published their 
own story. For example, Parent and Parent (2008) present their daughter’s story of 
recovery using FBT, as a case study for other families and health professionals to 
gain a better insight into the family perspective of FBT. They described FBT as an 
effective, intensive, short term treatment for AN and highlighted positives such as 
enhanced parental control, physical recovery through re-feeding, improvements in 
the family dynamics, and a return to normal adolescent development for their 
daughter, with these improvements sustained in the 12 months after treatment 
completion. While promising, clearly further research is needed to harness 
broader views of the family and patient experience of FBT. 
In summary, to date there has been a lack of qualitative research into the 
family experience of having an adolescent with AN participate in day program 
treatment. Only a few studies have investigated the adolescent and parent 
experience of FBT, however these studies have failed to examine the sibling 
perspective. Importantly, no previous study has compared the experiences of 
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patients and family members who have taken part in both day program treatment 
and FBT. Research suggests that understanding the acceptability of treatment for 
patients with eating disorders and their families is just as important as reviewing 
the effectiveness of these treatments (Newton, 2001).  
Aims of the Present Study 
Further investigation into how all family members including the patient, 
parents, and siblings, perceive participating in the different treatment modalities 
of day program treatment and FBT is required to gain a broader understanding of 
the family experience of treatment for AN in adolescents. The aim of the current 
study is to therefore investigate how adolescents, their parents, and siblings who 
have experienced both day program treatment and FBT, perceived their treatment 
experiences.  
Method 
Participants  
Participants were three families recruited from the Canberra Eating 
Disorders Program (EDP), which is a public outpatient eating disorders unit. Two 
of the adolescents were aged 16 years and met DSM-IV-TR (APA, 2000) criteria 
for a diagnosis of AN restricting subtype, and the other adolescent was aged 17 
years and met DSM-IV-TR criteria for a diagnosis of AN bingeing/purging 
subtype. All three adolescents were female and from intact families. The three 
adolescents initially engaged in the adolescent day program. After a period of 
recovery, all three adolescents relapsed and engaged in FBT as day program 
treatment for adolescents was no longer offered at the service. They therefore 
have a unique perspective of having participated in both day program treatment 
and FBT. The study was undertaken at the time of completion of FBT, at which 
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point all three adolescents had experienced a return of menstruation, and were 
weight restored to at least 95% of expected body weight.  
In addition to the three patients, all family members participated in the 
study including six parents (mother and father of each adolescent) and four 
siblings (two brothers for one adolescent, two brothers for another adolescent, and 
the third adolescent was an only child). The study received ethical approval from 
both the ACT Health and the Australian National University Human Research 
Ethics Committees (see Appendix B). 
Measures and Procedure 
At the completion of FBT, the adolescent with AN and their family 
members were invited to complete a questionnaire concerning their experiences of 
treatment. The questionnaire was designed to capture the adolescent, parent, and 
sibling perspectives of each treatment and their overall experience. More 
specifically, items assessed the positive and negative aspects of day program, the 
positive and negative aspects of FBT, the similarities and differences of each 
treatment, and advice they would provide to others after their experiences (see 
Appendix D for the full questionnaire and consent forms). Participants were asked 
to include their role (patient, parent or sibling) but remained anonymous to allow 
for greater honesty about their experiences.  
Results 
The Experience of Participating in Day Program Treatment 
The participants identified a range of positive aspects relating to day 
program attendance. Mothers, fathers, and siblings felt that the most important 
benefit of day program treatment was having others care for the adolescent with 
AN. They all reported that they felt a sense of support from having professionals 
involved, especially in relation to focusing on challenging feared foods. Parents in 
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particular highlighted a sense of relief while their child was engaged in day 
program treatment:  
Mother: It took some of the pressure off us having to deal with re-feeding.  
Father: It was a break from constantly having to monitor her.  
In contrast, patients described the primary advantage of day program 
treatment as affording the opportunity to meet other patients with AN. They 
reported this as being beneficial because they felt connected with the other 
patients (helping them to feel more understood and less isolated) and it also 
highlighted a desire to change as they confronted the severity of illness 
experienced by other patients with AN:  
Patient: People going through similar things…that you’re not alone.  
Patient: Seeing sufferers and not wanting to be like that.  
Despite minimising a sense of isolation being a valued aspect of day 
patient treatment, in other ways this modality was also reported to increase a sense 
of isolation due to the time commitment entailed. This disadvantage was noted by 
the patients, parents, and siblings alike. All participants reported that day program 
attendance resulted in isolation from peers, and difficulty with attending school 
and completing required school work. The patients and their siblings also 
described feeling that day program treatment led to the patient being isolated from 
the family unit:  
Patient: Day program seemed to ‘cut off’ the family.  
Sibling: We didn’t have as much of an insight into how she was taking it.  
In addition, parents and patients described the negative effects of 
interacting with other patients (in addition to the positive effects noted by patients 
as stated previously), in terms of potentially exacerbating eating disorder 
symptoms: 
 221 
Patient: I also felt it wasn’t really helpful for me to be surrounded by other 
sufferers at some points…hate to say it but anorexics are competitive!  
Mother: In touch with other clients therefore reinforcing negative attitudes. 
The Experience of Participating in FBT   
All family members reported that participating in FBT led to everyone 
feeling connected and included. The patients, parents, and siblings also indicated 
that during FBT they felt they had clearly defined roles and were able to unite to 
fight against AN, rather than fighting the patient: 
Patient: Becoming closer with my family, knowing they were always there to 
support me and they began to understand what was me and what was the 
disorder.  
Sibling: We had much more of a say and an insight into her experience.  
Mother: Everyone knew where we were up to and could help and encourage.  
Father: The inclusive nature of the discussions that involved the siblings also. It 
also provided an avenue for her [the patient] to raise issues with us in a 
controlled supportive environment.  
The main negative aspect of FBT, which was reported by all family 
members, was the cost of attending therapy for other family members. This cost 
included the time away from work and school, but also the extra pressure that 
targeting AN placed on family members and their relationships with one another: 
Patient: It meant that the battle with AN became family versus AN 24/7 because 
the parents had to take the initiative with the eating as well as helping to stamp 
out or correct other habits. 
Sibling: It led to some fights and disagreements which caused some tension at 
home.  
Mother: Hard to get all of the family to attend the meetings. 
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Father: The impact on schedules and activities for other family members, a small 
price to pay.  
Comparing the Experience of Day Program and FBT   
When asked to compare the two treatments, a number of common themes 
emerged. All family members agreed that both treatments challenged the eating 
disorder (particularly with exposure to feared foods) and families felt supported 
by the treating clinicians: 
Mother: Both involved seeing a therapist and setting goals around food and other 
eating disordered behaviours.  
Father: Similarities: professional support.  
All family members, particularly the patients and the siblings, reported 
that they found FBT to be more inclusive and supportive of ‘real world’ recovery 
relative to day program treatment: 
Patient: FBT and day program both involved food challenges and goal setting but 
to me FBT seems to better reflect reality as you set goals with family and friends 
that can be carried out in real life and so you don’t feel as scared of going out 
into the real world as you do when you leave the day program. It’s also nice not 
having a rigid meal plan that you get stuck in and can’t go outside of. 
Sibling: The day program is based solely on the patient, while the FBT focused a 
lot on the family and their opinion of the disorder.  
Mother: The day program was unrealistic in that parents/carers were not 
involved in the goal setting and so couldn’t help the sufferer see goals through. 
Also the meal plan is restrictive and rigid. FBT involves everyone in goal setting 
so they are more likely to be achieved and eating is aimed more at being like the 
rest of the family (eventually) and variety. 
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Father: Initially the day program provided a lifeline… but this system should be 
carefully weaned off quite soon to follow a more flexible approach (realistic) like 
the FBT program.  
This latter comment indicated a role for each of the treatment modalities. 
Indeed, all family members reported that they would recommend both treatments 
to families in the same situation, and found participating in both treatments 
beneficial. Parents and siblings highlighted the need to seek professional help, 
engage in treatment, and continue even when the process is difficult: 
Sibling: Don’t give up, if you stick to it, it’ll get better in time. 
Father: Not to let the condition dictate to the family. Set goals, an inch at a time 
initially. You may have to be cruel because if the family doesn’t stick together the 
condition will playoff one member against another. Be weak, you lose. Stand firm, 
you win, eventually!  
Although the families reported a combination of both treatments to be 
beneficial, mothers, siblings, and patients said they would recommend FBT to 
other families over and above day program, due to the inclusive nature of FBT. 
Adolescent: I know that I could not have come this far without my family because 
when I could no longer fight, they fought for me.  
Mother: FBT has worked well for us. It’s hard work, but set the goals and take on 
the battles. The whole family being on the same wave length is really important.  
Sibling: To do family based therapy, as it means that whole family has an opinion, 
the whole family gains knowledge on the disorder, and the disorder seemed to 
disappear faster. 
Discussion 
The current study sought to examine the patient, parental, and sibling 
perspectives of completing day program treatment and FBT for adolescents with 
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AN. The qualitative analysis of the three families’ responses indicated that overall 
each family member considered both treatment modalities to be beneficial in 
unique and overlapping ways, with most reporting wanting a combination of both 
treatments. In addition, there were also components of each treatment that the 
families felt could be improved.  
Findings of the Present Study 
More specifically, one of the positive aspects of both day program 
treatment and FBT reported by parents and siblings was a feeling of support from 
health professionals. This is unsurprising given that therapist expertise in the area 
has previously been reported as an important factor in treatment acceptability 
(Clinton et al., 2014; Federici & Kaplan, 2009; Halvorsen & Heyerdahl, 2007; 
Roots et al., 2009).  
Parents and siblings also highlighted meal supervision and the challenging 
of feared foods as useful components of both day program treatment and FBT. 
These factors are considered essential elements for recovery from AN 
(Hildebrandt et al., 2010), and were clearly viewed by family members as 
important steps towards recovery. Meal supervision and exposure to feared foods 
during day program treatment may also have been viewed as a positive as it may 
have reduced the number of meal conflicts at home.  
In contrast to parents and siblings, patients did not report the challenging 
of feared foods as a positive component of day program treatment, perhaps due to 
it being among the most challenging aspects of the program and one which they 
were required to do without family support but in the presence of others 
struggling with the same issue. Indeed, the negative aspects of undertaking 
treatment with others experiencing AN was noted by the patients and parents 
given the competitive and perfectionistic nature of those with AN and the 
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susceptibility of adolescents to peer influences (Beumont, & Touyz, 2003; 
Gardner & Steinberg, 2005; Hartmann et al., 2014). The impact of other patients’ 
illness behaviours has not been described in other qualitative research (e.g., 
Federici & Kaplan, 2009) but this may simply reflect a lack of research on the 
patient experience of group-based programs. 
This is not to suggest that connecting with other sufferers was without its 
positive aspects, with the patients reporting that meeting other patients with AN 
was a key positive feature of day program treatment. They reported this as being 
beneficial because they felt connected with the other patients and it also 
highlighted a desire to change. This appears to be a common experience in day 
programs. For example, Federici and Kaplan (2009) found that patients in their 
day program reported that meeting other people in the same situation allowed 
them to be open and share their experience of the illness.  
While patients, parents, and siblings listed noteworthy advantages of day 
program treatment, they also described a range of negative aspects. In addition to 
the potential negative influence of others with AN, all family members reported 
that day program treatment led to a sense of isolation for family members. They 
indicated that day program participation resulted in the patient being isolated from 
peers and the family unit, reduced attendance at school, and reduced time to 
complete school work. While one of the reported advantages of day programs 
compared with inpatient admissions is to allow for less disruption in psychosocial 
functioning (Zipfel et al., 2002), it appears that patients and their families do not 
feel this advantage when compared with other outpatient treatment options. 
Siblings also highlighted that they felt isolated from their sister’s treatment at the 
day program and this created a sense of disconnection within the family. These 
findings concur with previous results indicating that patients believed AN 
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marginalised their siblings (Lindstedt et al., 2015), and parents have reported 
requesting additional information sessions for siblings (Goodier et al., 2013). The 
current results would indicate that the family members can feel disconnected from 
each other during day patient programs, and this is particularly so for siblings.  
In contrast, family connection was a notable advantage of FBT. Patients, 
parents, and siblings all described that during FBT they felt connected, that 
treatment was inclusive, and that each family member had a clearly defined role in 
overcoming AN. These results are consistent with previous research on patient, 
parent, and sibling satisfaction after completion of FBT, where positives of 
treatment are reported as spending more time together and an improvement in 
family dynamics (Krautter & Lock, 2004; Paulson-Karlsson et al., 2006; Withers 
et al., 2014). However, these results may not be unique to FBT, and may be a 
consequence of having a family member with AN, rather than a direct result of 
treatment. Prior research has found that siblings report a closer family unit as a 
result of having a sibling living with AN (Dimitropoulos et al., 2009). 
Nevertheless, since these observations were not made in relation to day program 
treatment in the current study, it is possible that FBT is particularly beneficial for 
family cohesion. 
As with day program treatment, the advantages of FBT could also be 
disadvantageous. That is, although the inclusion of family members in FBT was 
highlighted as a key benefit, an identified negative feature of FBT was the extra 
input that was required from families, including time away from work and school, 
and pressure on relationships from re-feeding. These results are in contrast to 
other studies which have suggested complete patient and parent satisfaction with 
FBT as a treatment modality, with some parents unable to report any negative 
aspects associated with FBT (Krautter & Lock, 2004; Paulson-Karlsson et al., 
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2006). These results may reflect the fact that the current study directly asked for 
negatives associated with each treatment. Interestingly, despite sibling 
involvement being suggested as unnecessary by some parents (Krautter & Lock, 
2004), in the current study this was not mentioned and siblings reported their 
attendance as a positive factor in FBT.   
While an identified disadvantage of FBT, any burden stemming from 
family involvement was explicitly noted by one participant as being worth it 
given the beneficial impact of FBT on AN symptoms and family connectedness. 
In past research siblings also highlighted difficulties with family members 
becoming angry after sessions, difficulties at meal times, and pressure to fulfil the 
supportive sibling role (Withers et al., 2014). These problems with FBT were not 
suggested by the siblings in the current study and may reflect the siblings’ 
previous treatment experience of day program, or may reflect that siblings felt 
positive about FBT due to the adolescent recovering from AN. Indeed, the 
patients, parents, and siblings described FBT as being a more inclusive treatment 
compared with day program treatment. Mothers, siblings, and patients reported 
that they would recommend FBT over day program treatment, due to its inclusive 
nature (while acknowledging that both treatments were beneficial and that they 
would recommend both to others). The results of the current study highlight the 
importance of considering sibling perspectives in treatment and suggest that 
siblings want to be included in treatment, that patients and parents feel that sibling 
attendance is important, and that this further strengthens the family unit. 
Furthermore, all family members reported that the involvement of family 
members in FBT was more encouraging of ‘real world’ recovery compared with 
day program attendance. This finding is consistent with the results of Lindstedt et 
al., (2015) where adolescents reported that FBT encouraged recovery outside of 
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session. Likewise, Federici and Kaplan (2009) found that day program 
participants reported that they felt treatment did not sufficiently prepare them for 
discharge or the difficulties of recovery outside of the program.   
Clinical Implications  
The results of the current study indicate that family members, including 
patients, parents, and siblings alike, found positive aspects in both FBT and day 
program treatments for adolescents with AN and would recommend both 
treatments to other people. While FBT is currently recommended as a first line 
treatment when the evidence indicates it (for those who are under 19 years of age, 
with an illness duration of less than 3 years, and for those families with low levels 
of expressed negative emotion; Eisler et al., 2007; Russell et al., 1987; Strober, 
2014), for those who do have high levels of expressed negative emotion in the 
family or do not successfully gain weight in the early stages of FBT (Doyle et al., 
2010; Eisler et al., 2000), other options are necessary, such as day program 
treatment.  
While research typically evaluates treatments against one another, the 
families in the current study highlighted that FBT and day program treatment may 
be complementary treatments in terms of their respective advantages. Specifically, 
day program was reported to be positive due to creating exposure to feared foods, 
providing support in the form of a shared experience with other adolescents with 
AN, and offering professional support. FBT was described as positive because it 
provided an inclusive treatment for the entire family, as well as offering exposure 
to fear foods and professional support. A few studies (Girz et al., 2013; 
Henderson et al., 2014) have now combined the two treatments and have reviewed 
outcome data relating to FBT-based day programs for adolescents. In addition, 
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future research needs to focus on examining the adolescent, parent and sibling 
experience of FBT-based day programs.  
Limitations of the Present Study and Directions for Future Research  
While the key findings of this qualitative study emphasise the importance 
of including siblings in treatment, and that families find both FBT and day 
program treatments acceptable for a range of different reasons, there are some 
important limitations to consider. Firstly, the small sample size makes 
generalisations and comparisons with other studies difficult. For instance, each of 
the patients in the present study had initial positive outcomes from day program 
treatment and FBT. Thus of interest would be also gaining the perspectives of 
patients who experience poor outcomes or drop-out of treatment. 
Another limitation was that the participants were provided with specific 
questions to answer in written format. While this was done so that participants 
could remain anonymous and therefore encourage honest responding, it precluded 
the possibility of asking follow-up questions to obtain more detailed responses. 
To improve on the current study, future research should include a larger sample 
with patients, parents, and sibling’s perspectives being explored through a 
structured or semi-structured interview.  
Another noteworthy limitation is that the families in the current study all 
successfully completed FBT whereas they had relapsed following day program 
treatment. This difference in treatment outcomes, combined with the period of 
time since day program attendance, may have made participants view FBT in a 
more favourable light. Thus the comparisons between day program treatment and 
FBT must be interpreted with a high degree of caution. 
The current study presented the adolescent, parent, and sibling 
perspectives of participating in FBT and day program treatments for AN, and 
 230 
future research would benefit from continuing to review the qualitative experience 
and acceptability of other outpatient based treatments for adolescents. In 
particular, research should focus on comparing and reviewing the adolescent, 
parent, and sibling experiences of standard FBT compared with FBT-based day 
programs. 
Summary 
The current study emphasised the importance of reviewing the family 
perspective of day program treatment and FBT for adolescents with AN in order 
to optimise these treatment modalities. The families in the current study 
highlighted that FBT and day program treatment were generally acceptable 
treatments with both positive and negative features. Their unique, but 
complementary strengths, in terms of support from other adolescents with AN in 
day program treatment and from family members in FBT, suggests that 
combining these modalities is a fruitful line for further research.  
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Dear Ms Lisa McLeod, 
 
Protocol: 2014/170 
Day Program and Family Based Therapy in the treatment of Anorexia  Nervosa  
in adolescents 
 
I am pleased to advise you that your Human Ethics application received  
approval by the Chair of the Science & Medical DERC on 1 July 2014. 
 
For your information: 
1.  Under the NHMRC/AVCC National Statement on Ethical Conduct in Human  
Research we are required to follow up research that we have approved.  
Once a year (or sooner for short projects) we shall request a brief report  
on any ethical issues which may have arisen during your research or  
whether it proceeded according to the plan outlined in the above protocol. 
 
2. Please notify the committee of any changes to your protocol in the  
course of your research, and when you complete or cease working on the  
project. 
 
3. Please notify the Committee immediately if any unforeseen events occur  
that might affect continued ethical acceptability of the research work. 
 
4. Please advise the HREC if you receive any complaints about the research  
work. 
 
5. The validity of the current approval is five years' maximum from the  
date shown approved.  For longer projects you are required to seek renewed  
approval from the Committee. 
 
All the best with your research, 
 
Kim 
Ms Kim Tiffen 
Human Ethics Manager 
Research Ethics, Research Services, 
Ground Floor, Chancelry 10B 
Ellery Crescent, 
The Australian National University 
ACTON ACT 0200 
T: +61 6125 3427 F: +61 2 6125 4807 
Kim.Tiffen@anu.edu.au or 
human.ethics.officer@anu.edu.au 
 
http://researchservices.anu.edu.au/ori/human/index.php 
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Eating Disorders Program 
Phillip Heath Centre, Cnr Keltie & Corinna Sts, WODEN, ACT 2606 
Phone: 6205 1519 
 
Information for Consumers/Parents/Guardians 
 
Dear Consumer/Parent/Guardian,  
 
The Eating Disorders Program (EDP) strives to ensure that the treatment 
strategies undertaken are evidence-based and the most appropriate for your 
situation.  
To assist with maintaining the above we are seeking your permission to use your 
data/child’s data in research to evaluate our treatment programs. The information 
will be gathered as part of routine clinical administration and will not impact on 
the treatment provided to you/your child. The information will be used for 
research purposes only is generalised in nature and may include information such 
as height and weight, number of treatment sessions attended and the type of 
treatment (e.g. individual or group based). All information will be de-identified. 
This information has already been gathered as part of routine clinical practice and 
we are looking to analyse this information to ensure that the treatment we provide 
is of the highest standard and is consistent with other specialist eating disorder 
services.  
As mentioned above this information has already been gathered so if you wish to 
participate in the research you/ your child do not need to do anything. If you do 
not wish to have your/ your child’s de identified information used in the research 
then please complete the section on the consent form and return it to EDP.  
 
Should you have any comments or questions regarding this research you can 
contact the staff at EDP on (02) 62051519 or you may contact ACT Health 
Human Research Ethics Committee on 02 6205 0846, acthealth-hrec.act.gov.au or 
at Building 10, Level 6 Canberra Hospital.   
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Eating Disorders Program 
Phillip Heath Centre, Cnr Keltie & Corinna Sts, WODEN, ACT 2606 
Phone: 6205 1519 
 
Consent Form 
Dear Parent/Guardian/Consumer,  
The Eating Disorders Program (EDP) strives to ensure that the treatment 
strategies undertaken are evidence-based and the most appropriate for your 
situation. We are seeking your permission to use your child’s data or your data  in 
research to evaluate our treatment programs. Please read the information sheet for 
more information on this research.  
The information will be gathered as part of routine clinical administration (e.g. 
height, weight, number of appointments attended) and will not impact on the 
treatment provided to you or your child. All information will be de-identified.  
Your/your child’s participation is voluntary and you are free to withdraw at any 
time, without giving reason. The de-identified information for the research will be 
stored securely in locked filing cabinets which only the staff will have access to 
and the data will also be stored on a computer with password only access.  
Should you have any comments or questions regarding this research you can 
contact the staff at EDP on (02) 62051519 or you may contact ACT Health 
Human Research Ethics Committee on 02 6205 0846, acthealth-hrec.act.gov.au.   
If you agree to your child’s data being used in this research, you do not need to do 
anything.  
If you do not wish for your child’s data to be used in this study, please complete 
the form below and return it to EDP by.............. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
- - - - - - - - - - - - - - - - - -  
PLEASE NOTE:  
Please only complete this form if you do not want your child’s data to be used in 
this study. 
If you agree to your/your child’s data being used for this research you do not need 
to do anything.   
I, ____________________________, (name) do not give consent for my data or 
my child’s data (Child’s name __________) to be used for research purposes by 
the staff at the Eating Disorders Program.  
Signature: ____________________________   Date: ________________ 
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Eating Disorders Program 
Phillip Heath Centre,  Cnr Keltie & Corinna Sts, WODEN, 
ACT 2606 
Phone: 6205 1519 
Consent Form 
Dear Parent/Guardian,  
The Eating Disorders Program (EDP) strives to ensure that the treatment strategies 
undertaken are evidence-based and the most appropriate for your situation.  
To assist with maintaining the above we are seeking your permission to use your child’s 
data in research. The information will be gathered as part of routine clinical 
administration and will not impact on the treatment provided to your child. The 
information will be used for research purposes only is generalised in nature and may 
include information such as height and weight, number of treatment sessions and the type 
of treatment. It will also include you and your family completing a short questionnaire of 
your experiences of the Day Program and of Family Based Therapy at EDP. All 
information will be de-identified.  
I give consent for my child’s ........................... (name) de-identified information to be 
used as a case study in the research.                         
I acknowledge that: 
1) I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving reason.  
2) I understand that not providing consent or withdrawing will not have an impact 
on my child’s treatment at EDP.  
3) My child’s de-identified information will be used for research purposes only and 
may be used in this research or future studies.   
4) I agree to the use of anonymised quotes in publications.   
5) The information that I provide and that my child provides will be stored securely 
in locked filing cabinets (after it has been anonymised), which only the staff will 
have access to and the data will also be stored on a computer with password only 
access.  
I understand that I can contact the staff at EDP on (02) 62051519 if I have any comments 
or questions regarding this research. I understand that should I have any concerns 
regarding the data use I may contact ACT Health Human Research Ethics Committee on 
02 6205 0846, acthealth-hrec.act.gov.au or at Building 10, Level 6 Canberra Hospital.   
Name: …………………………. 
Signature: ………………………….                                     Date: ………………….. 
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Eating Disorders Program 
Phillip Heath Centre, Cnr Keltie & Corinna Sts, WODEN, ACT 
2606 
Phone: 6205 1519 
 
 
 
Eating Disorders Program – Questionnaire  
 
Thank you for agreeing to participate in the research. Please complete this form 
and hand it back to the clinician.  
 
This form has been completed by: (please tick one of the following) 
          Client                  Mum                Dad                  Carer                   Sibling 
 
What would you consider to be the best part of the Day Program? 
 
 
What would you consider to be negative experiences associated with the Day 
Program? 
 
 
 
What were positives about engaging in Family Based Treatment? 
 
 
 
What were negatives about engaging in Family Based Treatment? 
 
 
 
How would you describe similarities and differences between the 2 treatments? 
 
 
 
What would advice would you give to other people in the same situation?  
 
 
 
